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Nutrient deprivation of eukaryotic cells elicits a rapid survival response, 
including the induction of autophagy. Autophagy, or “self-eating”, involves the 
formation  of autophagosomes  from  an  unknown  membrane  source  and  the 
sequestration  of  cytosolic  components,  including  organelles  such  as 
mitochondria, endoplasmic reticulum and small vesicles. Autophagosomes then 
fuse with protease-containing endosomes and their contents are degraded. This 
allows the cell to recycle amino acids and to reuse them for the synthesis of 
new proteins.
To study the formation and fusion of autophagosomes, I have developed 
in vivo and in vitro assays, based on primary rat hepatocytes cultures. For the in 
vitro assay, the aim of which is to identify proteins involved in fusion, I have 
designed  specific  markers  and  internalized  them  into  endosomes  and 
autophagosomes.  Both  vesicle  populations  have  been  purified  and  used  to 
reconstitute fusion in vitro.  For the in vivo experiments I expressed the GFP- 
tagged autophagosomal marker, LC3, in cultured primary rat hepatocytes.  By 
measuring the translocation of GFP-LC3 from a cytosolic pool to newly formed 
autophagosomes, using a high throughput-imaging system, and by assaying for 
the lipidation of GFP-LC3,  I was  able to quantify the rate  and magnitude of 
autophagosome formation and fusion.  Starvation led to an increase in the rate 
of autophagosome formation, and the total number of autophagosomes per cell 
increased more than two-fold.  Autophagosome formation was independent of 
mTOR,  a negative  regulator of autophagy in yeast  and many  cell  lines,  and 
could  be  strongly  inhibited  by  leucine,  a  regulatory  amino  acid.  I  then 
investigated  the  role  of  microtubules  in  the  formation  and  fusion  of
2autophagosomes, using the microtubule-depolymerising drugs nocodazole and 
vinblastine.  I  found  that  nocodazole  treatment  reduced  the  rate  of 
autophagosome formation and completely inhibited their mobility. In addition, 
both drugs inhibited fusion with endosomes, showing that an intact microtubule 
network  is  also  required  for  fusion.  Interestingly,  vinblastine  also  strongly 
stimulated autophagosome formation, even in nutrient-rich medium. This effect 
was independent of mTOR activity, but required the autophagy proteins Atg5 
and  Atg6,  suggesting  that  vinblastine  affects  a  novel  signalling  pathway 
upstream of autophagy proteins.
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16Chapter 1
1  INTRODUCTION
Eukaryotic  cells  have  two  major  protein  degradation  pathways:  the 
proteasome and autophagy. Autophagy, or self-digestion, is a lysosomal protein 
degradation pathway that was observed first using electron microscopy in the 
late  fifties  by  Clark  et  al.  (Clark,  1957)  in  kidneys  of newborn  mice.  It  is 
generally believed to be responsible for the degradation of long-lived cytosolic 
proteins  and  organelles,  while  the  proteasome  degrades  certain  short-lived 
proteins  (for review  see  (Yorimitsu  and  Klionsky,  2005)).  Several  different 
types  of  autophagy  have  been  described  in  mammalian  cells,  including 
microautophagy, chaperone-mediated autophagy and macroautophagy.
Macroautophagy, also referred to as just autophagy, has been regarded 
for a long time only as a cellular response to nutrient deprivation and a rescue 
mechanism for cells to survive periods where nutrients are limiting.  Over the 
last years,  however,  it has  become  increasingly  clear that  autophagy  is  also 
involved in processes such as tissue remodelling (Rusten et al., 2004), innate 
immunity  (Deretic,  2005),  neurological  diseases  characterised  by  protein 
aggregates and tumorigenesis (Ravikumar et al., 2004; Webb et al., 2003).  In 
addition,  autophagy  has  been  suggested  to  be  an  important  cellular  “house­
keeping” process,  being  responsible  for the  degradation  and  the  turnover  of 
mitochondria and long-lived proteins (Tolkovsky et al., 2002).
Although autophagy was observed for the first time nearly 50 years ago, 
not  much  is  known  about  the  molecular  mechanisms  involved.  However,  a 
major  step  forward  in  understanding  autophagy  has  been  made  with  the
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independent identification  of over fifteen mutants  defective  for autophagy in 
the yeast S. cerevisiae by three research groups (Harding et al.,  1995; Thumm 
et  al.,  1994;  Tsukada  and  Ohsumi,  1993).  The nomenclature  of the proteins 
identified  in  those  screens,  as  well  as  others,  has  recently  been  unified 
(Klionsky et al., 2003) and all proteins required for autophagy are now called 
Atg (Autophagy proteins,  see also Chapter  1.1). Most of the Atg proteins are 
required for the formation of autophagosomes, and not much is known about 
proteins which act at later stages during the maturation of an autophagosome. In 
recent years homologues  for most  of the  yeast  proteins  have  been  found  in 
higher eukaryotes.
In  mammalian  cells,  when  autophagy  is  induced,  a  phagophore  or 
isolation  membrane  (Fengsrud  et  al.,  2004)  forms  in  the  cytoplasm.  The 
isolation membrane is a flat double membrane structure that grows in size and 
bends into a cup-shaped structure, thereby sequestering cytosol and organelles, 
such as mitochondria, endoplasmic reticulum and small vesicles. The isolation 
membrane then seals at the  edge to  form an early,  immature autophagosome 
(AVi, immature autophagic vacuole, Figure 3.5).
The sequestration of cytoplasmic constituents is generally believed to be 
non-selective (Kopitz et al.,  1990), although autophagy has been implicated in 
the  specific  removal  of damaged  mitochondria  (Tolkovsky  et  al.,  2002).  By 
electron microscopy  (EM)  A  Vis appear as double membrane vesicles,  which 
vary between 0.2 to 2 pm in diameter depending on the cell type. The inside of 
an  AVi  always  looks  similar  to  the  surrounding  cytoplasm,  suggesting  no 
degradation  of  the  content  has  taken  place.  In  freeze-fracture  studies  the 
membrane  has  been  found  to  be  particularly  protein-poor  (Fengsrud  et  al.,
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2000).  AVis  then  fuse  with  endosomes  or  lysosomes  giving  rise  to  late, 
degradative autophagosomes (AVd).
AVds (Figure 3.5) are characterized by their electron dense content and 
normally  only  the  limiting  membrane  is  visible.  AVds  contain  lysosomal 
hydrolases and membrane proteins such as Lamp2  and have  an acidic lumen 
(Dunn, 1990a). In AVds the final degradation of the autophagocytosed material 
occurs. AVds can be further subdivided into amphisomes, which comprise an 
intermediate stage, and autolysosomes, the final vesicle in the pathway (Figure 
1.1).
In  the  following  sections  of the  Introduction  I  will  summarize  the 
current knowledge on autophagy. I will first describe the genes found in yeast, 
followed by a chapter about autophagosome formation, in which I will discuss 
the  source  of the  autophagosome  membrane  and the  machinery required  for 
formation,  as  well  as  what  is  known  about  signalling  pathways  involved  in 
autophagosome  formation.  Finally,  I  will  summarize  the  current  knowledge 
about autophagosome fusion. In this thesis I define autophagosome maturation 
as all processes which are necessary to induce autophagosome formation and 
the  subsequent  fusion  events  of a  completely  formed  autophagosome  with 
compartments of the endocytic pathway.
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Figure 1.1: Autophagic pathway in mammalian cells. Upon the induction of 
autophagy,  autophagosomes  form  from  an  unidentified membrane  source, 
termed the isolation membrane or phagophore.  During the formation autopha­
gosomes  sequester cytosol and organelles, such as mitochondria,  endoplasmic 
reticulum and vesicles. An AVi then fuses, at least once, possibly several times 
with different compartments of the endocytic system in order to deliver its con­
tents  to  a  lysosome  for  degradation.  The  final  compartment  is  called an 
autolysosome or AVdChapter 1
1.1  Molecular  components  involved  in  veast 
autophagy
Most proteins found in the initial yeast screens (Table 1.1) are involved 
in the early steps of autophagosome formation (see also Chapter  1.2). Besides 
the  non-selective  bulk  autophagy  pathway,  yeast  also  have  several  types  of 
selective autophagy, such as the cytoplasm to vacuole targeting (Cvt) pathway, 
which is active in nutrient rich conditions and is responsible  for the  specific 
delivery  of  aminopeptidase  I  to  the  vacuole,  or  pexophagy,  the  selective 
removal  of peroxisomes.  All  these  pathways  require  Atg  proteins,  some  of 
which  are  specific  for  selective  autophagy.  Those  proteins  will  not  be 
considered in this introduction. Most of the proteins described below localize, 
at  least  partially,  to  the  pre-autophagosomal  structure  (PAS)(Suzuki  et  al.,
2001).  The  PAS  is  thought  to  be  the  point  of  origin  of  newly  formed 
autophagosomes in yeast.
A central role in the induction of autophagy in yeast is played by Atgl, 
the  only  kinase  so  far  identified  amongst  the  autophagy  proteins.  Atgl  is 
thought to be downstream of the kinase target of rapamycin (TOR), which is 
generally believed to be the nutrient sensor. In nutrient rich conditions TOR is 
active and Atgl3, which is downstream of TOR, is hyperphosphorylated. When 
autophagy is induced by starving cells of nutrients TOR is inactivated. Atg 13 is 
partially dephosphorylated and consequently binds to Atgl together with Vac8, 
Atgl 1  and Atgl7 (Kabeya et al., 2005; Kamada et al., 2000; Scott et al., 2000).
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This activates Atgl  and is necessary for autophagy (Kamada et al., 2000). In 
yeast there are no known downstream partners of Atgl.
Another complex, thought to be involved in the signalling to autophagy 
is the Vps34 complex I. Vps34 is a phosphatidylinositol 3-kinase, which forms 
a complex with Atg6, also called Beclinl  in mammalian cells, and Atg 14 and 
Vpsl5 (Kihara et al., 2001). Atgl8, a PI3P binding protein is recruited to the 
PAS in a Vps34 complex I dependent manner (Guan et al., 2001).
Besides  the two  signalling  complexes mentioned above there  are two 
ubiquitin-like  conjugation  processes  which  play  a  role  in  autophagosome 
biogenesis. The Atg5-Atgl2-Atgl6 conjugate (Kuma et al., 2002) is thought to 
be involved in autophagosome  formation, but is not present on a completely 
closed  AVi.  The  Atg8-phophatidylethanolamine  conjugate  (Ichimura  et  al., 
2004;  Kirisako  et  al.,  2000)  binds  specifically  to  autophagosomes  and  stays 
bound after formation is completed. Both conjugation systems will be described 
in more detail later on.
Atg9 is the only membrane protein identified so far, which is necessary 
for  autophagy.  In  yeast  Atg9  binds  to  the  PAS,  as  well  as  to  mitochondria 
(Reggiori  et  al.,  2005b).  Atg9  has  been  shown  to  cycle  between  those  two 
structures  in an Atg2  and Atg 18  dependent manner  (Reggiori  et al.,  2004a), 
however, its function remains unknown.
In 2001, Suzuki et al. (Suzuki et al., 2001) grouped the Atg proteins into 
three classes according to when they act in the pathway (Table 1.2). They used 
GFP tagged Atg5  and Atg8 and investigated their localization to the punctate 
PAS in Atg mutants.  In mutants where autophagy is inhibited at a late stage, 
both proteins are recruited to the PAS, while in mutants where autophagy is
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inhibited at a very early stage, neither Atg5, nor Atg8 are recruited the PAS. In 
intermediate mutants, only Atg5 is localized to the PAS. Using this approach 
Suzuki et al. could classify the Atg proteins into three functional groups which 
act  at distinct  time  points  during  autophagosome  formation.  The  autophagy- 
specific PI3 kinase complex is required early on in autophagosome formation, 
before the PAS is formed. The two ubiquitin-like conjugation mechanisms are 
required  for  PAS  formation  and  the  Atgl  kinase  complex  is  required  for 
autophagosome formation. Knocking out any of those genes inhibits autophagy 
in yeast. See table 1.2 for classification.
Table  1.1:  Autophagy  proteins  in  yeast  and  mammalian  cells.  Table 
modified from (Klionsky et al., 2003).
Atg
Name
Previous
nomenclature
Mammalian
homologue
Function
Atgl Apgl,  Aut3, 
CvtlO
Ulkl Protein kinase
Atg2 Apg2, Aut8 Not yet identified Peripheral  membrane  protein,  interacts  with 
Atg9
Atg3 Apg3, Autl Atg3 E2-like  enzyme,  conjugates  Atg8  to 
phosphatidylethanolamine (PE)
Atg4 Apg4, Aut2 Atg4 Cysteine  protease,  cleaves  C-terminal 
extension or PE from Atg8
Atg5 Apg5 Atg5 Conjugated to Atg 12 through internal lysine
Atg6 Apg6 Beclin Component of the PI3-kinase complex
Atg7 Apg7, Cvt2 Atg7 El-like enzyme, activates Atg8 and Atg 12
Atg8 Apg8,  Aut7, 
Cvt5
MAP1-LC3 Specific  autophagosome  marker,  ubiquitin- 
like protein conjugated to PE
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Atg9 Apg9,  Aut9, 
Cvt7
Atg9 Integral membrane protein
Atg 10 ApglO Atg 10 E2-like enzyme, conjugates Atg 12 to Atg5
Atg 12 Apgl2 Atg 12 ubiquitin-like  protein  conjugated  to  PE, 
conjugated to Atg5
Atg 13 Apgl3 Not yet identified Modifier  of  Atgl  activity, 
hyperphosphorylated
Atg 14 Apgl4, Cvtl2 Not yet identified Component of PI3-kinase complex
Atg 16 Apgl6, Cvtl 1 Atg 16 Component of Atgl2-Atg5 complex
Atg 17 Apgl7 Not yet identified Modifier of Atgl activity
Atg 18 AutlO, Cvtl 8 Wipi49 Peripheral  membrane  protein,  required  for 
localization of Atg2
Table 1.2: Classification of Atg mutants into late acting mutants (Class A), 
intermediate acting mutants (Class B) and early acting mutants (Class C) 
(Suzuki et al., 2001), depending on GFP-Atg5 and GFP-Atg8 localizing to 
the PAS. See text for further details.
GFP-Atg5 
on PAS
GFP-Atg8 
on PAS
Mutants
Class A + + Atgl, Atg2, Atg 13, Atg 17
Class B + - Atg3, Atg4, Atg7, Atg 10, Atgl2
Class C - - Atg6, Atg9, Atg 14, Atg 16
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1.2 Autophaqosome Formation
1.2.1  Two  ubiauitin-Hke  protein  conjugation  processes  are 
required for autophaqosome formation.
1.2.1.1  Ata5-Ata12 conjugation and complex
In 1998, Mizushima et al. (Mizushima et al., 1998) showed in a genetic 
study  in  yeast  that  autophagic  sequestration  of  cytosol  requires  a  unique 
ubiquitin-like  protein  conjugation  system,  which  leads  to  the  covalent 
conjugation of Atg5  to Atg 12,  two proteins  essential  for autophagy  in yeast 
(Figure  1.2). When Atg5 was mutated at Lys 149, conjugation could not occur 
anymore  and  autophagy  was  blocked.  Furthermore,  the  conjugation between 
Atg5  and Atg 12  is  also  inhibited  in Atg7  and Atg 10  mutants,  showing  that 
these  proteins  act  as  enzymes  in  the  conjugation process  (Mizushima  et  al., 
1998).  Atg 12  is first activated by binding to Atg7,  which acts  as  an El-like 
protein. Atg 12 is then handed over to Atg 10, an E2-like enzyme, before being 
conjugated  with  Atg5.  In  yeast,  the  Atg5-Atgl2  complex  has  further  been 
shown to interact with Atg 16, a small coiled-coiled protein (Kuma et al., 2002). 
The Atg5-Atgl2-Atgl6 complex then forms homo-oligomers, which localize to 
the pre-autophagosomal structure in yeast.
In mouse embryonic stem cells the Atg5-Atgl2 conjugate  localizes to 
the  isolation  membrane  (Mizushima  et  al.,  2001).  Using  GFP  tagged  Atg5 
Mizushima et al.  could clearly show that the cup-shaped isolation membrane 
develops  from  a  smaller  crescent-shaped  membrane  structure.  Furthermore,
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they demonstrated that the covalent conjugation of Atg5 and Atg 12 is essential 
for the elongation of the isolation membrane.
In addition, Mizushima et al. (Mizushima et al., 2001) could also show 
that the Atg5-Atgl2 conjugate is required for the targeting of Atg8, the only 
specific autophagosome marker, to the autophagosome membrane.  The Atg5- 
Atgl2 conjugate is not present on sealed autophagosomes in yeast (Kim et al., 
2002; Suzuki et al., 2001) nor in mammalian cells (Mizushima et al., 2001).
1.2.1.2  Ata8/LC3 conjugation
As mentioned above, Atg8 is the only specific autophagosome marker 
which  binds  to  newly  formed  autophagosomes  and remains  bound  after the 
formation of an autophagosome. In yeast, Atg8 has been shown to be important 
for the regulation of the size of newly formed autophagosomes. Atg8 mutants 
were  still  able to  form  autophagosomes,  however,  the  autophagosomes  were 
smaller  than  in wild  type  controls  (Reggiori  et  al.,  2003).  Mammalian  cells 
contain several homologues of Atg8; LC3  (Kabeya et al., 2000),  GABARAP 
and GATE 16 (Tanida et al., 2003) all of which have been shown to bind to the 
membrane  of autophagosomes.  Of these  three proteins,  LC3,  which  initially 
was identified as microtubule associated protein  1   light chain 3  (MAP1-LC3) 
(Mann and Hammarback,  1994), is the most investigated. Full length LC3 gets 
cleaved at a highly conserved C-terminal glycine residue by the protease Atg4 
(Hemelaar et al., 2003) to give rise to the cytosolic form LC3-I. Upon induction 
of autophagy LC3-I is modified by a ubiquitin-like process, involving Atg7 and 
Atg3  as El-like and E2-like  enzymes,  and the attachment of a lipid residue,
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presumably  phosphatidylethanolamine  to  the  glycine  residue  (Tanida  et  al., 
2004b), in an Atg5-Atgl2 dependent manner (Mizushima et al., 2001).
The  resulting  form  LC3-II  binds  to  isolation  membranes  and 
autophagosomes  and can be used as a specific marker for autophagy (Figure 
3.9). In HeLa cells 59 % of AVis and 29 % of AVds labelled positive for LC3 
in quantitative immuno-electron microscopy (Eskelinen, 2005). The other Atg8 
homologues,  GABARAP  and GATE 16  are  less  well  characterized,  but have 
also been  shown to be processed by the  same machinery prior to binding to 
autophagosomes (Kabeya et al., 2004). In human cells there exist at least three 
distinct  LC3  genes  with  different  tissue  expression  patterns,  termed  LC3A, 
LC3B  and LC3C  (He  et  al.,  2003).  In this  thesis  I  used  rat  GFP-LC3  as  a 
marker for autophagosomes.
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Figure  1.2:  Two  ubiquitin-like pathways are essential for autophagosome 
formation. Atg 12 is covalently conjugated to Atg5 by Atg7 and Atg 10, which 
act as El  and E2 enzymes, respectively. The Atg5-Atgl2 conjugate can then 
form hetero-oligomers via Atg 16. Formation of this complex is necessary for 
the elongation of the isolation membrane and for targeting Atg8 to autophago­
somes. Full-length Atg8 is cleaved at the C-terminus by Atg4, which exposes a 
C-terminal glycine residue.  Atg8 is then covalently attached to PE and targeted 
to the autophagosomal membrane.Chapter 1
1.2.2  The source of the autophaqosomal membrane
The  source  of  the  isolation  membrane  is  still  unknown  and  under 
debate.  Basically,  there  are  two  different  models  to  explain  autophagosome 
formation (Figure 1.3).
The  first  model  hypothesises  that  the  isolation  membrane  originates 
from existing cellular membranes. Dunn (Dunn,  1990a), for example, showed 
in 1990 that antibodies raised against integral membrane proteins of the rough 
endoplasmic reticulum (RER) labelled almost all AVis and he suggested that 
autophagosomes  form  from  the  ribosome  free  region  of the  RER.  In  yeast, 
Hamasaki et al. (Hamasaki et al., 2003) found that the early secretory pathway 
between  the  endoplasmic  reticulum  and  the  Golgi  is  necessary  for 
autophagosome formation, suggesting that this pathway either might contribute 
membranes to autophagosomes or that it is necessary to maintain a functional 
ER. The model that ER derived membranes contribute to the autophagosome 
membrane is further supported by the similar membrane thickness of ER and 
autophagosomes (Dunn,  1994; Fengsrud et al., 2004). In addition, Reggiori et 
al. (Reggiori et al., 2004b) suggested that both, ER and Golgi membranes might 
contribute to autophagosome formation. The involvement of Golgi membranes, 
was further supported by acid phosphatase staining of phagophores (Frank and 
Christensen, 1968). Because Golgi also stains for acid phosphatase (Locke and 
Sykes,  1975)  it  was  suggest  that  the  isolation  membrane  might  come  from 
Golgi membranes. In addition, autophagosome membranes have been shown to 
contain complex Golgi-derived carbohydrates, suggesting they are derived from 
post-Golgi compartments (Yamamoto et al., 1990).
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The second model hypothesises that the isolation membrane is formed 
de novo through non-vesicular transport or local synthesis of lipids (Juhasz and 
Neufeld,  2006).  In  yeast  Noda  et  al.  (Noda  et  al.,  2002)  suggested  that 
autophagosomes form in three steps, nucleation, assembly and elongation.
In addition, it is feasible that multiple membrane pools play a role in 
autophagosome formation. It is currently unclear how the isolation membrane 
grows and bends.  In theory,  it is possible that it either grows by fusion with 
other  isolation  membranes  or  that  it  grows  because  of the  incorporation  of 
newly synthesized lipids.
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Figure 1.3: The source of the autophagosomal membrane. Two models have 
been suggested to explain the origin of the isolation membrane. In the first 
model existing cellular membranes are remodelled to contribute the isolation 
membrane (A) or membranes might originate from vesicles (B). In the the de 
novo model, membranes are assembled at the site of isolation membrane forma­
tion. The lipids might originate from non-vesicular transport  (C), or local syn­
thesis (D). Figure taken from Juhasz and Neufeld, 2006.Chapter 1
1.2.3  Induction of autophagy
The primary and conserved role of autophagy is the response to nutrient 
deprivation.  In  GFP-LC3-transgenic  mice,  autophagy  was  found  to  be  up- 
regulated in almost all tissues, following starvation (Mizushima et al., 2004), 
showing its importance during times where nutrients are limited. Kuma et al. 
(Kuma et al., 2004),  for example,  showed that mice, lacking Atg5  die within 
one day after birth.  Shortly after birth, when the nutrient supply through the 
placenta of the mother is cut off, mice undergo a period of starvation until the 
nutrient supply through the milk is restored. During these first hours, autophagy 
was up-regulated in control mice and only returned to basal levels after 1 -2  
days.  The  Atg5  knockout mice,  which  were  not  able  to  undergo  autophagy 
showed reduced amino acid concentrations in plasma and tissues and had signs 
of  energy  depletion,  underlining  the  importance  of  autophagy  for  survival 
during (neonatal) starvation.
Despite  extensive  research,  the  signalling  mechanisms  by  which 
nutrients control autophagy are still not very well understood. No “amino acid 
receptor” has been identified so far, and it was only within the last 5-10 years 
that several proteins and signalling pathways were identified as being involved 
in  autophagy.  How  they  interact  and  converge  to  induce  autophagy  is  still 
unclear.  In  the  following  sections,  I  will  summarize  the  current  knowledge 
about  how  cells  are believed  to  sense nutrients,  especially  amino  acids,  and 
what implications this has for the induction of autophagy.
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1.2.3.1  Amino acids and growth factors
One of the first reports in the literature, showing that autophagy is up- 
regulated  in  response  to  amino  acid  starvation  was  published  in  1976  by 
Mitchener et al.  (Mitchener et al.,  1976).  They were able to demonstrate that 
HeLa  cells  contained  an  increased  number  of  autophagosomes,  containing 
sequestered  organelles,  after the  removal  of serum  and  amino  acids.  Before 
that,  in  1972,  Woodside  and  Mortimore  (Woodside  and  Mortimore,  1972) 
showed that  amino  acids,  when  added to  the  perfusion buffer,  can  suppress 
protein degradation in perfused rat livers, as measured by the release of Re­
labelled valine. Leu, Phe, Tyr, Trp, His and Gin, were found to be especially 
effective at inhibiting autophagic protein degradation in rat hepatocytes (Poso 
et al., 1982), with leucine being the strongest inhibitor of all amino acids. These 
amino acids are therefore called regulatory amino acids. Since then amino acid 
withdrawal has been shown to  induce autophagy in a number of mammalian 
cell lines and tissues (Gordon et al.,  1989; Gutierrez et al., 2004b; Mordier et 
al., 2000; Tassa et al., 2003), as well as Drosophila (Rusten et al., 2004),  C. 
elegans (Melendez et al.,  2003), Dictyostelium  (Otto et al.,  2004)  and plants 
(Contento et al., 2005).
Besides amino acids, growth factors, such as insulin and glucagon, can 
also  regulate  autophagy.  Glucagon  for  example  increases  autophagy  in 
hepatocytes  and  mycardiocytes  (Kondomerkos  et  al.,  2005),  while  insulin 
inhibits autophagy via the PI3K-Akt-Tscl/2-Rheb pathway upstream of mTOR 
(Garami et al., 2003; Kanazawa et al., 2004; Pfeifer, 1978; Poli et al., 1981).
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1.2.3.2  Amino acid sensing upstream of mTOR
Amino acid signalling is thought to converge at the mammalian target 
of rapamycin (mTOR) kinase (see also Chapter 1.2.3.3, Figure 1.4)(Beugnet et 
al., 2003), although, no amino acid receptor has been identified so far.
mTOR receives its upstream input through tuberous sclerosis complex 1  
and  2  (TSC1/2).  TSC1  heterodimerized  with  TSC2,  has  GTPase  activity 
towards Rheb, a protein that was shown to bind to the mTOR catalytic domain. 
TSC1/2 stimulates the conversion of Rheb-GTP to Rheb-GDP, which in turn 
inactivates mTOR (Long et al., 2005). This pathway has clearly been shown to 
be involved in the regulation of insulin signalling (Garami et al., 2003), but its 
involvement in amino acid signalling is still unclear.
TSC1'a and TSC2'/_  rat embryonic fibroblasts were initially found to be 
resistant to amino  acid starvation in contrast to wt cells,  as measured by the 
T389-phosphorylation (see also Chapter  1.2.3.4) of the mTOR substrate p70S6 
kinase, implying that the TSC1/2  complex is involved in amino acid sensing 
upstream of mTOR (Gao et al., 2002).
This  model,  however,  has  recently  been  challenged  by  Smith  et  al. 
(Smith et al., 2005). In TSC2'7 ' mouse fibroblasts, amino acid withdrawal led to 
the dephosphorylation of the ribosomal protein S6, as well as p70S6 kinase and 
other downstream targets of mTOR, such as 4E-BP, clearly demonstrating that 
mTOR was inactivated, despite TSC2 being knocked out.
Downstream of the  TSC1/2  complex is the  GTPase  Rheb,  which has 
been  shown to bind mTOR in an amino  acid  sensitive manner  (Long  et al., 
2005).  Withdrawal  of  all  extracellular  amino  acids  or  just  leucine  alone
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reversibly  inhibited  the  binding  of  Rheb  to  mTOR.  Additionally,  over­
expression  of  Rheb  activated  mTOR  and  induced  p70S6  kinase 
phosphorylation (Long et al., 2005). Re-addition of amino acids to starved cells 
increased the amount of GTP-bound Rheb (Roccio et al., 2006), while amino 
acid  starvation  followed  by  insulin  stimulation  did  not  increase  the  GTP 
loading of Rheb. Taken together, these data clearly show the involvement of 
Rheb  in  the  amino-acid  dependent  control  of  mTOR.  The  molecular 
mechanisms by which  amino acids regulate Rheb binding are, however,  still 
unclear. Also, it has to be yet formally demonstrated that Rheb function plays a 
role in the regulation of autophagy.
Besides the TSCl/2-Rheb pathway, the class III PI 3-kinase Vps34, has 
recently also been implicated in the sensing of amino acids upstream of mTOR 
(Byfield  et  al.,  2005;  Nobukuni  et  al.,  2005).  Vps34  forms  a  complex with 
Beclinl, the mammalian homologue of yeast Atg6. Byfield et al. (Byfield et al., 
2005)  immunoprecipitated  over-expressed  Beclinl  from  MCF7  cells  and 
measured  the  associated  Vps34  activity.  Amino  acid  deprivation  led  to  a 
decrease in Beclinl  associated Vps34 activity, while the amount of Beclinl - 
associated Vps34 did not change. Additionally, over-expression of Vps34 led to 
an activation of p70S6 kinase, putting Vps34 upstream of mTOR. Furthermore, 
inhibition  of  Vps34,  by  siRNA  knockdown,  had  no  effect  on  the 
phosphorylation  of TSC2,  suggesting  that  Vps34  is  not  part  of the  TSC1/2 
pathway towards mTOR. How amino acids modulate this interaction is unclear.
An interesting interaction has also been found for Beclinl  and the anti- 
apoptotic  protein  Bcl-2.  Beclinl  was  found  to  bind  to  Bcl-2  in  a  nutrient- 
dependent manner (Pattingre et al., 2005). Starvation of HeLa cells led to strong
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reduction  in  the  amount of Bcl-2  that  could be  co-immunoprecipitated with 
Beclinl.  On the  other hand,  incubation of the  cells  in nutrient rich  medium 
increased  the  amount  of bound  Bcl-2.  Pattingre  et  al.  suggested  that  Bcl-2 
binding to Beclinl might help to regulate the level of autophagy to prevent cells 
crossing  an  arbitrary  threshold  where  autophagy  becomes  a  cell  death 
mechanism,  instead of a survival mechanism.  The relation between the three 
proteins, Vps34, Beclinl  and Bcl-2 with regards to their ability to regulate the 
level of autophagy remains to be investigated.
Other amino  acid regulated pathways,  besides mTOR have  also been 
implicated  in the  induction  of autophagy.  In  HT-29  cells  Ogier-Denis  et  al. 
suggested  that  amino  acids  act  by  inhibiting  ERK  dependent  GAIP 
phosphorylation (Ogier-Denis et al., 2000), while Talloczy et al.  (Talloczy et 
al., 2002) suggested that eIF2alpha kinase is involved in amino-acid starvation 
induced autophagy in murine embryonic fibroblasts.
Additionally,  there  is  evidence  that  at  least  leucine  might  act  via  a 
putative leucine plasma membrane receptor, and it has been suggested that this 
pathway is mTOR independent (Kanazawa et al.,  2004).  Although it is  clear 
that amino acids inhibit autophagy, the “amino acid receptor” is still unknown. 
It is possible and may even be likely that eukaryotic cells might have several 
amino  acid  sensing  pathways,  which  potentially  converge  to  regulate 
autophagy.  How  these  pathways  and proteins,  e.g.  Rheb,  the Vps34-Beclinl 
and Beclinl-Bcl-2 complexes,  and possibly others,  interact and how they are 
coordinated in order to regulate autophagy in response to nutrient-deprivation 
remains to be determined.
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Figure 1.4: Proposed amino acid and insulin signalling pathways regulat­
ing autophagy. See also text for further details. Amino acids (AA) are implicat­
ed in regulating several protein-protein interactions that are possibly involved in 
the induction of autophagy. Most affected pathways are potentially upstream of 
mTOR.  AA withdrawal was  shown to  affect the Bcl-2  -  Beclinl,  Vps34 - 
Beclinl  and Rheb - mTOR interactions, leading to the inactivation of mTOR 
and the induction of autophagy. The TSC1/2 complex has also been implicated 
in amino acid sensing, although this is controversial. In addition, the existence 
of a putative leucine receptor, which inhibits autophagy independent of mTOR, 
has been suggested. Rapamycin (Rap) specifically inhibits mTOR activity. PM, 
plama membrane. AA and insulin input into the system depicted in red colour.Chapter 1
1.2.3.3  mTOR
The  Target  of rapamycin  (TOR)  kinase  plays  a  central  role  in  the 
control  of cell growth.  It acts as nutrient  sensor and has been  implicated in 
processes such as cell growth, ribosome biogenesis, protein translation, nutrient 
uptake and also  autophagy (Sarbassov dos  et al., 2005).  In mammalian cells 
mTOR  exists  in  two  complexes,  TORC1  and  TORC2.  Only  one  of these 
complexes  can  be  specifically  inhibited  by  rapamycin,  a  peptide  that  was 
initially isolated from a soil bacterium on the Easter Islands. Rapamycin binds 
to the protein FKBP12, which then interacts with TOR and inhibits its activity. 
The  rapamycin  sensitive  mTOR  complex  TORC1  is  composed  of G(3L  and 
raptor  proteins,  while  the  rapamycin-insensitive  mTOR  complex  TORC2 
consists  of GpL  and  rictor  (Sarbassov  dos  et  al.,  2005).  Whereas  TORC2 
controls the actin cytoskeleton (Jacinto et al., 2004), TORC1  is thought to be 
the nutrient sensor and the mTOR complex involved in autophagy (Hara et al., 
2002; Tzatsos and Kandror, 2006).
In  1995  Blommaart  et  al.  (Blommaart  et  al.,  1995b)  found  that 
rapamycin treatment of hepatocytes partially induced autophagic sequestration 
of electro-injected  cytosolic  14C-sucrose  and  protein  degradation.  This  was 
accompanied by an inhibition of phosphorylation of the ribosomal protein S6, 
indicating the involvement of the p70S6 kinase pathway.
However, the first time, TOR was directly linked to autophagy was in a 
study conducted by Noda and Ohsumi (Noda and Ohsumi,  1998).  Rapamycin 
induced autophagy, even when the yeast were incubated in full growth medium. 
Furthermore,  rapamycin did not induce  autophagy in Atg4,  Atg5  and Atg 10
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mutants,  indicating that TOR acts upstream of the Atg proteins as a negative 
regulator of autophagy.
Since  then  several  studies  using  different  cell  types  (Amer  and 
Swanson, 2005; Blommaart et al.,  1995a; Ravikumar et al., 2004) have shown 
that  TOR  or  mammalian  TOR  (mTOR)  is  clearly  involved  as  a  negative 
regulator  in  the  control  of autophagy.  Scott  et  al.  (Scott  et  al.,  2004),  for 
instance, could show that the Drosophila fat body contains an increased number 
of autolysosomes in TOR null mutants as compared to wild type flies. In some 
recent  studies  including  my  own,  however,  certain  cell  types,  such  as 
hepatocytes  or  C2C12  myotubes,  showed  some  degree  of  rapamycin- 
insensitivity (Kanazawa et al., 2004; Kochi et al., 2006; Mordier et al., 2000).
1.2.3.4  Downstream of mTOR
Not much is known about downstream effectors of mTOR with regards 
to autophagy. In yeast, Atg 13  is dephosphorylated when TOR is inhibited by 
either rapamycin treatment or starvation.  This leads to the tighter binding of 
Atg 13 to Atgl, an association which is essential for autophagy, but not the Cvt 
pathway.  It  is  currently  unknown  how  TOR  inactivation  leads  to 
dephosphorylation Atgl3. A direct phosphorylation and/or the regulation of a 
phosphatase  by  mTOR  would  be  possible,  but  has  not  been  shown  yet.  In 
mammalian cells, no Atg 13 homologue has been found so far.
In mammalian  cells,  p70S6  kinase  is  a potential  autophagy  regulator 
downstream of mTOR. p70S6 kinase is specifically phosphorylated by mTOR 
on threonine-389 during nutrient rich conditions and its activity correlates with 
the suppression of autophagy (Blommaart et al.,  1995a;  Moller et al.,  2004).
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p70S6  kinase  phosphorylates  the  ribosomal  protein  S6,  which  leads  to 
increased levels of translation. During periods of starvation or after rapamycin 
treatment, mTOR is inactivated. This in turn leads to the inactivation of p70S6 
kinase and the dephosphorylation of S6, a process which has been linked with 
the induction of autophagy (Blommaart et al., 1995a).
Controversially,  in Drosophila Scott et al.  (Scott et al., 2004) showed 
that p70S6 kinase activity is required for starvation induced autophagy. Scott et 
al. argued that p70S6 kinase either might be involved directly in the induction 
of autophagy  or  indirectly  by  regulating  protein  synthesis,  which  would  be 
consistent with data that protein synthesis is required for autophagy (Abeliovich 
et al., 2000). Furthermore, the authors suggested that down-regulation of p70S6 
kinase might limit the extent of autophagy during extended starvation periods, 
possibly as a protective mechanism against the potentially damaging effects of 
autophagy.
The  reason  for  this  apparent  difference  remains  to  be  investigated. 
Besides cell type  specific  differences it is possible that some residual p70S6 
kinase  activity  remains  after  autophagy  is  induced  in  Blommaart’s  rat 
hepatocytes. Alternatively p70S6 kinase might have also other targets than just 
S6, which might be involved in the induction of autophagy.
Most interesting to me,  is the suggestion that the extent of autophagy 
might be regulated through p70S6 kinase. If this turns out to be true, this would 
be a another built-in safety net, similar to what Pattingre et al (Pattingre et al., 
2005)  suggested  for  the  Beclinl-Bcl2  interaction,  which  might  control  the 
balance between autophagy as a rescue or cell death mechanism. However, this 
remains to be investigated.
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1.3 Autophaqosome Fusion
In yeast, autophagosomes fuse directly with the vacuole to deliver the 
cytoplasmic material for degradation.  In mammalian cells, on the other hand, 
autophagosomes  fuse  with  compartments  of the  endocytic  system.  It  is  not 
clear, however, if there is a preferred endosomal compartment for fusion or if 
an  autophagosome  undergoes  multiple  fusion  events  with  different 
compartments  of the  endocytic  system.  Depending  on  the  cell  type  there  is 
evidence  supporting  both  a  fusion  event with  early  endosomes  (Berg  et al., 
1998) and late endosomes (Berg et al.,  1998; Punnonen et al.,  1993; Tooze et 
al.,  1990)  as  well  as  with  lysosomes  (Gordon  et  al.,  1992;  Lawrence  and 
Brown,  1992). Additionally, autophagosomes have been demonstrated to fuse 
with small endosome derived vesicles and it has been suggested that it is this 
way they first acquire enzymes and lysosomal membrane proteins necessary for 
the  acidification  and  degradation  of their  content  (Punnonen  et  al.,  1993). 
However, the precise identity of these vesicles is not known. Dunn et al. (Dunn, 
1990b)  developed  a  model  in  which  the  acidification  of an  autophagosome 
starts through the fusion with small vesicles and the delivery of proton pumps 
and  lysosomal  membrane  proteins,  but  not  lysosomal  enzymes.  Next, 
autophagosomes fuse with late endosomes or MVBs, hydrolases are delivered, 
and an amphisome is produced (Berg et al., 1998). This might then be followed 
up by  another  fusion  step with  lysosomes,  which produces  an  autolysosome 
(Berg et al., 1998). The pH of an autolysosome was estimated by Tanaka et al. 
to be approximately 5.5 (Tanaka et al., 2000)(see Figure 1.8 for a model of the 
different  fusion  events).  Besides  the  heterotypic  fusion  with  endosomal
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compartments also heterotypic fusion between AVis and AVds or amphisomes 
has been observed (Eskelinen, 2005).
This all indicates that the maturation of an AVi to an AVd is a highly 
regulated process. It is very likely that some or all of these processes require 
specific SNARE and Rab proteins to generate the necessary specificity for the 
following  fusion events.  In the  following chapters  I will  first give  a general 
overview  about  membrane  fusion,  followed  by  a  summary  of  the  current 
knowledge about the regulation of autophagosome fusion and the role of the 
cytoskeleton in fusion.
1.3.1  Regulation of membrane fusion bv SNARE and Rab proteins
One of the most important distinguishing feature of eukaryotic cells is 
their compartmentalisation into several different membrane-bound organelles. 
Secretion  of hormones,  the  uptake  of extra-cellular  substances,  as  well  as 
organelle-homeostasis is therefore absolutely dependent on vesicular trafficking 
events to deliver and retrieve proteins or membrane.  These trafficking events 
have to be tightly regulated to maintain the specificity of the membrane fusion 
events.  Generally  there  are  two  types  of fusion,  heterotypic  and  homotypic 
fusion. The latter is less frequent, and can be found, for instance, in immature 
secretory granule biogenesis (Tooze et al., 2001) or endocytosis (Antonin et al., 
2000).
Membrane  fusion  can  be  subdivided  into  three  different  phases: 
tethering, docking and fusion. During this process two specific membranes are 
successfully brought  closer and  closer together by tethering  factors  and Rab 
proteins  until  specific  N-ethylmalemide-sensitive  fusion  protein  (NSF)
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attachment receptor (SNARE) proteins on both membranes can form a complex 
and  catalyse  the  fusion  of two membrane bilayers  through  a conformational 
change (Figure 1.7A).
Mammalian cells have approximately 35 different SNARE proteins and 
60 different Rab proteins (Bock et al., 2001), which are all required for distinct 
transport  steps  within  the  cell  and  which  are  highly  conserved  between 
organisms.
1.3.1.1  SNARE proteins
SNAREs are small proteins of 100-300 amino acids, consisting of a C- 
terminal transmembrane domain,  a helical SNARE domain and a variable N- 
terminal domain (see Figure 1.5 for localization of SNAREs). Initially SNAREs 
were  divided  into  v-SNAREs  and t-SNAREs  based  on  their  localisation  on 
vesicles or target membranes (Sollner et al.,  1993). Because this nomenclature 
does  not  work  in  the  case  of homotypic  fusion  events,  SNAREs  have been 
reclassified  as  R-SNAREs  and  Q-SNAREs  according  to  a  highly  conserved 
residue in the SNARE domain (Fasshauer et al., 1997).
The neuronal SNARES Sytaxin-1  (Bennett et al.,  1992), SNAP-25 (25 
kDa synaptosome-associated protein)(Oyler et al.,  1989) and VAMP (vesicle- 
associated membrane protein)(Trimble et al.,  1988) where the first identified. 
They  are  archetypical  SNAREs  and  form  the  basis  for  the  subdivision  of 
SNARE into smaller groups:  R-SNAREs (VAMPs), Qa-SNAREs (syntaxins), 
Qb-SNAREs (SNAP N-terminal) and Qc-SNAREs (SNAP C-terminal) (Figure 
1.5).
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SNAREs  function  by  binding  to  cognate  SNAREs  on  the  opposing 
membrane. This involves the parallel pairing of 4 SNAREs via their SNARE 
domain  and  leads  to  the  formation  of an  extremely  stable  helical  SNARE 
complex (Sutton et al., 1998). The complex is resistant to SDS (Hayashi et al., 
1994) and is stable up to 90 °C (Fasshauer et al., 1997). It is generally believed 
that one SNARE of each of the four groups is required, resulting in a Qa-Qb- 
Qc-R  configuration  of the  SNARE  complex,  also  called  the  trans-SNARE 
complex.  .  Complex  formation  then results  in  a  conformational  change  that 
brings the membranes close together and overcomes the energy barrier to drive 
fusion of the lipid bilayers (Figure 1.7B).
After fusion is complete the trans-SNARE complex is disassembled via 
the AAA ATPase NSF (N-ethylmaleimide-sensitive factor) and its co-factor 01- 
SNAP in an ATP dependent manner, allowing the single SNAREs to participate 
in the next round of fusion (Sollner et al., 1993)(Figure 1.7B).
Although SNARE function is relatively well understood there are still a 
number of questions remaining. For example, it is not clear how many SNARE 
complexes are required for membrane fusion to occur and how these multiple 
SNAREs would be concentrated in one area to generate, for example a fusion 
ring.  It  has  also  been  suggested  that  SNARE  complexes  might  induce  a 
hemifusion intermediate state, which then requires the action of other proteins
7 4 - to complete the fusion,  such as Ca  dependent synaptotagmin proteins (Jahn 
and Sudhof, 1999).
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1.3.1.2  Rab proteins
Rab proteins are a large family of conserved small monomeric GTPases, 
playing a role in membrane trafficking events. In humans, more than 60 Rab 
proteins have been identified so far. Like the SNARE’s, they localize to distinct 
cellular  compartments,  where  they  regulate  the  vesicular  transport  between 
organelles and are involved in, for instance, the tethering of vesicles to their 
target  membrane  (Figure  1.6).  In  addition  Rabs  also  play  role  in  vesicle 
budding and transport along microtubules. (Zerial and McBride, 2001).
Rab proteins constantly cycle between a GTP-bound active and a GDP 
bound inactive conformation.  This is facilitated by guanine  exchange factors 
(GEFs)  and GTPase activating proteins (GAPs)  and is coupled to membrane 
association and dissociation (Pfeffer, 1994). Since Rab proteins do not have any 
transmembrane  domains,  binding  to  the  membrane  requires  geranyl- 
geranylation by a Rab geranyl-geranyl transferase, which is facilitated by the 
Rab escort protein (REP) (Seabra and Wasmeier, 2004). GEFs then target the 
Rab  protein to  the membrane  and activate it by exchanging the bound GDP 
with  GTP.  Active  Rab  proteins  exert their  function by  binding  to  effectors, 
which  then  connect  the  two  opposing  membranes.  After  fusion  and  GTP 
hydrolysis, GDP dissociation inhibitor (GDI) binds to the Rab and removes it 
from the membrane. GDI solubilises Rab-GDP in the cytosol by enveloping the 
geranyl-geranyl groups (Rak et al., 2003)(Figure 1.7A).
Two  Rab  proteins  which  are  particularly  well  studied  are  Rab5  and 
Ypt7p,  the  yeast  Rab7  homologue.  Rab5  regulates  the  homotypic  fusion  of 
early endosomes, as well as transport from the plasma membrane to the early
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endosome.  One  effector  of  Rab5  is  early  endosome  antigen  1   (EEA1) 
(Christoforidis  et  al.,  1999).  EEA1  is  a  coiled-coiled  protein  with  a  Rab5 
binding site on each end, suggesting that it can bridge two endosomes that have 
membrane  bound  Rab5,  thereby  acting  as  a  tethering  factor.  EEA1  itself 
interacts with Stxl3, which is involved in early endosome fusion (McBride et 
al., 1999). A similar symmetric binding of a Rab protein has been shown in the 
case  of Ypt7p.  Ypt7p  binds  to  the  HOPS  complex  (homotypic  fusion  and 
vacuole protein sorting) on two vacuoles, thereby acting as a tether in vacuole 
fusion (Wang et al., 2002).
Until now a long list of Rab effector proteins have been found, many of 
them involved in tethering and binding to SNAREs, showing the importance of 
Rab proteins in the early phases of fusion. It is likely that this complex network 
of proteins is responsibly for the high specificity and fidelity of fusion events 
within  the  cell.  It  also  implies,  however,  that  the  recruitment  of proteins, 
required  for  fusion  (and  vesicle  budding  for  that  matter),  must  be  tightly 
regulated in a time-wise manner to ensure the integrity of the organelle and the 
vesicle trafficking pathway.
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1.3.1.3  The endocvtic pathway
The  data  present  in  the  literature  about  autophagosome  fusion  (see 
Chapter 1.3 and Chapter 1.3.2) clearly show that autophagosomes interact with 
the endosomal system. It is therefore important to understand the function and 
composition of the different endosomal populations and how they interact with 
each other.
The  endocytic  pathway  can  be  roughly  divided  into  early  and  late 
endosomes with lysosomes as the terminal compartment of the pathway. Early 
endosomes receive material  either from the trans  Golgi network or from the 
plasma  membrane  through  receptor-mediated  or  fluid-phase  internalization. 
From early endosomes the cargo is either sorted back to the plasma membrane 
via recycling endosomes or transported further into the cell to lysosomes via 
late endosomes. Well known example of this these processes are the transferrin 
receptor,  which  is  recycled,  and  the  LDL  which  is  degraded  in
lysosomes.
Late endosomes receive material either from early endosomes or from 
the  Golgi  apparatus.  They often contain internal membrane  structures  and/or 
small  vesicles  and  are  referred  to  as  multi-vesicular bodies  (MVBs).  These 
structures are formed by the internalization of the endosomal membrane via the 
ESCRT  protein  complex  (reviewed  in  (Raiborg  et  al.,  2003)).  From  late 
endosomes cargo can then be delivered to lysosomes.
Lysosomes are characterized by an acidic pH of approximately 5.0, the 
presence of acid hydrolases,  and a number of highly glycosylated membrane 
proteins, such as LAMPs or LIMPs. They receive traffic from the endocytic and
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biosynthetic pathway and are responsible for degrading endocytosed material or 
material delivered from the cytoplasm through autophagy.
Several models exist which explain how material is transported through 
the endosomal system to lysosomes. The vesicle transport model hypothesizes 
that early and late endosomes are stable and distinct organelles. Transport to 
late endosomes in this case occurs through vesicular transport. Late endosomes 
are then assumed to mature into a lysosome (Mullins and Bonifacino, 2001). In 
the maturation model, early endosomes form from vesicles originating from the 
plasma  membrane.  Material  is  then  retrieved  and  delivered  to  the  early 
endosome  via  vesicular  transport.  During  that  process  the  early  endosomes 
matures to a late endosome and finally lysosome (Rink et al., 2005; Stoorvogel 
et al., 1991).
Besides those two models, also kiss and run events have been suggested 
to occur between late endosomes and lysosomes, where the two vesicles briefly 
touch  to  exchange  material  and  then  separate  again,  keeping  their  late 
endosome/lysosome identity (Bright et al., 2005). Finally, it has been suggested 
that late  endosomes might fuse directly with  lysosomes,  generating a hybrid 
organelle (Mullock et al., 1998).
Early  endosomes  and  late  endosomes  have  a  distinct  protein 
composition, generating specificity for fusion events.  Rab4, Rab5  and Rab 11 
are associated with early endosomes, while Rab7 and Rab9 can be found on late 
endosomal  structures.  The  same  spatial  separation  also  exists  for  SNARE 
proteins. Early endosomes contain VAMP3, 8 and Stxl3, late endosomes have 
VAMP7,  8 and vtilb (Chen and Scheller, 2001; Pryor PR, 2004).  Both, early 
and late endosomes are Stx7 and Stx8 positive(Chen and Scheller, 2001).
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Considering,  that  autophagosomes  fuse  with  compartments  of  the 
endocytic pathway, it is likely that they need the same fusion machinery that 
endosomes or endosomal derived vesicle use to fuse with each other. However, 
it  is  currently  unclear  which  particular  Rabs  or  SNAREs  are  required, 
especially for the early fusion steps, and how they would be targeted to AVis. 
The  timing  of this  process  is  another  unknown.  To  prevent  open,  unsealed 
isolation membranes from fusing with endosomes, the fusion machinery would 
have to be delivered only after the autophagosome has formed or alternatively 
the activity of the fusion machinery would have to be regulated. This would, 
however, require the existence of a checkpoint system which would monitor 
autophagosome formation and closure. So far, there is no data, supporting this 
idea,  possibly  with  the  exception  of  GATE-16  function  during  Golgi 
reassembly after mitosis (Muller et al., 2002). GATE-16, an LC3 homologue, 
binds the Golgi SNARE GOS28 and thereby prevents it from binding to Stx5. 
The authors suggest that GATE-16 must be displaced from GOS-28 for trans- 
SNARE complex formation to occur, which might require a Rab  GTPase  as 
with the displacement of Slylp from Stx5.
1.3.2  Regulation of autophagosome fusion through proteins
Little  is  currently known in mammalian cells  about the regulation of 
autophagosome fusion and the proteins involved in it.  In yeast, the Vam3p t- 
SNARE  is  required  for the  docking  and fusion of autophagosomes  with  the 
vacuole (Darsow et al.,  1997).  In addition,  Sec 18, the yeast NSF homologue, 
and the t-SNARE vtil  have also been shown to be involved in autophagy in 
yeast as well as in plants (Ishihara et al., 2001; Surpin et al., 2003)
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In CHO cells, Rab24 translocates from a peri-nuclear structure to newly 
formed LC3-positive autophagosomes when autophagy is induced by starvation 
(Munafo and Colombo,  2002).  Additionally Rab7,  a protein required for late 
endosome fusion(Bottger et al.,  1996), has also been implicated in autophagy 
(Gutierrez  et  al.,  2004b;  Jager  et  al.,  2004).  Rab  7  localizes  mainly  to  the 
membrane  of AVds,  but  can  also  be  found  in  lower  quantities  on AVis  as 
measured by IF and electron microscopy. SiRNA knockdown of Rab7 led to an 
increase in AVd numbers, suggesting that a late fusion step is inhibited and that 
AVds are accumulating under those conditions (Jager et al., 2004). This was 
further confirmed by labelling early endosomes or lysosomes with rhodamine- 
dextran.  When  a  dominant  negative  form  of  Rab7  was  over-expressed, 
rhodamine-dextran  in  early  endosomes  was  still  transported  into 
autophagosomes,  while  rhodamine-dextran  chased  into  lysosomes  never 
reached autophagosomes (Gutierrez et al.,  2004b).  These results  suggest that 
Rab7  is not required  for autophagosome  fusion with  early endosomes but  is 
necessary for the fusion with lysosomes or late endosomes(Eskelinen, 2005).
Besides  the  above  mentioned  Rab  proteins,  the  only  mammalian 
SNARE  protein  which  has  so  far  been  implicated  in  autophagosome 
maturation,  is  Vtilb,  the  mammalian  homolouge  of yeast  vtil  (see  above) 
(Atlashkin et al.,  2003).  Isolated hepatocytes  from vtilb'7 '  mice  accumulated 
multivesicular bodies (MVB) and AVds in their cytoplasm, suggesting that the 
fusion of AVds with lysosomes and the subsequent complete degradation of the 
autophagosome contents is impaired.
Both,  Vtilb  and  Rab7  are  involved  in  the  fusion  of  AVds  with 
lysosomes.  The  AAA  ATPase  (ATPase  associated with  a variety  of cellular
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activities) SKD1, the mammalian homologue of yeast vps4 on the other hand, 
was shown to be  involved in the fusion of autophagosomes with endosomes 
(Nara  et  al.,  2002).  SKD1  plays  a  role  in  endosomal  transport  and  MVB 
biogenesis (Lin et al., 2005).  Over-expression of a dominant-negative mutant, 
SKD1(E235Q) in HeLa cells, impaired autophagy-dependent long-lived protein 
degradation  and  led  to  the  accumulation  of mainly  AVis  after  starvation. 
Additionally,  the  transport  of  the  late-endosome  specific  lipid 
lysobisphosphatidic  acid to  the  autophagosomal  membrane  was  inhibited,  in 
HeLa  cells  over-expressing  dominant  negative  SKD1(E235Q)  (Nara  et  al., 
2002).
Finally,  mice  deficient  in  cathepsin  D  or  in  cathepsin  B  and  L 
accumulate autophagy-like structures (Koike et al., 2005), as well as the LC3-II 
form in their brain, showing that the lysosomal function is necessary to execute 
the last step of autophagy, the degradation of the autophagosome contents.
Together these data indicate that autophagosome  fusion is a step-wise 
process.  It is feasible that the sequential fusion is necessary for acquiring the 
necessary fusion machinery for subsequent fusion events and the maturation of 
an autophagosome (Eskelinen, 2005).
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1.3.3  The role of the cvtoskeleton in autophaaosome maturation
The role of the microtubule cytoskeleton in autophagosome fusion has 
been extensively investigated in the past. Most of those studies were based on 
the  use  of  nocodazole  and  vinblastine,  drugs  which  bind  to  tubulin  and 
depolymerise microtubules.
The first report,  that microtubules have been implicated in autophagy 
was in a study by Arstila et al. (Arstila et al.,  1974) published in 1974. In this 
study, vinblastine was injected intraperitoneally into rats and after 4 hours the 
liver was fixed. An accumulation of autophagosomes was observed by electron 
microscopy in the parenchymal cells of the liver and it was suggested by the 
authors that this increase might be related to the microtubule depolymerising 
action of vinblastine.
In  1977  Amenta et al.  (Amenta et al.,  1977)  showed that vinblastine 
treatment  of  rat  embryonic  fibroblasts,  incubated  in  serum  free  medium, 
inhibits the release of 14C-leucine in a protein degradation assay, showing that 
microtubules are necessary for autophagic protein degradation
Five years later, in 1982 Hirsimaki et al (Hirsimaki and Pilstrom,  1982) 
suggested  that  autophagosomes  accumulate  in  hepatocytes  after  vinblastine 
injection into mice because their turnover is retarded, but that vinblastine did 
not  prevent  the  fusion  of  lysosomes  with  autophagosomes  (Hirsimaki  and 
Reunanen,  1980).  In  the  same  year  Kovacs  et  al.  (Kovacs  et  al.,  1982) 
published an EM based  study in which they classified autophagosomes into 
three groups: type I autophagosomes, which are early autophagosomes, type II 
autophagosomes, which contain highly denatured material at various stages of
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degradation,  and  type  III  autophagosomes,  which  contain  electron  dense 
remnants of digested material. Vinblastine treatment of isolated rat hepatocytes 
led  to  an  accumulation  of  type  I  autophagosomes,  as  well  as  type  III 
autophagosomes.  In  addition,  vinblastine  treatment  also  inhibited  protein 
degradation, suggesting that vinblastine inhibits the fusion of autophagosomes 
with lysosomes.  This study was followed up by Hoyvik et al.  (Hoyvik et al., 
1986)  who  could  show  that  vinblastine  treatment  of  isolated  hepatocytes 
inhibited  the  degradation  of  14C-lactose  internalized  into  autophagosomes, 
strengthening  the  conclusion  that  vinblastine  inhibits  the  fusion  of 
autophagosomes.
Similar observations were made by Aplin et al. (Aplin et al.,  1992a) in 
nocodazole  treated  NRK  cells.  Starvation  of NRK  cells  in  the  presence  of 
nocodazole led to an increase in autophagosome numbers and at the same time 
a decrease in autophagic protein degradation. About 50 % of the accumulated 
autophagosomes  were  late  autophagosomes,  where  vesicle  acidification  had 
started,  however,  they  were  lacking  hydrolytic  enzymes,  suggesting  that 
microtubules  are  important  for  the  fusion  of  late  autophagosomes  with 
lysosomes. Nocodazole had no effect on autophagosome formation.
More recently two publications (Iwata et al., 2005; Webb et al., 2004) 
could show that microtubules are necessary for the autophagic degradation of 
Huntington aggregates.
The  data  presented  above  strongly  indicates  that  microtubules  are 
required for efficient autophagosome fusion as several groups could show an 
accumulation of early  autophagosomal  structures  and impaired trafficking  of 
autophagocytosed  material  to  lysosomes,  resulting  in  the  inhibition  of
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autophagic  protein  degradation.  However,  seemingly  in  contradiction  to  the 
data presented above, several studies have been published which showed that 
autophagosome  fusion was  independent  of microtubule  depolymerisation  by 
nocodazole or vinblastine. Vinblastine treatment of Ehrlich ascites tumour cells 
did  not  prevent  the  delivery  of  lysosomal  enzymes  into  autophagosomes 
(Punnonen and Reunanen,  1990),  suggesting that the  accumulation has been 
caused  by  the  retarded  maturation  of  late  autophagosomes.  Nocodazole 
treatment of Ehrlich ascites tumour cells, on the other hand, had no effect at all 
on autophagosome number in comparison to untreated cells (Reunanen et al., 
1988),  also  suggesting  that  microtubules  are  not  needed  for  autophagy.  In 
cultured rat fibroblasts, horse-radish peroxidase (HRP) and cationized ferritin, 
internalized  into  endosomes,  could  reach  autophagic  vacuoles  even  if 
microtubules were disrupted by vinblastine (Punnonen et al., 1993).
Despite  extensive  investigations  about  the  role  of  microtubules  in 
autophagosome fusion, the data is still highly controversial. Depending on the 
cell-type  and  experimental  approach,  microtubules  have  been  shown  to  be 
required  or  not  for  fusion.  One  possible  reason  for  that  might  be  that  the 
microtubule network was not fully depolymerised at the start of the experiment, 
as  in  most  studies  vinblastine  or  nocodazole  was  added  to  the  cells  at  the 
beginning of starvation. Depending on the concentration of the drugs and the 
sensitivity  of the  cells to the drugs,  the microtubule network would only be 
depolymerised after an initial lag period during which autophagy is unaffected.
Although  there  is  a  large  amount  of  data  about  microtubules  and 
autophagy in the literature, not much is know about other cytoskeleton types in 
autophagy.  In  yeast,  actin  has  recently  been  involved  in  selective  types  of
58Chapter 1
autophagy, such as the cytoplasm to vacuole (Cvt) pathway and pexophagy, the 
selective degradation of peroxisomes, but not in non-selective bulk autophagy 
(Reggiori et al., 2005a). In a conditional actin mutant preApel, the substrate of 
Cvt vesicles was not targeted to the pre-autophagosomal structure, leading to an 
early  block  of the  pathway.  Depolymerisation  of the  actin  cytoskeleton  in 
mammalian  NRK  cells  with  cytochalasin  B  and  D  impaired  also 
autophagosome formation (Aplin et al., 1992a). In Ehrlich Ascites tumour cells, 
on the other hand, actin depolymerisation with cytochalasin B had  no effect on 
vinblastine induced autophagy (Hirsimaki and Hirsimaki, 1984).
Hardly  anything  is  know  about  the  role  of the  cytoskeleton  during 
autophagosome formation. There is at least one report, showing that the actin 
cytoskeleton is important for formation, while microtubules were found to be 
not involved in formation (Aplin et al., 1992a).
1.4 Aim of the thesis
The aim of this thesis was to investigate the molecular requirements for 
autophagosome formation and fusion. Despite recent advances in the field there 
is  still  not  much  known  about  those  two  processes.  Neither  are  the  fusion 
partners  of an autophagosome  well  defined,  nor is  the  order in which  AVis 
interacts  with  the  endosomal  system,  or the molecular machinery  for  fusion 
very well understood. In addition the role of microtubules for autophagosome 
formation,  as  well  as  fusion,  is  unclear  and  controversial  and  most  of the 
findings presented above were published before the Atg genes were found. A 
more in depth analysis of the role of the cytoskeleton in formation and fusion,
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by utilizing the specific autophagosome marker LC3 as well as specific siRNA 
depletion  of Atg  proteins,  was  missing  at  the  beginning  of  this  thesis.  I 
therefore decided to study autophagosome maturation by using a variety of in 
vivo and in vitro approaches.
Since  most  tissue  culture  cell  lines  have  only  a  limited  capacity  to 
undergo autophagy, I opted to develop a system based on cultured primary rat 
hepatocytes and adenoviral transduction methods.  Rat hepatocytes have been 
widely used for morphological studies in the autophagy field and were therefore 
an ideal system for my studies.
Once  the  rat hepatocyte  system was  established,  I  developed  a  light 
microscopy  based  technique  to  investigate  autophagosome  formation  and 
fusion independently in vivo. Using this assay I investigated the role of mTOR 
and  microtubules  in  autophagosome  formation,  as  well  as  the  role  of 
microtubules in fusion of autophagosomes.
In parallel I started to develop an in vitro autophagosome fusion assay 
to identify the different fusion partners of autophagosomes and the Rab- and 
SNARE-proteins required for fusion.
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2  MATERIALS AND METHODS
2.1  Reagents
2.1.1  Chemicals and enzymes
Reagents were obtained from Amersham, BDH, BioRad, Calbiochem, 
Cell  Signalling  Technologies,  Clontech,  Fisher  Scientific,  Gibco,  Invitrogen, 
Merck,  Molecular  Probes,  New  England  Biolabs,  Qiagen,  Sigma  Aldrich, 
Stratagene and TAAB. Taq polymerase, distilled H2O , PBS, LB medium, SOC 
medium, sterile glycerol, Earle’s Saline, Dulbecco’s Modified Eagle’s Medium 
(DMEM),  F12 medium,  DMEM:F12 minus valine, DMEM minus antibiotics 
and glutamine were provided by Cancer Research UK Central Services.
2.1.2  Antibodies
All  HRP-conjugated  secondary  antibodies  were  from  Amersham 
Pharmacia,  and all  fluorescently-conjugated  antibodies  were  from  Molecular 
Probes. The following primary antibodies were used:
Table 2.1: Primary antibodies
Antigen Antibody Source Dilution  and
name application
Atg5 a-Atg5 Eeva Lisa Eskelinen 1:500 WB
Atg6 a-Atg6 BD Transduction Laboratories 1:500 WB
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GFP SG5 Tim Hunt, Cancer Research UK 1:2000 WB 
1:50 EM
HA 12CA5 Cancer  Research  UK 
Monoclonal Services
1:2000 WB
LC3 STO 227 This study 1:750 WB
LC3 a-LC3 Tomatsu  Yoshimori,  National 
Institute of Genetics
1:1000 WB 
1:20'EM
p70S6Kinase a -  p70S6K Cell Signalling Technology 1:1000
p70S6Kinase
Thr389
a-phospho-
p70S6K
Cell Signalling Technology 1:1000
Tubulin a-tubulin Sigma Aldrich 1:200 IF
EEA1 a-EEAl BD Transduction Labs 1:2500 WB
MP6R ST052 Sharon Tooze,  Cancer Research 
UK
1:500 WB
Rab7 a-Rab7 Angela  Wandinger-Ness,  Uni­
versity of New Mexico
1:2000 WB
Lamp2 a-Lamp2 Zymed 1:1000 WB
62Chapter 2
2.1.3  Constructs and Viruses
Following constructs and viruses were used in this thesis: 
Table 2.2: Constructs and viruses used in this study
Construct Source
GFP-LC3 Tamotsu Yoshimori  National Institute of 
Genetics
Streptavidin (SV) Peter Stanton, University of Washington
GFP Adenovirus Philippe  Halban,  University  Hospital 
Geneva
GFP-LC3 Adenovirus This study
SV-HA-LC3 Adenovirus This study, Viraquest
2.1.4  Oligonucleotides
Oligonucleotides  were  obtained  from  the  Cancer  Research  UK 
Oligonucleotide Synthesis Service or Sigma. The following primers were used.
Table 2.3: Primers for cloning of the GFP-LC3 adenoviral construct:
Primer Sequence
GFP-LC3-F 5 ’-CACCATGGTGAGCAAGGGCGAGGAGCTGTTC-3 ’
GFP-LC3-R 5 ’ -T  C  AC  AAGC  AT  GGCT  CT  CTTCCT  GTT  G-3 ’
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Table 2.4: Primers for cloning of the SV-HA-LC3 adenoviral construct
Primer Sequence
HA-F 5 ’ -T  CG  AG  AT  GGC  AT  ACCC  AT  ACG  ACGTCCC  AG  A 
CTACGCTAA-3’
HA-R 5 ’ -  AGCTT  AGCGT  AGT  CTGGG  ACGT  CGT  AT  GGGT 
ATGCCATC-3’
LC3-F 5 ’-CTCAGAACTAGTTCCGTCCGAGAAGACCTTC-3 ’
LC3-R 5’-GTCGGCGCGGCGGCCGCCAAGCATGGCTCT 
CTTCCTGTTGC-3 ’
NSV-stop-F 5’-GTCTGCTGCTTCTATCGCGGGATCCACTAGTTCC-
3’
NSV-stop-R 5’-CTGCTGCTTCTATCGCGGGATCCACTAGTTC
CGTCC-3’
2.1.5  Peptides
Peptides were obtained from Cancer Research UK’s Peptide Synthesis 
Laboratory.
Peptide:
LC3
HA
Sequence:
PSEKTFKQRRSFEQRC
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2.1.6  Bacterial strains
E. coli strain: Application:
DH5a cloning
XL 1-blue cloning
Topi pENTR cloning
XL 10-Gold Mutagenesis
2.1.7  Animais
Male Wistar rats were obtained from Charles River (UK) at a weight of 
approximately 250 g.
2.2  Methods
2.2.1  DNA techniques
2.2.1.1  Preparation of plasmid  DNA
Plasmid purifications on a small or large scale were performed with the 
Qiagen Mini Prep or endotoxin-free Maxi Prep kit, respectively. Bacteria were 
grown in 5 ml or 200 ml cultures containing the appropriate selection drug for 
minipreps or maxipreps, respectively. Plasmid concentrations were determined 
as described in Chapter 2.2.1.2. In the case of cloning experiments, the plasmid 
insert  was  sequenced  using  insert  or plasmid  specific  primers  (see  Chapter
2.2.1.5).
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2.2.1.2  Quantification of DNA
DNA  concentrations  were  quantified  in  a  spectrophotometer  at  a 
wavelength of 260 nm after dilution in H2O . An OD260 of 1   corresponds to 50 
pg DNA/ml double stranded DNA. To assess the purity the absorbance ratio 
OD260/280 was recorded additionally. It was usually between 1.6 and 1.8.
2.2.1.3  Polymerase Chain Reaction (PCR)
PCR reactions were  carried out in  100  pi reactions  containing  50 ng 
template DNA, 250 pM dNTPs (Pharmacia), 2 pM forward and reverse primer, 
and 2.5 units Taq polymerase.
1  cycle Denaturing 94 °C for 3 min
35 cycles Denaturing 94 °C for 1  min
Annealing 55 °C for 30 s
Extension 72 °C for 1  min/kb
1  cycle Extension 72 °C for 5 min
2.2.1.4  Restriction digestion
Restriction digests were carried out in 20 pi reactions containing  1   pg 
DNA,  5  units  restriction  enzyme  (New  England  Biolabs)  and  2  pi  lOx 
restriction buffer supplied with the enzyme. Samples were incubated at 37 °C 
for  1   -  4 hours before the reaction was stopped by adding 5x sample buffer 
(Bromphenol blue in 50% glycerine, ImM EDTA pH 8.0).
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2.2.1.5  DNA sequencing
Fluorescent  cycle  sequencing  was  performed  with  the  ABI  dye 
terminator kit (Perkin Elmer).  3.2 pmol gene  or vector specific primer were 
mixed with 500 ng double stranded DNA, 8 pi ABI reaction mix and H2O  to a 
final volume of 20 pi. Cycle sequencing conditions were as follows:
25 cyles  Denaturing  96 °C for 10 s 
Annealing  50 °C for 5 s
Extension  60 °C for 4 min
To remove primers  and dye terminators,  samples were purified using 
the DyeEx 2.0 kit (Qiagen).  SDS-Page gel electrophoreses was performed by 
Cancer  Research  UK  Sequencing  Service.  Sequences  were  aligned  with 
Sequence Navigator (ABI) or by performing a translated BLAST search on the 
NCBI web site.
2.2.1.6  DNA aaarose gel electrophoresis
Depending  on the  size  of the  DNA,  0.8  -   2%  (w/v)  agarose  was
dissolved in TAE  buffer  (Tris-HCl  pH 8.0, 20 mM acetic acid,  1  mM EDTA).
Ethidium bromide was added to a final concentration of 0.5  pg/ml.  Samples 
were mixed with 5x sample buffer (Bromphenol blue in 50% glycerine,  ImM 
EDTA pH 8.0) and separated in TAE at 100 Volts constant.
2.2.1.7  Gel purification of DNA fragments
The desired DNA  fragment was  cut out from an agarose gel  and the 
DNA  was  isolated  and  purified  from  the  gel  slice  with  the  QIAquick  gel 
extraction kit (Qiagen).
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2.2.1.8  Ligation
Gel purified DNA fragments and vectors were mixed at a molar ratio of 
approximately  5:1  and  ligated  with  400  Units  of T4  ligase  (New  England 
Biolabs) in 20 pi reactions for either 1  hour at room temperature or over night 
at 16 °C. 5 pi of the ligation was then transformed into E. coli (see also Chapter 
2.2.1.9).
2.2.1.9  Bacterial transformation
A  50  pi  aliquot  of competent  XL 1-Blue  cells  was  mixed  with  5  pi 
ligated DNA or  100 ng plasmid and incubated on ice for 30 minutes before 
being heat shocked at 42 °C for 45 seconds. 900 pi ice cold SOC medium was 
added and the reaction was incubated at 37 °C for a further 30 minutes. When 
ligations  were  transformed,  bacteria  were  spun  down  at  6000  rpm  for  10 
minutes in a micro centrifuge. The bacterial pellet was resuspended in  100 pi 
LB medium and plated out on agar plates containing kanamycin or ampilicin. In 
the case of vector transformations 50 pi of the reaction were plated out without 
prior spinning.
2.2.1.10  Bacterial crvo-preservation
Bacterial cultures were stored as 30 % glycerol stocks at -80 °C.
2.2.1.11  Mutagenesis
Site-directed mutagenesis was carried out with the QuikChange XL kit 
(Stratagene) according to manufacturers instructions. Primers were designed so
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that they had a minimum GC content of 40 %, terminated in either a G or C 
base and had a melting temperature of at least 78 °C.
1  cycle Denaturing 95 °C for 1  min
18 cycles Denaturing 95 °C for 50 s
Annealing 60 °C for 50 s
Extension 68 °C for 1  min/kb plasmid
1  cycle Extension 68 °C for 7 min
Parental DNA was then digested with 10 units Dpnl at 37 °C for 1  hour 
and DpnI-treated DNA was transformed into XL 10-Gold Ultracompetent Cells 
(Stratagene) according to manufacturers instructions.
2.2.2  Tissue culture techniques
2.2.2.1  Maintenance of mammalian cells
HEK293A  cells  (Invitrogen)  were  maintained  in  growth  medium 
(DMEM supplemented with  10 %  foetal calf serum and 4.8  mM glutamine). 
Twice a week cells were split 1:10. For this, HEK293A cells were washed once 
with PBS (137 mM NaCl, 3.35 mM KC1, 10 mM Na2HP04, 1.84 mM KH2P04, 
pH 7.2) and then incubated in trypsine/versene (0.05 % trypsin (w/v), 0.02 % 
EDTA (w/v), 1  % phenol red in PBS) until cells came off the plastic. HEK293 
cells were then either split into a new flask or seeded into dishes or plates at the 
desired concentration.
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2.22.2  Transient Transfection
Transient  transfections  in  HEK293A  cells  were  carried  out  with 
Lipofectamine  2000  (Invitrogen)  according  to  manufactures  instruction. 
Growth medium was changed to growth medium without antibiotics one day 
before transfection.  Cells were then incubated in Optimem in the presence of 
the  reaction  mix,  containing  plasmid  DNA  and  Lipofectamine  2000.  The 
reaction mix was prepared in polypropylene tubes.  After 6  hours  cells were 
washed with  PBS  and normal  growth medium  (DMEM  with  10%  fetal  calf 
serum) was added back.
2.2.2.3  Storage and recovery of mammalian cells
For storage in liquid nitrogen HEK293A cells were trypsinised and spun 
at 1000 rpm for 5 minutes in swing bucket centrifuge (Heraeus). The cell pellet 
of one confluent T75 flask was resuspended in 3 ml growth medium, containing 
20 % foetal calf serum and 10 % sterile DMSO. Cells were frozen at -80 °C in 
1   ml  aliquots  in  a  Cryo  1   °C  Freezing  Container  (Nalgene)  filled  with 
isopropanol  to  allow  slow  freezing  (l°C/min).  After  a  week,  cells  were 
transferred to liquid nitrogen for long term storage.
To recover cells, aliquots were rapidly thawed at 37 °C in a waterbath 
and added to one T75 flask, containing 25 ml of growth medium. The medium 
was replaced the following day, after the cells had attached to the plastic.
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2.2.3  Protein techniques
2.2.3.1  Protein quantification
Protein  concentrations  of samples  were  measured  using  the  BioRad 
protein assay reagent.  IgG standards and samples were diluted in 800 pi H2O  
and incubated with 200 pi protein assay reagent for at least  15 minutes.  The 
absorbance  at  OD595  was  measured  and  compared  to  the  standard  curve  to 
calculate protein concentrations.
2.2.3.2  Preparation  of  cell  lysates  and  SDS-polvacrvlamide  ael 
electrophoresis
Hepatocytes or HEK293 cells were washed once with ice cold PBS, and 
then scraped off in PBS. Cells were spun down for 5 min at 1000 g, and lysed 
in TNTE  (20 mM Tris pH  7.5,  150  mM NaCl,  0.3  %  Triton X-100,  5  mM 
EDTA)  plus protease  inhibitors  (250  pM  PMSF,  50  pg/ml  chymostatin,  0.5 
pg/ml  leupeptin,  50  pg/ml  antipain,  0.5  pg/ml  pepstatin  A,  0.1  mg/ml 
pefabloc).  Nuclei  and  insoluble  debris  was  removed  from  TNTE  lysates  by 
spinning  in  a  microcentrifuge  (10  min,  13000  rpm,  4  °C).  Protein 
concentrations were determined (see Chapter 2.2.3.1) and samples were mixed 
with 5x sample buffer (312.5 mM Tris-HCl pH 6.8,  16 %  p-mercaptoethanol 
(v/v), 15 % SDS (w/v), 50 % glycerol (w/v), 0.015 % bromophenol blue (w/v)).
Before loading samples were boiled for 3  minutes.  Equal amounts of 
protein were loaded per lane, and separated on either 12 % SDS-PAGE gels or 
10 % SDS-PAGE gels using 90 V constant for 12 minutes, then 120 V until the 
dye front reached the bottom of the gel. See below for composition of gels. Gel
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systems used were either  1.5  mm thick Bio-Rad mini  gels (Mini-Proteian II 
electrophoresis cell) or Cambridge electrophoresis midi gels
Table 2.5:  Running gel composition. 4x Lower buffer (6 mM Tris-HCl pH 
8.8,1.6 % SDS). The volumes are sufficient for one mini gel
10 % Gel 12 % Gel
4x Lower buffer 2.25 ml 2.25 ml
30 % Acrylamide 
0.8 % Bis
2.993 ml 3.6 ml
h 2o 3.708 ml 3.1 ml
Temed 4.5 pi 4.5 pi
10 % APS 45 pi 45 pi
Table 2.6:  Composition of stacking gel. 4x Upper buffer (2 M Tris-HCl pH 
6.8, 1.6 % SDS) The volumes are sufficient for one mini gel
4.5 % Gel
4x Upper buffer 1  ml
30 % Acrylamide 
0.8 % Bis
0.6 ml
h 2o 2.356 ml
Temed 4 pi
10 % APS 40 pi
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2.2.3.3  Western blotting
After SDS polyacrylamide gel electrophoresis, proteins were transferred 
to nitrocellulose membranes  (Schleicher &  Schuell) using the  Genie blotting 
system  (Idea  Scientific  Company).  Gels  and nitrocellulose  membranes  were 
embedded in a sandwich of 2 sheets 3MM Whatman paper and several pads on 
each side. Proteins were blotted at 4°C for 50 minutes at 25 volts constant in 
blotting buffer (20 mM Tris-OH,  150 mM glycine, 20 % methanol). Transfer 
and equal protein loading was tested with Ponceau S  (Sigma)  staining.  Blots 
were  blocked  by  incubating  the  membrane  in  blocking  buffer  (PBS,  5  % 
skimmed milk powder, 0.02 % Triton X-100) for 1  hour at room temperature or 
over night at 4 °C. Membranes were then incubated with the primary antibody 
in blocking buffer for at least 1  hour at room temperature, after which they were 
washed  3x  in  blocking  buffer  and  incubated  with  the  secondary  HRP- 
conjugated  antibody  (Amersham)  diluted  1:2000  in  blocking  buffer. 
Membranes were then washed 3x  10 minutes in PBS plus 0.02 % Tween-20 
and incubated in enhanced chemiluminescence substrate (ECL, Amersham)
2.2.3.4  Immunoprecipitation (IP)
IPs were usually carried out in either TNTE or IP-buffer (50 mM Tris- 
HC1 pH 7.4, 300 mM NaCl, 5 mM EDTA,  1   % Triton X-100). Lysates were 
first incubated with 5 pg antibody for at least 1  hour at 4 °C on an end over end 
rotator, before the addition of either 30 pi of a 50 % protein A or protein G- 
sepharose slurry for an hour. Sepharose beads were washed 3x with PBS before 
use. In the case of the in vitro fusion assay, based on the internalization of HA 
antibodies  into  endosomes  (see  Chapter  2.2.8.6),  protein  G-sepharose  beads
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were added directly, and samples were incubated for 1  hour at 4 °C on an end 
over end rotator. Beads were then washed 4x in PBS and either used for HRP 
enzyme assays (see Chapter 2.2.8.2) or for western blotting. In the case of the 
latter, the 4th wash was removed completely and the beads were boiled for 3 
minutes with 30 pi 5x sample buffer in order to elute the bound antigen from 
the beads and to denature the proteins. To separate the beads from sample, the 
bottom of the Eppendorf tubes was pierced using a 25  gauge needle, and the 
tube placed into another empty Eppendorf. The eluent was spun through into 
the empty Eppendorf and either frozen at -20 °C or subjected immediately to 
SDS-PAGE and western blotting analysis.
2.2.4  Microscopy
2.2.4.1  Immunocvtochemistrv and confocal imaging of fixed sam ples
Hepatocytes  were  washed  once  in  PBS  and  fixed  in  3  % 
paraformaldehyde  in  PBS  for  20  minutes  at  room  temperature.  Cells  were 
rinsed 3 times with PBS and then incubated in 50 mM NH4CI in PBS for  10 
minutes before permeabilization with 0.1% Triton X-100 in PBS for 3 minutes. 
After that, cells were washed in PBS and incubated for 20 minutes in blocking 
buffer  (10%  goat  serum,  2%  BSA,  0.02%  Tween  20  in  PBS),  followed by 
incubation for 20 minutes in blocking buffer with the primary antibody. Cells 
were then washed 3  times with blocking buffer, incubated for 20 minutes  in 
blocking buffer with the secondary antibody, washed 3 times with PBS, once 
with  water  and mounted  on  glass  slides  with  Moviol.  Secondary  antibodies 
used were either Alexa488 or Alexa555 conjugated. Cells were imaged using a 
Zeiss  LSM  510  confocal  microscope  equipped  with  a  Zeiss  63x,  1.4NAChapter 2
Differential  Interference Contrast (DIC)  Plan-Apochromat  or Phase  Contrast 
oil-immersion  objective  and controlled by Zeiss  LSM  510  software.  Images 
were collected using the 493 nm line of an argon laser and the 543 nm and 633 
nm lines of a helium-neon laser with 4x or 8x averaging.
2.2.4.2  Confocal time lapse microscopy
Movies  showing  formation  and  movement  of  GFP-LC3-positive 
vesicles  in  living  hepatocytes  were  recorded  using  an  Olympus  1X70  laser 
scanning confocal microscope equipped with an ultraview real time  spinning 
disc (Wallac),  an Olympus 60X,  1.2W UPlan Fluor oil immersion objective. 
Hepatocytes were  either pre-incubated with 50  pM nocoazole  in full  growth 
medium  or left untreated,  washed 4x with Earle’s  Saline,  containing 20 mM 
HEPES,  with  or without nocodazole  and  then placed  into  an  environmental 
chamber  immediately.  Images  were  captured  every  10  or  every  23  seconds 
using  Ultraview  Imaging  Suite  Version  5.5  software  (Perkin  Elmer)  and 
processed  with  either  Metamorph  6.2  (Molecular  Devices)  or  Volocity  3.0 
(Improvision) software. Movies were generated by exporting processed images 
to AVI movies using Microsoft Video 1  compression at a 100 % quality setting.
2.2.4.3  High throughout microscopy
Low  magnification  images  of  saponin-extracted  hepatocytes  (see 
Chapter  2.2.7.1)  on  coverslips  were  acquired  with  an  automated  high 
throughput Discovery-1   microscope  equipped with  a 20X,  0.75  NA,  S-Fluor 
objective using the DAPI and GFP filter set (Chroma).  16 or 9 images (4 x 4 or 
3x3)  per  coverslip  were  captured  automatically  using  Metamorph  6.2
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software.  (Molecular  Devices).  The  microscope  was  set  up  to  focus 
automatically  using  the  built-in  image-based  focusing  algorithm  with  the 
following  settings:  Find 200  nm,  Wide  200  nm, Narrow  8  nm.  Laser-based 
focussing was not used.
2.2.4.4  Transmission electron microscopy (TEM)
Hepatocytes were seeded in 6 cm dishes at a density of 1.25 x 106 cells, 
and either mock-infected or infected with an adenovirus encoding GFP or GFP- 
LC3.  After  18-24  h  in  culture,  cells  were  fixed  for  1   hour  in  2.5% 
glutaraldehyde in 0.1  M Sorensen’s buffer, pH 7.4, washed 3x in Sorensen’s 
buffer  and  scraped  off the  culture  dish  in  1%  gelatin.  After  the  cells  were 
pelleted,  and post fixed with  1% OSO4 for 30 min, they were dehydrated by 
incubating  the  pellet  in  increasing  concentrations  of ethanol,  from  70%  to 
100%, then incubated over night in 50:50 epon:ethanol and finally embedded in 
Agar 100 resin. Sections were contrasted with 2% uranyl acetate and lead citrate 
and  examined  with  a  JEOL  1200  electron  microscope.  EM  images  were 
acquired with a GATAN Multiscan 600CW camera. EM was performed by Dr. 
Xiao-Wen Hu (Cancer Research UK)
2.2.4.5  Immuno electron microscopy
Uninfected  and  GFP-LC3  infected  hepatocytes  were  fixed  with  4% 
paraformaldehyde, 0.2% glutaraldehyde in 0.1  M Sorensen’s buffer for  1   h at 
room temperature and processed as described (Tokuyasu, 1973). Sections were 
immuno-labelled  with  rabbit  anti-GFP  antibody  (1:500)  or  rabbit  anti-LC3 
antibody  (1:60),  followed by protein A,  conjugated to  10 nm gold particles.
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Immuno-electron  microscopy  was  performed  by  Dr.  Xiao-Wen  Hu  (Cancer 
Research UK).
2.2.5  Adenovirus techniques
2.2.5.1  Construction of adenoviruses
GFP-LC3  was  PCR-amplified using  the  forward  and reverse  primers 
described in Chapter 2.1.4, and cloned into the vector pENTR using the TOPO 
cloning kit (Invitrogen). GFP-LC3 was then subcloned into pAd/CMV/V5-Dest 
using the  LR Clonase  Kit  (Invitrogen).  To  produce  viruses  HEK293A were 
seeded at 5 x 105  cells per well in a 6-well plate and transfected the following 
day with the Pac I-digested GFP-LC3 destination vector using Lipofectamine 
(Invitrogen) (see also Chapter 2.2.2.2). 48 hours post transfection,  cells were 
trypsinised and transferred to  10  cm tissue culture  dish containing  10  ml  of 
growth medium. After 10 days, when approximately 80 % of the cells showed 
cytopathic  effects,  cells  and  medium  were  harvested  and  subjected  to  3 
freeze/thaw cycles in dry ice/methanol before spinning down the debris at 5000 
g  for  15  minutes  at  room  temperature.  Supernatants  were  frozen  as  1   ml 
aliquots at -80 °C to further amplify the virus.
2.2.5.2  Adenovirus amplification
Adenoviruses were amplified in HEK293A cells by adding 600 pi of the 
initial crude lysates to one 90% confluent T174 flask. 48 hours later 90-100 % 
of  cells  showed  cytopathic  effects  and  were  harvested.  Adenoviruses  were 
purified using the Adeno-X Virus Purification Kit (BD Biosciences) according 
to the manufacturers instruction.
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2.2.6  Primary rat hepatocvte preparation and cultures
2.2.6.1  Isolation of primary rat hepatocytes
Primary  hepatocytes  were  isolated  from  approximately  300  g  male 
Wistar rats by a two-step  collagenase perfusion method according to  Seglen 
(Seglen,  1993).  See Figure 2.1  for a depiction of the perfusion setup.  Wistar 
rats  were  first  anesthetised  by  an  injection  of a  0.3  ml/100  g  body  weight 
solution of 25 % Hypnorm, 25 % Hypnovel, 50 % H2O  and the abdomen was 
opened by a transverse incision,  while the rat was lying on its back with its 
snout to the left.  The intestines were folded away and  1000 units of heparin 
were injected into the right iliolumbar vein. Using a crescent-shaped surgical 
needle, a ligature was placed around the portal vein between the liver and the 
last tributary vein (see also Figure 2.2). A tube connected to the pump inlet of 
the perfusion apparatus was put into a bottle with 500 ml perfusion buffer (150 
mM NaCl, 6 mM KC1,  10 mM HEPES, 4 mM NaOH), the flow rate was set to 
20 ml/min and the pump was switched on. The portal vein was then cut halfway 
through,  approximately  5-10  mm  above  the  ligature,  using  fine  surgical 
scissors.  A  cannula  was  inserted  into  the  vein  and  secured  in  place  by 
tightening the ligature.  Care was taken not to push the cannula past the first 
portal branch as this leads to insufficient perfusion of the small lobes of the 
liver.  Once  the  cannula  was  in  place,  the  vena cava was  cut  to  release  the 
pressure  of the perfusate  flow  and to  sacrifice  the  animal.  At  this  stage  the 
perfusion  buffer  flow  rate  was  increased  to  50  ml/min  and  the  liver  was 
removed from the carcass and placed on top of a metal mesh on a beaker. After 
most of the 500 ml perfusion buffer has been consumed, the metal mesh with
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the  liver  and  the  pump  inlet  was  switched  to  a  beaker  containing  50  ml 
collagenase buffer (12000 units collagenase,  30 mM CaC^,  80 mM NaCl,  3 
mM KC1,  10 mM HEPES, 4 mM NaOH). Collagenase buffer was re-circulated 
through the liver for 8 minutes before the liver was placed in a 10 x 10 cm dish 
with 37 °C suspension buffer (55 mM NaCl, 2 mM KC1, 1  mM KH2PO4, 1  mM 
Na2S04, 30 mM HEPES, 30 mM TES, 36 mM Tricine, 50 mM NaOH) and the 
cells were raked out with a metal tooth dog’s comb.
Cells were then filtered through a coarse 250 pm nylon mesh to remove 
cell clumps and connective tissue debris. After a 30 minutes incubation in a 20 
cm glass petri dish at 37 °C with gentle rocking to allow the cells to recover 
from the pefusion, cells were cooled down to 4 °C, filtered through a 250 pm 
nylon mesh  on  top  of a  100  pm  mesh  and  transferred  to  a beaker.  Before 
hepatocytes were seeded into tissue culture dishes they were washed 3x in wash 
buffer (perfusion buffer, containing  1   mM CaCh) with brief spins in between 
(40 g, 2 minutes, 4 °C).
79Figure 2.1: Perfusion apparatus. (1) Peristaltic pump; (2) water-jacketed 
glass coil, connected to a circulating water bath to ensure that perfusion and 
collagenase buffer are at 37 °C; (3) bubble trap and portal cannula; (4) liver 
support dish - glass funnel with metal mesh placed inside; (5) buffer reservoir 
for recirculation of collagenase buffer. Figure taken from Seglen, 1993.Figure 2.2: Perfusion relevant liver anatomy. (1) Insertion site for portal can 
nula; (2) cannula aligned to the portal vein before insertion; (3) heparin injec 
tion site into iliolumbar vein. Figure taken from Seglen, 1993.Chapter 2
2.2.6.2  Culturing and transduction of primary rat hepatocytes
Isolated hepatocytes were seeded on collagen-coated (10 pg/ml in 30 % 
EtOH) coverslips or cell culture dishes in full growth medium (1:1 DMEM/F12 
containing EGF (30 ng/ml), dexamethasone (10 ng/ml), insulin (400 ng/ml) and 
collagen (10 pg/ml)). Three hrs after seeding, the hepatocytes were either mock 
infected  or  infected  with  adenovirus  encoding  various  constructs.  The 
adenoviruses were  diluted  in  a  small  amount  of growth  medium  and  added 
directly to the cell  culture dishes.  After two hours the growth medium was 
exchanged, and the cells were incubated overnight. All viruses were titrated to 
infect 90% to 100% of the isolated hepatocytes after a 2 hr exposure to virus.
2.2.6.3  Induction of autophaav and drug treatments
To induce autophagy, the growth medium was either replenished with 
fresh growth medium (FM), or cells were washed four times with Earle’s saline 
(ES),  and  starved  for  various  times  in  the  last  wash.  Where  indicated,  the 
following was added: Vinblastine (50 pM), taxol (5pM), nocodazole (50 pM), 
wortmannin (100 or 200 nM), LY294002 (10 nM), 3-methyladenine (10 mM), 
leucine (0.8 mM), rapamycin (25  nM unless  otherwise indicated), regulatory 
amino acids (RegAA (pM): Leu, 204; Tyr, 98; Pro, 437; Met, 60; His, 92; Trp, 
93;  Ala,  475),  Pepstatin A  (28  pg/ml)  and E64D  (10  pg/ml).  In the case  of 
vinbastine, taxol and nocodazole, cells were pre-treated for 30 minutes in full 
growth medium.
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2.2.7  Autophaqy assays
2.2.7.1  Saponin extraction
For  quantitative  analysis  of  GFP-LC3  puncta,  cells  were  saponin- 
extracted for 5 minutes (0.5% Saponin in 80 mM PIPES pH 6.8, ImM CaCl2, 5 
mM  EGTA)  before  fixation  with  3%  PFA.  Nuclei  were  stained  with 
Hoechst33342  (5  pg/ml)  in  PBS  for  1   minute.  The  coverslips  were  washed 
twice more with PBS and mounted with Moviol.
2.2.7.2  Quantification of autophaaosomes bv immuno fluorescence
Low resolution images for the quantification of autophagosomes were 
acquired from saponin-extracted GFP-LC3-infected hepatocytes cells grown on 
glass  coverslips  using  an  automated  Discovery-1   microscope  (Molecular 
Devices) with a 20X, 0.75 NA objective. 16 fields were acquired per condition. 
Autophagosomes  were  counted using  the  Granularity  plug-in module  of the 
Metamorph 6.2 software package (Molecular Devices). Granule size and local 
threshold were  chosen so  that  all  vesicles were  recognized by  the  software. 
Within one experiment settings were kept the same.
2.2.7.3  Quantification of autophaaosomes bv electron microscopy
Quantification  of  the  number  of  autophagosomes  per  pm  in  epon 
sections was performed using conventional random sampling techniques using 
two separate grids for each time point. Between 20 and 30 pictures were taken 
of  each  grid.  Images  with  grid  bars  or  other  non-relevant  material  were 
manually excluded. The samples were assessed in a double-blind fashion. AVis 
and  AVds  were  distinguished  using  well-documented  criteria,  and  counted
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manually.  This was performed by Dr. Xiao-Wen Hu (Cancer Research UK). 
The area covered by cells in each picture was measured using Metamorph 6.2 
software.  First,  the micrographs acquired were visually inspected to  exclude 
dead cells from the area analysis. Next, a threshold was assigned to the image 
to distinguish between cells and background. The threshold was then used to 
create a binary image, where the colour white was assigned to cells and black to 
the background.  After applying  an “Open-Close”  filter to remove  noise,  the 
"Integrated Morphometric Analysis"  tool was used to measure the  cell area. 
This tool  creates  a region around the cells  and returns the pixel area of this 
region, which was then used to calculate square microns.
2.2.7.4  Protein degradation assay
To measure the degradation of long-lived proteins through autophagy 
hepatocytes were isolated and seeded in 6 well dishes at a density of 0.5 x 106  
cells.  On the same day,  after the hepatocytes had attached (usually 5  hours), 
cells were washed 3x with PBS and the medium was exchanged to fresh growth 
medium containing reduced concentrations of valine  (65  pM)  and  14C-valine 
(0.2 pCi/ml) to label cellular proteins over night. Cells were then chased for 4 
hours  in  fresh  growth  medium,  containing  2  mM  valine  to  allow  the 
degradation of short-lived proteins through the proteasome. For the time course, 
cells  were  then  either  incubated  in  ES  or  FM  with  or  without  protease 
inhibitors,  containing  2  mM  valine.  At  various  time  points  aliquots  of the 
medium were removed and precipitated with  10 % TCA/1% phosphotungstic 
acid for at least 30 minutes  at 4  °C.  Precipitated proteins were pelleted in  a 
microcentrifuge (4 °C, 8000 rpm, 30 min) and the soluble fraction was mixed
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with  10 ml  of scintillation liquid and counted.  For the experiments with the 
microtubule drugs, cells were pre-treated with vinblastine, nocodazole and taxol 
as  described  in  Chapter  2.2.6.3.  At  the  end  of the  experiment,  cells  were 
harvested  in  1   ml  ice  cold  PBS,  containing  1%  Trition  X-100,  and  TCA 
precipitated and pelleted as described above. The TCA insoluble fraction was 
counted. Percentage degradation was calculated as cpm medium over total cpm 
in  the  medium  and  cells  times  100  as  described  by  Gronostajski  et  al. 
(Gronostajski and Pardee, 1984).
2.2.7.5  Co-localization of LvsoTracker Red with GFP-LC3
Hepatocytes infected with adenoviruses encoding GFP-LC3 were either 
left untreated or were pre-treated with 50 jl iM  nocodazole or 50 pM vinblastine 
for 30 minutes in full growth medium, followed by 120 minutes starvation with 
the respective drug.  Hepatocytes infected with  adenovirus encoding  SV-HA- 
LC3 were starved for  120 minutes. LysoTracker Red (100 nM) was added to 
the starvation medium during the last 30 minutes of the experiment, and cells 
were  fixed  and  mounted  as  described  above  in  2.2.4.1.  Pictures  for the  co­
localization  were  acquired  with  a  Zeiss  LSM  510  confocal  microscope  as 
described by Naslavsky et al (Naslavsky et al., 2003). Co-localization was then 
measured using the LSM 510 software and was expressed as percentage of the 
total area of LysoTracker Red, which co-localizes with GFP-LC3  or HA-SV- 
LC3  structures,  respectively.  The  threshold  to  distinguish  background  from 
signal was set individually for each sample.
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2.2.7.6  Inhibition of autophaav with siRNA
Protein knockdown was accomplished by transfecting HEK293A cells, 
stably expressing GFP-LC3 cells with siRNA (5nM final concentration) using 
Oligofectamine  reagent  according  to  manufacturer's  protocols.  A  siControl2 
siRNA (Dharmacon, Lafayette, CO, USA) which engages the RISC complex 
but  produces  non-targeting  siRNA,  a  SMART  pool  siRNA  (Dharmacon) 
towards  Atg5  (NM_004849),  or  a  custom  designed  siRNA  duplex  towards 
human Atg6/Beclinl was used. 72 hours post transfection, cells were then lysed 
for immunoblotting or treated with 50 pM vinblastine. These experiments were 
performed by Dr. Edmond Chan (Cancer Research UK).
2.2.8  In vitro fusion assay
2.2.8.1  Biotinvlation of horseradish peroxidase (HRP)
HRP was biotinylated as described by Gruenberg et al.  (Gruenberg et 
al.,  1989) using the Biotin-X-NHS-Kit (Calbiochem). Briefly, 70 mg HRP was 
dissolved  in  7  ml  of 0.1  M NaHC0 3 and mixed with  77  mg biotin-X-NHS 
dissolved in 1.75 ml dimethylformamide. The solution was incubated at room 
temperature on an end-over-end rotator for at least 1   hour, after which it was 
dialysed over night against PBS, using Snakeskin dialysis tubing (Pierce) with a 
molecular weight cut off of 3.5 kDa.
2.2.8.2  HRP enzyme assay
The HRP enzymatic activity of cell lysates, endosomes preparations or 
fusion  assay  samples  was  measured  in  a  spectrophotometer  at  455  nm  as 
described by Gruenberg et al.  (Gruenberg et al.,  1989a).  100  pi sample were
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mixed with 900 pi of HRP assay buffer (0.342 mM O-dianisidine and 0.003% 
H2O 2 as substrates in 0.5 M Na-phosphate buffer, pH 5 containing 0.1% Triton 
X-100) and incubated in the dark for up to 1  hour. HRP activity was stopped by 
adding 0.4 % sodium azide and samples were measured.
2.2.8.3  Endosome purification from rat liver
Early and late endosomes from rat liver were purified according to Ellis 
et  al.  (Ellis  et  al.,  1992).  The  necessary  continuous  Ficoll  gradients  were 
prepared the day before the purification and left over night to smoothen out at 4 
°C. 39 ml Beckman Quick-Seal tubes were filled with 5 ml 45 % Nycodenz to 
serve as a cushion, then a 30 ml 25 % to 1  % (w/v) Ficoll gradient (Ficoll, 250 
mM sucrose, 20 mM TES, 1  mM EDTA) was made on top of that. On the day 
of  the  experiment,  approximately  300  g  Wistar  rats  were  anesthetised  as 
described  above  (Section  2.2.6.1)  and  perfused  with  recirculated  perfusion 
buffer,  containing  either  2  mg/ml  biotinylated  HRP  or  0.2  mg/ml  anti-HA 
antibody  for  30  minutes.  The  temperature  of  the  perfusion  buffer  was 
maintained at 37 °C throughout. The liver was then briefly minced with scissors 
and homogenized in 3x weight (g) with STM buffer (250 mM sucrose, 20 mM 
TES,  ImM MgCy using a potter homogenizer. Homogenates were spun in a 
JA20 rotor at 2000 g for 10 minutes at 4 °C to generate a PNS. 5 ml PNS was 
loaded on top of each Ficoll gradient, the tubes sealed and spun at 50000 rpm in 
a vti50 rotor for 1  hour at 4 °C. Acceleration and deceleration were set to 3.  1  
ml fractions were then collected from the bottom and the refractive index was 
measured. For each gradient, fractions with a refractive index between  1.360
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and  1.366,  corresponding  to  late  endosomes,  and between  1.366  and  1.373, 
corresponding to lysosomes, were pooled.  STM buffer was added to 20.5 ml 
and the samples were spun at 45000 rpm in a Ti70 rotor for 76 minutes at 4 °C 
to  concentrate  the  endosomes.  The  pellets  were  then  resuspended  in  STM 
buffer, equal to a quarter of the volume of the original PNS, and samples were 
snap frozen and stored in liquid nitrogen.
2.2.8.4  Autophaaosome purification from cultured hepatocytes
Autophagosomes  were  isolated  from  hepatocytes  according  to 
Stromhaug et al.  (Stromhaug  et al.,  1998)  with the  following  modifications. 
Cells were isolated as described above (Chapter 2.2.6.1), seeded on 5 collagen 
coated 25 x 25  cm square tissue culture dishes and on the same day infected 
with HA-SV-LC3 encoding adenoviruses (see also Chapter 2.2.6.2). The next 
day, cells were washed 3x with PBS and autophagy was induced by incubating 
the hepatocytes in Earle’s  saline,  containing  50  pM vinblastine  for 2  hours. 
Hepatocytes were then scraped off in PBS and the cells from all 5 plates were 
pooled,  pelleted  (400  g,  15  minutes,  4  °C)  and  resuspended  in  10  ml  of 
homogenization buffer (HB) (250 mM sucrose,  10 mM HEPES, pH 7.4). Cells 
were broken with a dounce homogenizer (Wheaton) and the result checked by 
trypan blue  staining.  Usually  20  strokes  were  required  for more  than  90  % 
breakage. Lysosomes were removed from the samples by adding 5 ml 1.5 mM 
gly-phe  p-naphthylamide  in  HB,  and  the  homogenate  was  incubated  for  7 
minutes at 37 °C, before centrifuging the samples for 2 minutes at 2000 g and 
4°C to generate a PNS. 14 ml PNS were loaded on a Nycodenz step gradient (7 
ml  13.5  % and  16 ml 9.1  % Nycodenz in HB in SW28 Beckman tubes) and
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spun for 1  hour with 28000 rpm at 4 °C; acceleration and deceleration set to 1. 
Finally,  the  autophagosome  band  between  the  two  Nycodenz  steps  was 
collected  and  used  immediately  for  fusion  assays  or  frozen  at  -20  °C  for 
western blotting.
2.2.8.5  Generation of rat liver cvtosol
Livers of starved rats were minced with scissors and homogenized in 
STM buffer (see Chapter 2.2.8.3), equal to 3x the weight of the livers (g). The 
homogenate was centrifuged in a JA20 rotor for 10 minutes at 2000 g at 4 °C 
and then  spun further in  a Ti70 rotor at  100000  g  for  1   hour at 4  °C.  The 
supernatant was  collected and desalted on PD10  columns (Pharmacia).  1   ml 
aliquots  were  snap  frozen  and  stored  in  liquid  nitrogen.  Typical  cytosol 
concentrations were about 20 mg/ml.
2.2.8.6  In  vitro  reconstitution  of  fusion  between  autophaaosom es  and 
endosom es. containing anti-HA antibodies
Autophagosomes were  always prepared fresh.  Aliquots  of endosomes 
were  thawed rapidly  at  37  °C  and  centrifuged  as  100  pi  aliquots  in  1.5  ml 
Eppendorf tubes at 35000 rpm for 37 minutes at 4 °C in a Ti50.2 rotor. Pellets 
were resuspended in either 100 pi rat liver cytosol (approximately 20 mg/ml) or 
STM  buffer  and  mixed  with  100  pi  autophagosomes,  25  pi  HA-peptide  (1 
mg/ml  in  STM buffer)  and  10  pi  ATP-regenerating  system  (100  mM  ATP, 
pH7;  800 mM creatine phosphate, 3200 U/ml creatine phosphokinase and 30 
mM GTP). Samples were incubated at either 37 °C or 4 °C for 45 minutes. As 
controls single components of the fusion reaction were  omitted and replaced
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with the buffer they were made in. After 45 minutes samples were placed on ice 
for 4 minutes before TNTE was added. Samples were vortexed and incubated 
on ice for 20 minutes before being centrifuged at  12000 rpm at 4 °C for  10 
minutes in a microcentrifuge. The supernatant was then transferred to a new 
tube and incubated for at least one hour on a end over end rotator. Beads were 
then spun down for 2 minutes at 2000 rpm at 4 °C and washed 3x with PBS. 
Samples were then prepared for SDS-PAGE as described in Chapter 2.2.3.4.
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2.3 Supplemental Material on CD
2.3.1  Description of movies
Movie  Ml.  Infected  cultured  hepatocytes  expressing  GFP-LC3  were 
imaged with  an  Ultraview  spinning  disk microscope.  Frames  were  acquired 
every 23 seconds for 2 hours, and all frames are shown. The frame rate of the 
movie is 15 per second.
Movie M2. As described in Ml.
Movie M3.  As  described  in Ml,  but  frames  were  acquired  every  10 
seconds for 15 minutes, starting 7 minutes after the beginning of starvation. All 
frames are shown The frame rate of the movie is 10 per second.
Movie  M4.  As  in  Ml,  but  cells  where  pre-treated  with  50  pM 
nocodazole in FM for 30 minutes. Frames were acquired every 10 seconds for 
15 minutes, starting 5 minutes after the beginning of starvation. All frames are 
shown The frame rate of the movie is 10 per second.
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3  AUTOPHAGOSOME  FORMATION  IN 
PRIMARY RAT HEPATOCYTES
3.1  Aim
Tissue culture cell lines have only a low capacity to undergo autophagy. 
In NRK cells, for instance, up to 0.8% of the cytoplasmic volume is occupied 
by autophagosomes after a 2 hour starvation period in amino acid free medium 
(personal communication from Eeva-Liisa Eskelinen, University of Helsinki). 
In tissues and primary cells in culture on the other hand autophagy is induced to 
a  much  greater  extent  upon  starvation.  In  cultured  mouse  hepatocytes,  for 
example,  up  to  3%  of  the  cytoplasmic  volume  was  occupied  by 
autophagosomes  even  under  full  growth  medium  conditions  (Tanaka  et  al., 
2000).  As shown in GFP-LC3  transgenic mice, tissues with particularly high 
numbers  of  autophagosomes  after  starvation  are  liver,  kidney  and  heart 
(Mizushima et al., 2004). We therefore decided to use primary rat hepatocytes 
as  our model  system to  investigate autophagosome maturation,  as  they have 
been extensively used  in the past to  study  autophagy.  Most of these  studies 
however were based on morphological methods only. For that reason I decided 
to  develop  a  primary  rat  hepatocyte  model  which  is  amenable  to  genetic 
modification, using adenoviruses to specifically express a GFP-tagged version 
of the  autophagosome  marker  MAP1-LC3  (GFP-LC3).  Using  a  variety  of 
microscopic and biochemical techniques I confirmed that GFP-LC3 is localized 
correctly to  autophagosomes  and  over-expression itself has no  effect  on the
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induction of autophagy.  Furthermore I determined the rate of autophagosome 
formation using time course experiments with fixed or live cells.
3.2 Generation of LC3 specific antibodies
I developed rabbit polyclonal antibodies against the N-terminal domain 
of rat  LC3.  For  this  purpose,  a peptide  comprising  amino  acids  2-18  (see 
Chapter 2.1.5  for sequence) was  synthesized  and  coupled to  keyhole  limpet 
hemocyanin.  The  conjugated  peptide  was  sent  to  Harlan  (England)  for 
immunization of rabbits. The antibodies ST0227 and ST0228 recognized the 
endogenous protein by  western  blotting  of liver  lysates  and  this  interaction 
could  be  competed  by  pre-incubation  of the  antibody  with  excess  peptide 
(Figure  3.1).  However,  these  antibodies  did  not  give  a  specific  signal  in 
immuno-fluorescence  experiments.  These  findings  indicate  that  these 
antibodies are valid probes for the detection of endogenous and over expressed 
LC3 (see also Figure 3.9).
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Figure 3.1: Both antibodies, ST0227 and ST0228, recognize LC3.  1.5 mg
hepatocyte lysate from starved Wistar rats was separated on a  12 % mini gel, 
with a comb with 2 wells only (marker and sample) and blotted to nitrocellulose. 
The nitrocellulose membrane was cut into thin strips and probed with an anti- 
LC3 antibody provided by Tamotsu Yoshimori (TY), pre-immune serum (PS), 
sera from test bleeds and final bleed (S1-S5) or serum from the final bleed, pre­
incubated with 0.1  mg/ml antigen-peptide for 1   hour (C). Serum concentration 
was  1:1000.  A)  STO227 antibody.  B)  ST0228 antibody.  Arrows indicate the 
two LC3 forms LC3-I (I) and LC3-II (II), running at approximately 17 kD and 
14 kD, respectively.Chapter 3
3.3 Culturing of hepatocytes
Hepatocytes, when seeded on tissue culture plastic or coverslips, do not 
attach very well.  I  therefore  tested 3  different collagen  coating protocols  to 
optimize the culture  conditions.  Hepatocytes were  isolated from rat liver by 
collagenase perfusion  according to  Seglen  (Seglen,  1993)  and  5  x  105   cells 
were, as shown in Figure 3.2, either seeded in (A) untreated 35 mm dishes or in 
(B) untreated 35 mm dishes, but with 10 ng/ml collagen type IV in the medium 
or in (C)  35  mm  dishes,  which have been  coated over night with  10  ng/ml 
collagen in 30 % ethanol, with additional collagen in the growth medium. The 
following day cells were washed, visually inspected and counted. Cells seeded 
on untreated plastic, were often round and only about 50 % were attached and 
flat. The density was generally low, indicating a loss of cells. Adding collagen 
to the growth medium reduced the number of round cells and the cell density 
was slightly higher than in untreated dishes. The best result was obtained when 
dishes  were  coated  with  collagen  over  night  and  collagen  was  additionally 
present in the medium. Most cells were flat and the cell density was the highest 
of all 3 treatments, indicating that cells had attached firmly. However, even in 
this  case  there  were  approximately  5  %  dead  cells.  For  the  following 
experiments in this thesis, collagen was added to the medium and additionally 
dishes were coated with collagen over night.
95Figure 3.2: Optimization of collagen coating. 5 x 105 hepatocytes were seed­
ed either on untreated plastic (A), or on untreated plastic, but with  10  pg/ml 
collagen in the growth medium (B), or on plastic, coated over night with  10 
pg/ml collagen, and with collagen in the medium (C). The following day, cells 
were visually inspected (A-C) or trypsinized and counted (D). Data in D is the 
mean of 3 replicates +/- SEM. Bar equals 100 pm.Chapter 3
3.4 Infection  of  hepatocytes  with  GFP-LC3 
encoding adenoviruses
Since primary hepatocytes are difficult to transfect with liposome based 
methods,  I decided to use adenoviruses instead. Tsutsui et al.  (Tsutsui et al., 
2003), for instance, showed that a multiplicity of infection (MOI) as low as  1  
was enough to infect 80 % of cultured hepatocytes, while a MOI of 10 was 
sufficient to infect 100 % of cells. I therefore generated a GFP-LC3 encoding 
adenovirus  and  tested  it  by  infecting  cultured  primary  rat  hepatocytes  with 
different amounts of virus. Cells were seeded on coverslips in 6 well dishes and 
allowed to attach for three hours, before 0,  1   or 10 pi virus was added to the 
growth medium. After 2 hours the medium was exchanged with fresh growth 
medium and cells were incubated over night. Cells were then either starved for 
two hours in Earle’s Saline (ES), a physiological salt solution, which doesn’t 
contain any nutrients,  or left in full medium (FM), before being fixed.  Cells 
were  visualized  using  epifluorescence  and  confocal  microscopy.  In  initial 
experiments,  I  incubated  the  cells  over  night  with  the  virus,  a  treatment 
resulting in cell death. After a 2 hour incubation, hepatocytes were healthy and 
their morphology didn’t change in comparison to uninfected cells.  1   pi virus 
was sufficient to infect more than 95 % of cells. In hepatocytes incubated with 
full medium, cytoplasmic GFP-LC3 was largely diffuse, and was also detected 
in the nucleus. After 2 hrs of starvation in Earle’s saline, there was a dramatic 
increase of punctate vesicular structures labelled with GFP-LC3  (Figure 3.3). 
Uninfected hepatocytes had a high level of autofluorescence.
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Analysis of these cells with confocal microscopy showed that many of 
the punctate structures are “doughnut” shaped, with GFP-LC3 staining the rim 
of a  vesicular  structure  (Figure  3.4).  To  verify  that  the  GFP-LC3  positive 
vesicles formed in starved hepatocytes are autophagosomes I incubated cells for 
2 hours with various PI3-kinase inhibitors, which have been shown to inhibit 
the formation of autophagosomes (Codogno and Meijer, 2004). As shown in 
Figure  3.4,  the  formation  of GFP-LC3-positive  vesicular  structures  during 
starvation  was  inhibited  by  treating  starved  cells  with  LY294002  (LY),  3 
methyladenine (3MA) or wortmannin (WM).  Addition of those drugs had no 
visually apparent effect on the health of the hepatocytes. These results suggest 
that  cultured  and  infected  hepatocytes  respond  to  starvation  by  inducing 
autophagy and that GFP-LC3 is targeted to newly formed autophagosomes.
98FM
Figure 3.3: Epifluorescence microscopy of hepatocytes infected with GFP- 
LC3. Hepatocytes were seeded in 35 mm tissue culture dishes, infected with  1  
pi (A), 10 pi (B) or 0 pi (C) GFP-LC3 encoding adenovirus. The following day, 
cells were either incubated in full medium (FM) or starved in Earle’s Saline 
(ES)  for 2 hours, before being fixed and analysed using an epifluorescence 
microscope with a 40 x objective. Images were recorded with the same settings. 
Bar equals 10 pmFigure 3.4: Confocal microscopy of  rat hepatocytes infected with GFP- 
LC3. Hepatocytes were isolated, seeded and infected with adenoviruses encod­
ing GFP-LC3, and incubated overnight in full medium (FM). The following day, 
cells were either left untreated (UT) in FM, or were starved in ES for 2 hours, 
with no drugs  (UT) or in the presence of 10 nM LY294002  (LY),  200 nM 
wortmannin (WM) or 10 mM 3-methyladenine (3MA) and then visualized for 
GFP with a LSM 510 laser scanning microscope. Bar equals 10 pm.Chapter 3
3.5 Characterization of the starvation response bv 
electron microscopy
To further confirm that infection itself has no effect on autophagy and 
that the GFP-LC3 labelled structures are autophagosomes and not an artefact of 
viral infection, Xiao-Wen Hu performed both conventional thin section electron 
microscopy and immunogold labelling of cryosections.
Hepatocytes  were  isolated  and  infected  with  GFP-LC3  encoding 
adenoviruses. The following day the cultured hepatocytes were starved for 10, 
45  or  90  minutes  in  Earle’s  Saline,  before  being  fixed  and  processed  for 
conventional  electron  microscopy.  Within  10  minutes,  autophagosome 
formation was induced and autophagosomes could be identified by the presence 
of a double membrane structure, containing sequestered cytosol and organelles, 
such as mitochondria (Figure 3.5). The autophagosomes ranged in size from 0.8 
-  2 pm, and could be classified into early, immature autophagosomes (AVis) 
and into late, degradative autophagosomes (AVd). The latter could be identified 
based  on  their  electron  dense  core,  characteristic  of  a  degraded  content 
(Eskelinen, 2004).
Additionally,  to  confirm  that  GFP-LC3  gets  targeted  to  these  newly 
formed  autophagosomes,  cryoimmunogold  labelling  experiments  of infected 
hepatocytes  expressing  GFP-LC3  were  performed  by  Xiao-Wen  Hu. 
Hepatocytes were isolated, infected with GFP-LC3 encoding adenovirus or not, 
and starved for 2 hours in ES. Using both an anti-GFP antibody and an anti- 
LC3  antibody,  Xiao-Wen  Hu  could  identify  vesicles  with  gold-particle
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decorated  membranes,  which  had  the  morphology  of  autophagosomes  and 
contained sequestered cytosol and sometimes also mitochondria (Figure 3.6).
To characterize the starvation response in more detail and to make sure 
that viral infection alone does not induce autophagy, I performed a time course 
experiment with cultured hepatocytes to analyse the morphology and number of 
AVis  and AVds  over a  120  minutes  starvation period.  Cultured hepatocytes 
were  either  mock  infected  or  infected  with  GFP  or  GFP-LC3  encoding 
adenoviruses. The following day, cells were starved in ES  for 0,  30 and  120 
minutes,  fixed  and  processed  for  conventional  electron  microscopy  (Figure 
3.7A).  Comparison of Avi and Avd numbers at 0,  30  and  120 mins in non­
infected cells, GFP, or GFP-LC3-infected cells showed that there was no clear 
effect of either adenovirus on the type or number of A  Vs present.
To  analyse  the  distribution  of early  and  late  autophagosomes  during 
starvation in more detail a more extensive time course was performed using 
GFP-LC3-expressing hepatocytes. Cells were starved for 0,  15, 30, 60 and 120 
minutes,  fixed  and  processed  for  electron  microscopy  (Figure  3.7B). 
Quantification of autophagosomes from random sampled pictures, showed that 
the  AVi  number  increased  immediately  upon  shifting  cells  to  starvation 
medium, and continued to rise until about 30-60 minutes, after which a plateau 
was reached. The number of AVds increased over the whole time course of the 
experiment.
In summary, these experiments show that cultured and infected primary 
hepatocytes are still able to respond to starvation and that GFP-LC3 is targeted 
correctly to newly formed autophagosomes.  In addition,  infection with GFP- 
LC3 encoding adenoviruses did not affect the normal starvation response. After
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an initial burst, AVi numbers stayed constant, while the number of AVds was 
continuously increasing.
103Figure 3.5:  Conventional thin section electron microscopy of infected 
hepatocytes. (A-C) Hepatocytes were infected with adenovirus  expressing 
GFP-LC3 and cultured over night. Cells were starved for 10 mins (A), 45 mins 
(B) or 90 mins (C), fixed and thin section electron microscopy was performed 
by Xiao-Wen  Hu.  Immature,  early autophagosome  (AVi),  degradative  late 
autophagosome (AVd), Nucleus (Nu). Bar equals 500 nm.ccGFP
ocLC3
Figure 3.6: Immunogold electron microscopic analysis of LC3 in starved 
rat hepatocytes. Hepatocytes were either infected with adenovirus expressing 
GFP-LC3 (A and B), or uninfected (C and D) and fixed 2 hours after starvation 
in ES. Cryosections were labelled with anti-GFP (A) or anti-LC3  (B-D) fol­
lowed by 10 nm protein A gold. Bars equal 100 nm.A
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Figure 3.7:  Quantitative electron  microscopic analysis of autophagosome 
formation. A) Quantification of AVis and AVds in non infected (NON) cells or 
cells infected with GFP (GFP) or GFP-LC3  virus (LC3).  B) AV number in 
GFP-LC3 infected hepatocytes. A minimum of 40 images were captured from 2 
grids. Error bars indicate SEM.Chapter 3
3.6 Quantification  of  autophaqy  bv  fluorescence 
microscopy and western blotting
Having confirmed that the infection and expression of GFP-LC3  does 
not affect the ability of hepatocytes to induce autophagy, I decided to use an 
automated  epifluorescence  microscope  to  accurately  quantify the  number  of 
GFP-LC3 positive vesicles in hepatocytes. This microscope system has a built 
in automatic focusing mechanism and allows therefore the unbiased collection 
of images at low magnification (typically 20X) from large numbers of cells (on 
average greater than 2500 cells per condition). GFP-LC3-positve structures per 
nucleus were counted using Metamorph 6.2 software.  See Figure 3.8A and B 
for  an  example  of how  the  microscope  and  the  software  works.  Since  the 
counting algorithm of Metamorph 6.2 is based on generating local thresholds 
and detecting spots of a defined size, which are brighter than the surrounding 
area, I permeabilized hepatocytes with a low concentration of saponin before 
fixation. This removed most of the soluble nuclear and cytosolic fluorescence 
and made it easier for the software to count the autophagosomes. Cells in FM 
(Figure 3.8A and C) had only a few (approximately 5 per cell) punctate GFP- 
LC3-positive structures. In ES-starved cells on the other hand, there was a clear 
increase  in  the  amounts  of punctate vesicular staining  (Figure  3.8B  and  D), 
which could be measured using this system (Figure 3.8E).
In addition to the autophagosome number,  I  examined the processing 
and modification of both GFP-LC3  and endogenous  LC3  after starvation by 
western blotting.  During  starvation  soluble  LC3  (LC3-I)  is  cleaved by Atg4
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(Tanida  et  al.,  2004a)  and modified by  the  addition  of a  lipid,  most  likely 
phosphatidylethanolamine (Kabeya et al., 2004), to form LC3-II.  On western 
blots the LC3-II form has a lower mobility and  can be clearly distinguished 
from the unconjugated LC3-I form. Therefore I infected cultured hepatocytes 
with  GFP-LC3  encoding  adenoviruses,  or  alternatively  used  non  infected 
hepatocytes,  and starved them for 2 hours  in ES,  before  solubilization.  In a 
parallel  set  of  samples,  hepatocytes  were  saponin  extracted  before 
solubilization. In uninfected and unextracted cells in FM, both LC3-I and LC3- 
II were detected using an antibody against endogenous LC3, however, the band 
corresponding to LC3-I was predominant (Figure 3.9A). Using an antibody to 
GFP,  GFP-LC3-I and GFP-LC3-II were detected in lysates from unextracted 
cells  in  both  FM  and  ES.  After  120  min  in  ES,  the  amount  of the  faster 
migrating  LC3-II  increased,  as  did  the  GFP-LC3-II  (Figure  3.9B).  Western 
blotting of saponin extracted cells (SAP in Figure 3.9) more clearly revealed 
increased levels of LC3-II and GFP-LC3-II, both of which selectively remained 
on the membranes after saponin extraction, indicating that the higher molecular 
weight form is the cytosolic  form and the  lower molecular weight form the 
membrane bound, lipid conjugated LC3 form.
Together these results indicate that spot counting and analysis of LC3 
processing  are  suitable  methods  to  investigate  starvation  induced 
autophagosome formation.
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Figure 3.8:  Quantification of autophagosomes in GFP-LC3 expressing 
hepatocytes. Hepatocytes expressing GFP-LC3 were incubated for 120 minutes 
in either FM (A, C) or ES (B, D) and processed as described in Materials and 
Methods. GFP-LC3-positive puncta were counted using Metamorph 6.2. Panel
A)  and B) shows the principle of the counting algorithm. Metamorph creates a 
computer generated image by detecting Hoechst stained nuclei and GFP-LC3 
spots based on an intensity and size threshold. Total GFP-LC3  spot number is 
then divided by the number of nuclei. Data in (E) was obtained from data simi­
lar to that shown in C) and D) and is the mean +/- SEM of 16 pictures, contain­
ing approximately 2500 cells. Bar equals 10 pm.Mr(k) FM  ES FM  ES
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Figure 3.9: LC3 processing in rat hepatocytes after starvation. Uninfected 
or GFP-LC3 infected hepatocytes were incubated in FM or ES for 2 hours and 
then either saponin extracted (SAP) or not (UNEXT), scraped, solubilized and 
subjected to western blotting with (A) an anti LC3  antibody or (B) anti GFP 
antibody.Chapter 3
3.7 Time  course  of autophaaosome formation  in 
fixed cells
Having developed and established the light microscopy based counting 
technique,  I  decided  to  study  the  kinetics  of autophagosome  formation  in 
cultured primary hepatocytes. I therefore infected cells with GFP-LC3 encoding 
adenoviruses and performed a series of time courses over  120 minutes,  after 
which I analysed the appearance of fluorescent GFP-LC3 puncta. In a parallel 
set of cells I also analysed the lipid modification of GFP-LC3.
Additionally,  in  order  to  investigate  the  time  required  for 
autophagosomes to fuse with degradative compartments, I decided to incubate 
hepatocytes in the presence of lysosomal protease inhibitors and to compare the 
degree  of degradation  of GFP-LC3  between  treated  and  untreated  cells  by 
looking  at  both,  the  vesicle  number  and  GFP-LC3  processing  by  western 
blotting.
To test which protease inhibitors work best in cultured hepatocytes I 
carried out an initial pilot experiment where I incubated cells in the presence of 
E64,  leupeptin  or  pepstatin  A  (Figure  3.10).  E64d  is  specific  for  cysteine 
proteases, but does not inhibit serine proteases. Leupeptin is a dual specificity 
serine/cysteine protease inhibitor, which inhibits enzymes such as papain and 
cathepsin B, while pepstatin A is an aspartic proteinase inhibitor and inhibits 
for instance cathepsin D and pepsin. Maximal inhibition of lysosomal proteases 
and maximal GFP-LC3-I/II protection was obtained with the protease inhibitors
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(PI) E64D and pepstatin A; in the following experiments E64D and pepstatin A 
were always added together.
For  the  time  course  experiments,  GFP-LC3  expressing  cells  were 
incubated  in  FM  or  ES  for  various  times,  without  or  with  the  lysosomal 
protease inhibitors,  and then  extracted with  saponin,  fixed,  and analysed for 
GFP-LC3 positive autophagosomes (Figure 3.11A and B). In ES, the number of 
A  Vs  increased  until  30  to  60  minutes  and  then  reached  a  plateau.  When 
protease inhibitors were added to ES, the number of autophagosomes continued 
to increased over the time course of the experiment. On the other hand, cells, 
which were incubated in FM had a constant low number of autophagosomes 
over  120 minutes. Addition of protease inhibitors substantially increased this 
low  number.  After  120  minutes  in  FM  with  PI,  hepatocytes  had  a  similar 
number of autophagosomes than cells starved in ES.
In parallel experiments I analysed the appearance and accumulation of 
GFP-LC3-II by western blotting (Figure 3.11C).  The results  largely reflected 
the data obtained using the vesicle count assay. In FM without PI, GFP-LC3-II 
was only present in very low amounts; however, could be clearly detected after 
90 minutes if protease inhibitors were added (Figure 3.11C top panel). In ES, 
GFP-LC3-II started to increase after 15 minutes; addition of protease inhibitors 
enhanced this effect even more (Figure 3.11C bottom panel).
The  fact  that  autophagosomes  could  be  accumulated  in  FM  when 
protease inhibitors where added, suggests that hepatocytes have a basal rate of 
AV formation. Starvation of the cells quickly stimulates AV formation within 
15 minutes (see also Chapter 3.5). The addition of protease inhibitors increases
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the number of AVs, and the amount of GFP-LC3-II detected in both FM and 
ES, reflecting an inhibition of degradation.
To  confirm  that  the  time  course  of  AVd  appearance  parallels 
autophagosomal degradation, and that this is inhibited by E64D and pepstatin 
A,  I  measured  the  degradation  of 14C-valine  labelled proteins  in  GFP-LC3- 
expressing hepatocytes during a 2 hour incubation in FM or ES, with or without 
protease inhibitors (Figure 3.1 ID). Degradation of long-lived proteins has been 
used to quantify autophagy in many cell types (Mizushima, 2004). I found that 
incubation of cells  in ES  resulted in the highest rate  of degradation  of Re­
labelled proteins, and this degradation was fully inhibited by protease inhibitors 
to a level comparable to cells incubated in FM, or FM plus protease inhibitors.
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Figure 3.10: Lysosomal protease inhibitors protect GFP-LC3 degradation.
GFP-LC3  expressing hepatocytes were either incubated in FM or in ES  for 2 
hours, or in ES with 28 jig/ml pepstatin A or 0.25 mg/ml leupeptin or 10 pg/ml 
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Figure 3.11: Quantification of autophagosome formation and protein deg­
radation  in  cultured  hepatocytes. Hepatocytes expressing GFP-LC3  were 
incubated  in FM or ES, without or with the protease inhibitors E64D and 
pepstatin A (PI)  for 0,  15,  30,  60,  90  and  120 mins.  A)  Time course of 
autophagosome formation. Automated quantification was performed on approx­
imately 2800 cells per time point on images acquired with a 20X objective. B) 
Representative images of the hepatocytes acquired for quantification from the 
120 min time points.  C) Immunoblotting with anti-GFP antibody was per­
formed on samples taken from the same time points. D) 14C-valine labelled pro­
tein degradation in hepatocytes incubated in FM and ES with or without PI. 
Samples were taken from the medium at 0,  15, 30, 60, 90 and 120 mins. Bar in
B)  equals 10 microns. Data in A (means +/- SEM of 16 acquired fields), B and 
C are representative of 3 independent experiments. Data in D (mean +/- SEM of 
triplicates) are representative of 2 independent experiments.Chapter 3
3.8 Autophagosome formation in live hepatocytes
Since  over  expression  of  GFP-LC3  also  provides  the  possibility  to 
visualize the  formation of autophagosomes in live  cells,  I  decided to  record 
time-lapse  movies  of  starved  hepatocytes.  GFP-LC3  expressing  cells  were 
therefore  transferred  to  ES  and  imaging  was  immediately  started  using  a 
confocal  spinning  disk  microscope.  The  microscope  was  equipped  with  an 
environmentally  controlled  chamber  to  ensure  that  the  temperature  was 
maintained at 37°C during image acquisition over a period of 2 hours.
GFP-LC3-positive  structures  appeared within  5  minutes  of starvation, 
and increased in number over the following 45-60 minutes, after which the total 
number appeared to stay constant. Between 60 and 120 minutes, the GFP signal 
on  some  vesicles  faded  and  vesicles  seemed  to  disappear,  while  new 
autophagosomes appeared, suggesting the turn over of vesicles (see also Figure 
3.11). A panel of images extracted from one movie (see supplementary movie 
Fig.  Ml)  is  shown  in  Figure 3.12.  Most autophagosomes  moved  over  short 
distances  only,  in  a  stop-start random  fashion  and  only  a  few  more  motile 
autophagosomes were seen, which moved in a random direction, occasionally 
reversing (Figure 3.13A, arrowhead; see also supplementary movie Figure Ml 
and M2). There was no indication of a directional movement, and there was no 
detectable  clustering  in  a  juxtanuclear  area.  Frequently,  autophagosomes 
appeared  to  interact  or  fuse,  and  then  to  move  apart  again  (Figure  3.13B). 
Sporadically, tubular structures extended from the autophagosomal membranes,
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which were relatively stable over 1  minute, before retracting (Figure 3.13C) and 
occasionally autophagosomes could be seen to move along these structures.
To compare the appearance of autophagosomes during starvation in live 
cells with fixed cells, I analysed the number of GFP-positive structures in the 
movies using Metamorph 6.2 software and found that the shape of the curve 
(Figure 3.12B) correlated well with the time course shown in Figure 3.11 A.
In the electron microscopy analysis in Figure 3.7B, I could show that 
after 60 minutes of starvation most autophagosomes are AVds.  This suggests 
firstly, that most GFP-positive structures in the movies have matured to late 
autophagosomes through fusion with endosomes  or lysosomes  and secondly, 
that fusion does not change the mobility of autophagosomes
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Figure 3.12: Dynamics of autophagosome formation in live cells during 
starvation. Live-cell confocal imaging was performed on hepatocytes express­
ing GFP-LC3  after transfer to ES at 37°C.  Confocal sections were acquired 
using an Ultraview microscope over 120 min at 23 sec intervals. A) Representa­
tive images from the supplementary movie (see Ml and M2) at 0, 15, 30 and 60 
min.  B) Quantification of total number of autophagosomes  formed in each 
frame of the movie (whole field, 6 cells). Data is representative of 2 movies. 
Bar in A) equals 10 pm.1:55:55
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Figure 3.13: Autophagosomes fuse, move, send out tubular structures. A),
B), and C) are enlarged areas of the cell shown in Figure 3.12 and illustrate AV 
movement, interaction, and tubule formation, respectively. Arrowhead in A) 
identifies the moving AV,  arrow identifies an immobile GFP-LC3  vesicle. 
Arrowhead in B) identifies interacting AVs, in C) the growing, and retracting, 
end of the tubule. Time on panels show in hr:min:sec when the frames were 
captured. Bar is 2 pm.  *Chapter 3
3.9 Discussion
When autophagy was described first in the late fifties (Clark, 1957), the 
only way to identify autophagosomes was by electron microscopy. In the mid 
90ies,  a huge  step  forward  has  been  made  in  the  autophagy  field  with  the 
independent identification of the yeast autophagy genes by several groups at 
approximately  the  same  time  (Harding  et  al.,  1995;  Thumm  et  al.,  1994; 
Tsukada and Ohsumi, 1993). One of the proteins identified in those screens was 
Atg8, which is the only protein identified so far that binds specifically to and 
remains associated with newly formed autophagosomes. LC3, the mammalian 
homolouge  of  Atg8  has  proven  to  be  an  excellent  tool  to  identify 
autophagosomes in mammalian cells at both the light and ultrastructural level 
when tagged with GFP (Kabeya et al., 2000).
For our studies we decided to use rat hepatocytes as a model for several 
reasons.  First,  hepatocytes  have  been  used  extensively  in  the  past  to  study 
autophagy  and  autophagosomes  are  therefore  morphologically  very  well 
defined and characterised in this cell type,  and  secondly hepatocytes have  a 
high  capacity  to  undergo  autophagy.  A  big  disadvantage,  however,  is  that 
primary hepatocytes are difficult to transfect and most studies were therefore 
restrained to using morphological or biochemical assays only.
I therefore decided on using an adenoviral system to express GFP-LC3 
in order to investigate the molecular mechanisms involved in the formation of 
autophagosomes and the regulation of this pathway in mammalian cells.
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In  this  thesis  I  can  show  that  cultured  primary  rat  hepatocytes  are 
amenable to genetic manipulation and that over-expression of GFP-LC3  does 
not induce autophagy on its own, contrary to what has been reported for other 
tissue culture model systems. This might be because hepatocytes have a larger 
capacity to buffer increased quantities of exogenous protein and are therefore 
less “stressed” or because the induction of autophagy is more tightly controlled 
than in other cell lines. In addition, adenoviral infection per se has no effect on 
the morphology or the life span of hepatocytes in culture. Using the adenovirus 
system I was able to infect up to  100% of cells thereby allowing quantitative 
analysis to be carried out.
I  found that hepatocytes have  a low basal  level  of autophagy  in full 
growth  medium,  which  can  be  made  visible  by  the  addition  of lysosomal 
protease inhibitors. At steady state I found between 1  to 5 autophagosomes per 
nucleus.
After  the  cells  were  shifted  to  starvation  medium  autophagosomes 
formed rapidly and an increase in GFP-LC3 labelled vesicles could be seen as 
soon as after 15 minutes, which is similar to what Kabeya et al. (Kabeya et al., 
2000) reported previously. As expected this increase could be inhibited by the 
addition  of PI3K  inhibitors.  Interestingly  after  approximately  60  minutes  I 
always  saw that the number of autophagosomes  reached  a plateau of 11-15 
autophagosomes per nucleus. I speculated that this could either mean that the 
new synthesis of autophagosomes is down regulated after 30 to 60 minutes or 
alternatively, that the GFP-LC3 in autophagosomes formed during the first 30 
to 60 minutes gets degraded when it reaches the lysosome. A possible reason 
for the downregulation could be a feedback mechanism, whereby the cell stops
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the production of new autophagosomes because it has generated enough new 
amino acids to allow the replenishment of the cellular amino acids pool, thereby 
alleviating the requirement for ongoing or additional autophagy. Alternatively, 
the machinery to form autophagosomes is limiting. To address this question I 
incubated starved cells in the presence of protease inhibitors. In this case the 
number of GFP-LC3 positive autophagosomes continued to increase in a linear 
fashion,  showing  that  autophagosomes  are  continuously  formed  during  the 
short term  starvation experiments. This was also confirmed by the quantitative 
electron  microscopy  time  course  where  the  number  of AVds  continued  to 
increase,  while  the  number  of AVis  reached  a  plateau  at  60  minutes.  This 
suggests  that after 60 minutes many of the  GFP-LC3  positive  structures are 
AVds, as expected also from previous studies (Dunn, 1994).
In  addition,  by  using  live-cell  imaging  and  by  following 
autophagosomes labelled with GFP-LC3,1 could confirm the time course data 
obtained with fixed cells. I detected GFP-LC3-positive autophagosomes within 
5 minutes after transferring the cells to ES. Most autophagosomes moved in a 
seemingly random start-stop manner over relatively short distances, while only 
a  few  vesicles  travelled  over  longer  distances.  Frequently  I  saw  GFP-LC3- 
positive structures interacting, possibly fusing with each other.  Judging from 
the movies, however, it is unclear if these potential fusion reactions would be 
homotypic fusions between different AVis or AVds or if they are heterotypic 
fusions between an AVi and AVd. In addition, I regularly observed GFP-LC3- 
positive  tubules  extending  from  the  autophagosomes  and  retracting,  and  in 
some cases it appeared as if the autophagosomes followed the tubular structure. 
The exact nature and function of these GFP-LC3 positive tubules is currently
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unclear.  It is,  however,  conceivable that these  structures might be related to 
microtubules,  since  LC3  has  initially  been  described  to  be  a  subunit  of 
Microtubule-associated  protein  1A  and  B  (MAP1-LC3)  (Mann  and 
Hammarback,  1994). Further research will be required to determine the exact 
nature and function of these tubules.  There was no discemable change in the 
movement  or  localization  of  the  autophagosomes  over  the  120  minutes 
incubation.
Being able to infect 95% to 100% of the hepatocytes with the GFP-LC3 
encoding  adenovirus  I  could  for  the  first  time,  evaluate  the  kinetics  of 
autophagosome formation using an automated imaging system and Metamorph 
6.2 software. I found that AVis form with U n of approximately 15 minutes in 
ES. The rapid induction I observed in the cultured hepatocytes is clearly faster 
than what Mizushima et al. (Mizushima et al., 2004) have observed in the liver 
of GFP-LC3 transgenic mice, where GFP-LC3-labelled autophagosomes could 
only  be  detected  after  24  hours  starvation  of  the  animal,  suggesting  that 
cultured hepatocytes are more sensitive to nutrient deprivation.  I hypothesize 
that this could be either because they are derived from rats starved for 20 hours 
or as a result of the ex-vivo culturing conditions, or both.
In  conclusion,  I  have  developed  a  system  based  on  the  adenoviral 
expression of GFP-LC3  in cultured primary hepatocytes.  I was able to  show 
that hepatocytes are amenable to genetic manipulation and that GFP-LC3  can 
be used to study autophagosome formation in fixed cells as well as in real time 
after  amino  acid withdrawal  or drug  treatments.  Furthermore,  I  was  able  to 
show that hepatocytes undergo basal autophagy,  even in  full medium.  Basal
123_________________________________________________________Chapter 3
autophagy might full-fill house keeping functions,  such as the degradation of 
old and damaged mitochondria or the degradation of long-lived proteins.
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4  AMINO ACID SIGNALLING
4.1  Ajm
Amino  acid  deprivation  of cells  is  one  of the  strongest  inducers  of 
autophagy. It is generally believed that the Target of Rapamycin (TOR) plays 
an  essential  role  in  sensing  the  level  of  amino  acids  (Feng  et  al.,  2005; 
Tokunaga et al., 2004) and it has been shown that amino acid withdrawal leads 
to the inactivation of TOR (Hara et al.,  1998).  In yeast (Noda and Ohsumi, 
1998) and in many cell lines inhibition of TOR or mammalian TOR (mTOR), 
respectively, by rapamycin results in the induction of autophagy independent of 
nutrient  levels,  as  measured  by  an  increase  in  protein  degradation,  LDH 
sequestration and the number of AVis  and AVds by EM (Blommaart et al., 
1995a; Eskelinen et al., 2002; Mordier et al., 2000;  Shigemitsu et al.,  1999). 
Recently,  however,  there  have  been  some  conflicting  reports  showing  that 
amino  acids  can  inhibit  autophagy  also  via  TOR-independent  pathways 
(Kanazawa et al., 2004; Mordier et al., 2000). Based on a serendipitous result I 
obtained with rapamycin, we therefore decided to study the role of mTOR in 
autophagosome  formation using  our  primary  rat  hepatocyte  system  and  the 
quantification assay I developed.
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4.2 Autophaaosome formation  is  independent of 
mTOR
During  the  initial  characterization  of the  virally  infected  hepatocytes 
expressing  GFP-LC3,  I  also  incubated  them  in  FM  containing  25  nM 
rapamycin. Intriguingly after a visual inspection I found that rapamycin, when 
added  to  FM,  did  not  induce  autophagosome  formation  (Figure  4.1 A).  To 
ensure that the rapamycin I added was active, and that the concentration was 
high  enough  to  inhibit  mTOR,  I  incubated  cells  with  or  without  25  nM 
rapamycin for 120 minutes in FM or ES. The cells were then harvested in the 
presence  of  phosphatase  inhibitors  and  blotted  with  a  phospho-specific 
antibody  against  threonine  389  of  p70S6K,  a  residue  specifically 
phosphorylated  by  active  mTOR  (Feng  et  al.,  2005).  In  FM,  rapamycin 
treatment of hepatocytes inhibited p70S6k phosphorylation within 120 minutes, 
demonstrating  that  a  concentration  of  25  nM  rapamycin  is  sufficient  to 
inactivate mTOR (Figure 4.IB).  ES  incubation,  on the other hand,  was  also 
sufficient to inhibit mTOR activity in the cultured hepatocytes, regardless of the 
rapamycin addition. As a control I checked the total p70S6K levels to ensure 
that  starvation or rapamycin treatment has no  effect  on the total  amount  of 
p70S6K (Figure 4. IB).
To quantify the above observed effect of rapamycin on autophagosome 
numbers, I incubated cells in FM or ES with or without 25 nM rapamycin for 
120 minutes and then analysed the saponin-extracted and fixed cells using the 
automated epifluorescence microscope (Figure 4.2A). As expected, hepatocytes 
expressing  GFP-LC3  had  only  a  low  number  of  autophagosomes  when
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incubated in FM, while incubation in ES for 120 minutes caused a significant 
increase  in  the  number  of  GFP-labelled  autophagosomes.  Addition  of 
rapamycin  to  full  medium  did  not  significantly  increase  the  number  of 
autophagosomes formed during the 2 hour incubation period (p<0.01), showing 
that inactivation of mTOR had no effect on the total autophagosome number 
per cell (Figure 4.2B).
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Figure 4.1: Inhibition of mTOR does not induce autophagosome formation 
in hepatocytes. Cultured hepatocytes expressing GFP-LC3 were incubated in 
either FM or ES in the absence (UT) or presence of 25 nM rapamycin (Rap) for 
2 hrs. After incubation cells were A)  fixed and visualized with a confocal LSM 
510 microscope, or B) extracted in TNTE buffer, plus phosphatase inhibitors. 
Anti-p70S6K or anti-phospho-p70S6K antibodies were used to detect p70S6K 
in FM or ES with or without rapamycin.  Bar in A equals  10 microns.  Data 
shown in A  and B is representative of 3 independent experiments.FM ES
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Figure 4.2:  Quantification of autophagosome formation in hepatocytes 
treated with rapamycin. Cultured hepatocytes expressing GFP-LC3  were 
incubated in either FM or ES in the presence or absence of 25 nM rapamycin 
(Rap or R)  for 2  hours.  After incubation  cells  were A)  and B)  saponin 
permeabilized and fixed and B) quantified with the Discovery-1   microscope. 
3300 cells were quantified per condition in B.  Bar in A) equals  10 microns. 
Data shown in A and B is representative of 3 independent experimentsChapter 4
4.3 Leucine is a strong inhibitor of autophagy
About  the  same  time  when  I  found that  inactivation  of mTOR with 
rapamycin did not activate autophagy, Kanazawa et al. (Kanazawa et al., 2004) 
reported data using proteolysis as a read-out for autophagy, which suggested 
that the addition of leucine may rescue autophagy independently of mTOR and 
possibly  through  an  unidentified  recepTOR  in  the  plasma  membrane  of rat 
hepatocytes. Therefore, using the GFP-LC3 expressing hepatocyte cultures and 
our  quantitative  assay,  I  decided  to  investigate  whether  leucine  addition  to 
starvation medium can suppress autophagosome formation to the same extent 
as  medium  containing  a  complete  amino  acid  mixture,  and  if  addition  of 
rapamycin can overcome the inhibitory effect of leucine.  So far there has not 
yet been a clear correlation of the effect of leucine or leucine and rapamycin on 
autophagosome  formation.  Additionally,  I  studied  the  effects  of regulatory 
amino  acids  (Reg  AA),  which  suppress  protein  degradation  by  autophagy 
(Meijer  and  Dubbelhuis,  2004),  on  the  formation  of the  GFP-LC3  positive 
vesicles. Reg AA are a selection of 8 amino acids which have been found to be 
particularly  effective  in inhibiting  autophagy  (Leu,  Tyr,  Pro,  Met,  His,  Trp, 
Ala). Most Reg AA are essential amino acids.
I  incubated hepatocytes  expressing  GFP-LC3  for  120  minutes  in  ES, 
containing Reg AAs, 0.8 mM leucine, 0.8 mM leucine plus 25 nM rapamycin 
or isoleucine. As a control I used cells incubated in FM or ES without additions 
(Figure  4.3).  In  accordance  with  earlier experiments,  ES  starvation  for  120 
minutes  increased  the  number  of autophagosomes  approximately  threefold.
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Addition of 4X the plasma serum level of leucine to ES during the starvation 
period suppressed the formation of autophagosomes to a level comparable to 
FM or regulatory amino acids in ES, while the addition of isoleucine had no 
effect, showing that the effect is specific for leucine. In addition, the inhibitory 
effect  of  4X  leucine  on  autophagosome  formation  was  not  changed  by 
simultaneous  addition  of  rapamycin  (Figure  4.3),  suggesting  that  leucine 
inhibits autophagy in a largely mTOR independent manner.
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Figure 4.3: Leucine inhibits autophagosome formation largely independent 
of mTOR. Infected cultured hepatocytes expressing GFP-LC3 were incubated 
for 2 hours  in either FM, or ES containing regulatory amino acids (RegAA 
(pM): Leu, 204; Tyr, 98; Pro, 437; Met, 60; His, 92; Trp, 93; Ala, 475), 0.8 mM 
(4x plasma level) leucine (Leu), 0.8 mM leucine plus 25 nM Rapamycin (Leu, 
Rap) or 0.8 mM (4 x plasma level) isoleucine (lie). 100% the maximum number 
of puncta obtained after incubation in ES. Data shown is representative of 4 
independent experiments.Chapter 4
4.4 Leucine  signals  through  a  novel  pathway 
largely independent of mTOR
Using protein degradation assays, it has previously been demonstrated 
that leucine (Mortimore et al., 1987), and a non-membrane permeable analogue 
of  leucine,  Leu8-MAPs  (Mortimore  et  al.,  1994),  inhibit  autophagy  in 
hepatocytes in a mTOR-independent manner.
I  thus  decided  to  study  the  effect  of Leug-MAPs  addition  to  ES  on 
autophagosome  formation.  For  that  reason  I  infected  cultured  primary  rat 
hepatocytes with GFP-LC3  encoding adenoviruses and either incubated them 
for  120 minutes in FM or in ES, containing 4x leucine, 4x Leug-MAP or 4x 
Ileg-MAP  as  a  control  (Figure  4.4).  After  saponin  extraction  and  fixation  I 
quantified the number of autophagosomes using the automated epifluorescence 
microscope. In accordance with the experiment in Figure 4.3, leucine addition 
inhibited autophagy to a level similar than in hepatocytes in FM. Interestingly 
Leug-MAP  addition  also  significantly  inhibited  autophagosome  formation, 
however,  not to the same  level as leucine.  Ileg-MAP  treatment,  on the other 
hand, had no statistically significant effect on the number of autophagosomes 
when  compared to  ES  alone.  In summary  these  results  suggest  that  leucine 
inhibits  autophagy  partially  through  a  putative  receptor  from  the  plasma 
membrane in agreement to the data presented by Kanazawa et al. (Kanazawa et 
al., 2004).
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Figure 4.4: Leucine inhibits autophagosome formation via a novel pathway 
originating from  the  plasma  membrane.  Infected cultured hepatocytes 
expressing GFP-LC3 were incubated for 2 hours in either FM, or ES containing 
0.8 mM (equals 4X plasma concentration) leucine (Leu),  or either 0.8 mM L8- 
MAP or 0.8 mM  I8-MAPs.  100% the maximum number of puncta obtained 
after incubation in ES. * for L8-MAPs p<0.01  versus ES, Leu, I8-MAPs. Data 
shown is representative of 2 independent experiments.Chapter 4
4.5 Discussion
When  I  developed  our rat  hepatocyte  model  I  found that rapamycin 
treatment did not induce the formation of GFP-LC3-positive autophagosomes 
when added to full growth medium. The concentration of rapamycin I used was 
sufficient to inhibit mTOR activity as measured by the phosphorylation status 
of T389 in p70S6 kinase.
This  was  unexpected  as  Blommaart  et  al.  (Blommaart  et  al.,  1995a) 
published in 1995 that rapamycin treatment of isolated rat hepatocytes induces 
autophagy,  although  not  to  the  same  extent  than  amino  acid  starvation. 
However,  Kanazawa  et  al.  (Kanazawa  et  al.,  2004)  found  in  2004  that 
rapamycin  had  no  effect  on  protein  degradation,  supporting  our  data  on 
autophagosome formation.  The biggest difference between Kanazawa’s  data, 
my data and Blommaart’s data is that Blommaart used cycloheximide in his 
protein degradation assays to inhibit the reincorporation of amino  acids  into 
new proteins during the time course of the assay. Cycloheximide treatment on 
its  own  has  been  shown  to  suppress  autophagy  (Khairallah  and  Mortimore, 
1976)  and  to  induce  p70S6  kinase  phosphorylation  (Price  et  al.,  1989). 
Rapamycin treatment, on the other hand, reduces p70S6 kinase phosphorylation 
by inhibiting mTOR activity.  In yeast,  the  combined treatment of cells with 
rapamycin and cycloheximide, led to a reduction of autophagosome size. It is 
therefore conceivable that the additional cycloheximide treatment might have 
influenced  Blommaart’s  results.  In  our  own  preliminary  experiments  using 
cycloheximide  I  observed  that  rapamycin  treatment  can  partially  induce
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autophagy in hepatocytes, incubated in ES with 4x leucine and cycloheximide, 
thereby repeating Blommaart’s data, while rapamycin treatment alone did not 
induce autophagosome formation,  although I  could clearly show that mTOR 
was inhibited.
The fact that rapamycin addition to full medium or starvation medium, 
containing 4x leucine, did not stimulate autophagosome formation supports the 
idea that amino acids, and especially leucine, may inhibit autophagy in cultured 
primary hepatocytes through a mTOR-independent mechanism. This hypothesis 
was  further  strengthened  by  the  partial  suppression  of  autophagosome 
formation  by  the  membrane  impermeable  leucine  analogue  Leug-MAP, 
supporting the data for a putative plasma membrane leucine receptor which is 
not upstream of mTOR or signals independently of mTOR (Kanazawa et al., 
2004; Mordier et al., 2000). Additionally, since Ileg-MAP treatment could not 
inhibit autophagy, this also suggests that amino acid sensing might be a highly 
specific  process,  possibly  involving  several  specific  “amino  acid  receptors” 
located in the cytoplasm or on the plasma membrane.
mTOR seems to be clearly involved in the regulation of autophagy by 
insulin (Kanazawa et al., 2004) and could  still be involved in later events in 
autophagy,  but  does  not  appear  to  be  part  of the  sensory  mechanism  for 
starvation  in  the  primary  rat  hepatocyte,  as  well  as  in  C2C12  myotubes 
(Mordier et al., 2000).
Using our high throughput counting assay,  I was able to correlate the 
results obtained using protein degradation assays with our results relating to the 
formation of autophagosomes. Protein degradation assays measure the flux of 
proteins through the system, which relies on a formed autophagosome fusing
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with  an  endocytic  compartment,  acidification,  degradation,  and  finally, 
transport of the free amino acids out of the autolysosome and into the cytosol 
and medium. However, protein degradation assays do not measure the extent of 
autophagosome formation directly as any block or disturbance at any stage in 
this  pathway  may  give  the  impression  of  autophagy  being  inhibited. 
Visualization  by  electron  or  light  microscopy  and  quantification  of 
autophagosome formation, under the conditions investigated above, however, 
should allow a definitive conclusion to be made about the mTOR-independent 
effect of leucine, and can also provide a system amenable to the identification 
of  the  putative  plasma  membrane  leucine  receptor  and  its  downstream 
signalling molecules.
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5  THE  ROLE  OF  MICROTUBULES  IN 
FORMATION AND FUSION
5.1  Aim
As discussed in chapter 1, microtubules have been shown to be required 
in a number of different membrane trafficking steps. The role of microtubules 
in autophagosome formation and fusion, however, is not completely clear and 
there  are  several  conflicting  reports  in  the  literature.  Depolymerising 
microtubules  with  nocodazole,  for  instance,  had  no  effect  on  the  fusion  of 
autophagosomes with lysosomes in Erlich ascites tumour cells (Reunanen et al., 
1988),  while  Aplin  et  al.  (Aplin  et  al.,  1992b)  showed that  autophagosome 
fusion  was  inhibited  in  NRK  cells.  Similar  conflicting  reports  have  been 
described when microtubules were disrupted with vinblastine.  Fengsrud et al. 
(Fengsrud  et  al.,  1995)  showed  that  fusion  was  inhibited  in  isolated 
hepatocytes, while Punnonen et al. (Punnonen et al., 1993) demonstrated that in 
cultured  rat  fibroblasts  fusion  with  prelysosomal  compartments  was  not 
affected.
I  therefore  decided  to  study  the  role  of microtubules  in  fusion  and 
maturation, using the quantitative high throughput system, developed in chapter 
3.6,  and the microtubule perturbing drugs taxol, vinblastine,  and nocodazole. 
Taxol  is  a microtubule  stabilizer (Schiff and Horwitz,  1980),  which  inhibits 
microtubule dynamics. Vinblastine and nocodazole (Panda et al., 1996; Samson 
et al., 1979), on the other hand, both prevent tubulin polymerization by binding
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to tubulin subunits, and therefore ultimately lead to the depolymerization of the 
microtubule  network.  In  order  to  investigate  formation  and  fusion 
independently,  the  drugs  were  used  in  conjunction  with  lysosomal  protease 
inhibitors.
5.2 Effect  of  microtubule  drugs  on  cultured 
primary rat hepatocytes
To  assess  the  effect  of  nocodazole,  taxol  and  vinblastine  on  the 
microtubule network in cultured primary rat hepatocytes I  isolated cells  and 
infected  them  with  adenoviruses,  encoding  GFP-LC3.  The  following  day, 
hepatocytes  were  either  left  untreated  or  were  pre-incubated  with  50  pM 
nocodazole, 5  pM taxol or 50  pM vinblastine in full growth medium, before 
transferring them to starvation medium, containing the respective drug.  Cells 
were then either fixed directly after the pre-treatment (t = 0) or after 15 or 120 
minutes starvation and stained with an anti-tubulin antibody (Figure 5.1).
After  the  30  minute  pre-incubation  with  either  nocodazole  or 
vinblastine,  the  microtubules  were  largely  depolymerised,  with  single,  long 
microtubules remaining in nocodazole treated cells. In cells treated with taxol, 
the microtubule network stayed intact, and no obvious difference to untreated 
cells could be observed. After a further 15 or 120 minutes incubation in ES in 
the  presence  of  nocodazole  or  vinblastine  the  microtubule  network  was 
completely depolymerised. In the vinblastine treated samples large aggregates 
could be observed, which became more numerous over the time course of the 
experiment.  On  the  other hand,  in  the  taxol  treated  and  untreated  cells  the
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microtubule network was unchanged, also indicating that starvation alone does 
not affect the structure of the microtubule network. In summary, these results 
suggest that the 30 minut pre-incubation and the drug concentrations used, were 
sufficient to  largely depolymerize the microtubule network.  Importantly,  the 
cells didn’t change shape  during the course  of the experiment and generally 
looked healthy.
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Figure 5.1: Effects of nocodazole, taxol and vinblastine on the  microtubule 
structure. Hepatocytes were pre-treated with 50 pM nocodazole, 5 pM taxol or 
50  pM vinblastine in FM for 30 mins, and then either fixed and stained for 
tubulin immediately (0 min), or incubated for a further 15 or 120 minutes in ES 
with the drug. Projections of z-stacks acquired on a LSM 510 confocal micro­
scope are shown. Bar equals 10 pM.Chapter 5
5.3 Microtubules are required for autophaqosome 
fusion with deqradative compartments
5.3.1  Autophaqosome  number  in  vinblastine  and  nocodazole 
treated cells is protease inhibitor insensitive
Hepatocytes  expressing  GFP-LC3  were pre-treated with  the  different 
microtubule drugs as described above and either incubated in FM or ES for 2 
hours, with or without PI. I then quantified the number of autophagosomes and 
assayed for GFP-LC3 lipidation, using western blot analysis. In untreated cells, 
the number of autophagosomes increased from approximately 3 per nucleus to
14 after starvation. Addition of PI to ES or FM increased the number to 20 and
15  autophagosomes per nucleus, respectively (Figure 5.2B), which correlated 
well with the results  from the time course  shown in Figure 3.11,  as  did the 
analysis  of  GFP-LC3  processing  (Figure  5.2C).  The  number  of 
autophagosomes  and  the  amount  of GFP-LC3-II  in  cells  treated  with  taxol 
largely mirrored untreated cells, both in the absence and presence of protease 
inhibitors.
Incubation  of  hepatocytes  with  nocodazole,  however,  resulted  in  a 
number of differences. Firstly, the number of autophagosomes after starvation 
in ES with nocodazole, approximately 10, was not increased by the addition of 
protease  inhibitors,  as  it  was  in  untreated  cells.  Secondly,  the  number  of 
autophagosomes in cells incubated in FM with nocodazole was elevated after a 
2 hour incubation and this number was insensitive to the addition of protease 
inhibitors.  GFP-LC3-II  formation  in nocodazole  treated  cells  reflected  these
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results (Figure 5.2C), as there was a constant elevated level of GFP-LC3-II in 
both FM and ES, which was not sensitive to protease inhibitors.
Incubation with vinblastine had similar effects as nocodazole treatment 
on  the  number  of  autophagosomes  with  regard  to  the  insensitivity  of the 
autophagosome  number  to  protease  inhibitors  in  FM  as  well  as  in  ES. 
Interestingly however, the number of autophagosomes was highly elevated in 
the  pre-treated  sample,  and  this  did  not  significantly  change  after  120  min 
(Figure  5.2B).  Accordingly,  the  amount  of  GFP-LC3-II  was  also  strongly 
increased by vinblastine (Figure 5.2C).
I  used  the  sensitivity  of  GFP-LC3  fluorescence  and  GFP-LC3-II 
amounts  to  protease  inhibitors  as  an  indirect  measure  of  fusion  of 
autophagosomes  with  a  degradative  compartment.  In  nocodazole  and 
vinblastine treated hepatocytes addition of protease inhibitors had no protective 
effect on the number of GFP-LC3  positive vesicles and the amount of GFP- 
LC3-II,  suggesting  that  fusion  was  inhibited.  Additionally,  the  number  of 
autophagosomes and the amount of GFP-LC3-II was  increased after 2 hours 
incubation in FM with nocodazole or vinblastine, indicating the accumulation 
of autophagosome due to a lack in fusion and degradation.
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Figure 5.2.  Effect of microtubule drugs on  fusion. Hepatocytes were pre­
treated with 50 pM nocodazole, 5 pM taxol or 50 pM vinblastine in FM for 30 
mins, and then either fixed immediately, or incubated for a further 120 minutes 
in FM or ES, with or without the drug. A) Representative images of GFP-LC3 
distribution at  120 min in ES, without or with drug, after saponin extraction 
acquired with a Discovery-1  microscope. B) Quantification of autophagosomes 
after treatment with drugs. Images of the cells were analysed as described in 
Materials and Methods.  C)  Samples from the time course were analysed by 
immunoblotting with anti-GFP antibody. Bars in A) equals 10 microns. Data in 
B  (mean +/- SEM of 16 acquired fields) is representative of 3  independent 
experiments.Chapter 5
5.3.2  Vinblastine and nocodazole treatment reduces the overlap of 
GFP-LC3  with  LvsoTracker  Red  and  inhibits  protein 
degradation
Since  the  data presented  above  is  an  indirect  measure,  I  decided  to 
directly measure the role  of microtubules  for the  fusion  of autophagosomes 
with  degradative  endosomes  using  two  approaches.  First,  I  measured  the 
amount  of co-localization  of LysoTracker  Red  labelled  late  endosomes  and 
lysosomes  with  GFP-LC3-positive  vesicles  using  confocal  microscopy,  and 
secondly,  I  measured  protein  degradation  in  14C-valine  labelled  cells,  after 
incubation with nocodazole or vinblastine.
For  the  co-localization  experiments  I  starved  GFP-LC3  expressing 
hepatocytes  for  2  hours  in  ES  or  pre-incubated  them  with  nocodazole  or 
vinblastine in FM and starved them for a further 2 hours in ES, containing the 
respective drug. LysoTracker Red was added to the starvation medium after 90 
minutes  in  ES.  Cells  were  then  fixed  and  the  extent  of co-localization was 
quantified using confocal imaging and the LSM software (Figure 5.3A and B). I 
found  that  in  untreated  cells,  approximately  20%  of the  LysoTracker  Red 
signals co-localized with GFP-LC3, while in nocodazole or vinblastine treated 
cells there was less than  10%  co-localization between LysoTracker Red and 
GFP-LC3 vesicles. To ensure that treatment with nocodazole or vinblastine did 
not  affect  the  total  number  of  LysoTracker  Red  positive  vesicles  or  the 
distribution  of these  vesicles,  I  quantified  the  number  of LysoTracker Red- 
positive  puncta using  Metamorph  6.2  software  and  visually  compared  their 
distribution  in  the  cell  (Figure  5.4).  I  could  find  no  statistically  significant
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difference between samples. Additionally the distribution of LysoTracker Red 
positive vesicles seemed to be unaffected by the drug treatment.
For  the  protein  degradation  assay,  GFP-LC3  expressing  hepatocytes 
were either left untreated or were pre-treated with nocodazole or vinblastine in 
FM.  Cells were then further incubated in FM or ES with or without protease 
inhibitors  for  an  additional  2  hours  (Figure  5.5).  In  untreated  cells,  ES 
incubation resulted in an increase in protein degradation that was reduced by 
the addition of protease inhibitors,  confirming the results obtained in Figure 
3.11. Nocodazole or vinblastine pre-treatment of cells followed by 2 hours in 
ES led to a clear reduction in the amount of protein degradation. Some residual 
protein  degradation  remained  which  was  sensitive  to  protease  inhibitors, 
suggesting that a very low amount of fusion still occurs, despite the vinblastine 
and nocodazole treatment.  Taxol on the other hand had no  effect on protein 
degradation, and was similar to untreated cells.
In summary, nocodazole and vinblastine treatment of hepatocytes led to 
a  strong  reduction  in  the  co-localization  of  LysoTracker  Red-positive 
endosomes and lysosomes, and GFP-LC3-positive autophagosomes, as well as 
a  clear  reduction  in  the  amount  of  protein  degradation.  These  results 
demonstrate  that  fusion  of  autophagosomes  with  endosomes  or  lysosomes, 
requires an intact microtubule network.
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Figure 5.3: Nocodazole  and vinblastine inhibit 
fusion of autophagosomes with endosomal com­
partments. A) Co-localization of LysoTracker Red 
with GFP-LC3. Hepatocytes were either untreated 
(UT), or pre-treated with 50 pM nocodazole (N) or 
50 pM vinblastine (V) and then starved in ES for 
120 mins in the absence or presence of the respec­
tive drug.  LysoTracker Red was added 30 mins 
before fixation.  The Overlap panel  shows the co­
localization detected by the LSM  510  software. 
Insets show two examples of autophagosomes co- 
localizing  with  LysoTracker  Red-positive 
organelles.  Top arrow indicates the position of 
autophagosome  shown  in the left inset, bottom 
arrow shows the autophagosome in the right inset. 
B) Quantification of co-localization. Data in A and 
B (mean +/- SEM of 10 and 9 fields, respectively) 
is representative of 2 independent experiments. Bar 
in A is 10 pm.* •-
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Figure 5.4: Microtubule drugs do not affect the number of LysoTracker 
Red-positive vesicles. Hepatocytes were either left untreated or were pre­
treated with 50 pM nocodazole or 50 pM vinblastine in FM for 30 minutes, and 
then incubated for a further 2 hours in ES with the respective drug. 30 minutes 
before fixation LyoTracker Red was added. A) number of LysoTracker Red- 
positive puncta per nucleus. All columns are not significantly different from 
each other (p > 0.05). B) Low magnification epi-fluoresence images of samples 
from (A). Data in A (mean +/- SEM of 9 fields, approximately  1000 cells) is 
representative of 2 experiments. Bar in B equals 10 pMCZlFM
FM + PI
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Figure 5.5:  Vinblastine and  nocodazole inhibit autophagosomal protein 
degradation.  14C-valine protein degradation assay.  Hepatocytes were either 
untreated, or pretreated with 5 pM taxol or 50 pM nocodazole or 50 pM vin­
blastine and then incubated for a further 2 hours in FM or ES with or without PI 
and the respective drug. Data (mean +/- SEM of triplicates) is representative of 
2 independent experiments.Chapter 5
5.4 Microtubules  facilitate  autophaqosome  for­
mation
Interestingly,  after  120  minutes  starvation  in  ES  the  number  of 
autophagosomes in nocodazole treated samples was less than in untreated cells 
(Figure  5.2).  This  was  unexpected,  as  a block  in  fusion  should  lead  to  the 
accumulation of autophagosomes to an amount similar to what I measured in 
starved hepatocytes in the presence of protease inhibitors.
I  therefore  decided  to  investigate  if  autophagosome  formation  was 
affected by  the  absence  of microtubules.  Hepatocytes  were  pre-treated  with 
nocodazole for 30 minutes, and then further incubated with or without protease 
inhibitors  in  FM  or  ES,  containing  nocodazole.  As  a  control  I  included 
hepatocytes  starved in ES  with protease inhibitors.  The presence  of protease 
inhibitors should ensure that I measure formation only and that the degradation 
of GFP-LC3 during the time course of the experiment does not influence the 
result.
In agreement with the  data  shown  in Figure  5.2  I  found that  at  120 
minutes the amount of autophagosomes in FM with nocodazole was elevated to 
a level similar to cells starved in ES with nocodazole (Figure 5.6A). Addition 
of protease inhibitors to both, FM and ES, containing nocodazole, had no effect 
and  did  not  further  increase  the  number  of  GFP-LC3  positive  puncta. 
Interestingly, in ES  and nocodazole treated samples,  at early time points the 
rate of autophagosome formation was reduced in comparison to cells starved in
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ES in the presence of protease inhibitors, showing that formation was affected 
by nocodazole.
I  next  investigated  the  effect  of  nocodazole  on  autophagosome 
movement using live cell imaging. For this reason I pre-treated hepatocytes for 
30  minutes  with  nocodazole  in  FM,  before  transferring  them  to  ES,  also 
containing  nocodazole.  As  a  control  I  used  hepatocytes  starved  in  ES. 
Approximately 5 minutes after switching the cells to ES I started imaging for 
15 minutes. Images were acquired every  10 seconds to increase our ability to 
detect moving vesicles. In ES the majority of the GFP-LC3 positive structures 
moved rapidly over short distances (see supplementary movie Fig. M3), while 
the autophagosomes in the nocodazole treated cells (see supplementary movie 
Fig.  M4)  showed  very  little  or  no  movement.  Figure  5.6C  shows  frames 
extracted from the movies M3 and M4. Together, these results suggest that an 
intact microtubule network facilitates the formation of autophagosomes in ES, 
and that newly formed autophagosomes move on microtubules.
151Figure  5.6:  Nocodazole  inhibits  fusion  and  reduces  the  rate  of 
autophagosome formation. A) Time course of autophagosome formation. 
Hepatocytes were pre-treated without or with 50 pM nocodazole (N)  for 30 
minutes, saponin extracted and fixed immediately, or incubated for a further 15, 
30 or 120 mins in ES with PI, and without or with nocodazole. At  15 minutes 
the nocodazole-treated sample is statistically different to ES + PI (p < 0.05). B) 
Representative images from the time course in A. C) Representative enlarged 
areas from the supplementary movies (see S3 and S4). Cells were incubated in 
ES (upper panel) or were pre-treated with nocodazole in FM and then shifted to 
ES plus nocodazole (lower panel). Time is shown in hr:min:sec. Arrowhead 
indicates a moving autophagosome. Data in A (mean +/- SEM of 16 acquired 
fields)  is representative of 2 independent experiments.  Bar in B)  equals  10 
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5.5 Vinlastine  induces  autophaav  and  inhibits 
fusion
Intriguingly,  besides  its  effect  on  fusion,  vinblastine  treatment  of 
hepatocytes  led  to  a  large  increase  in  the  number  of  GFP-LC3  positive 
autophagosomes, as well as to an increase in the amount of GFP-LC3-II. This 
increase was apparent in FM, as well as in ES, and was not sensitive to protease 
inhibitors (see Figure 5.2). In addition, the increase was already clearly visible 
after 30 minutes pre-treatment in FM.
I  therefore  decided  to  investigate  the  effect  of  vinblastine  on  the 
formation in a time course over 120 minutes (Figure 5.7A). As also shown in 
Figure 5.2, there was a strong increase in the number of autophagosomes after 
the 30 minute pre-treatment in FM (t=0 min).  During this pre-incubation the 
number of vesicles increased more than threefold. This correlated well with the 
increase  in  the  amount  of  GFP-LC3-II  at  t=0  (Figure  5.7B).  During  the 
following 120 minute incubation FM or ES with or without PI in the presence 
of vinblastine  the  number  of vesicles  increased  further.  This  increase  was 
independent of the treatment. As a control hepatocytes were incubated in FM 
plus  PI  or  in  ES  with  or  without  PI.  When  vinblastine  was  added  at  the 
beginning  of the  experiment  (Figure  5.7C)  the  number  of autophagosomes 
started to  increase within  15  minutes  incubation in FM or ES.  Interestingly, 
after  15  minutes  starvation  in  the  presence  of  vinblastine  the  number  of 
autophagosomes was consistently higher than in hepatocytes incubated in FM
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with  vinblastine.  However,  this  increase  was  no  longer  apparent  after  30 
minutes (Figure 5.7C).
The effect of vinblastine on autophagosome formation in FM and ES, 
however, seems to be unrelated to its depolymerising effect on microtubules, as 
the full extent of the depolymerisation of the microtubules occurred only after 
30 minutes of pre-treatment (Figure 5.1). At 30 minutes there were still single 
microtubules  left  in  the  cell.  Additionally,  depolymerising  the  microtubule 
network with nocodazole did not correlate with the accelerated autophagosome 
formation observed after treatment with the vinblastine.
Based on those results I wanted to investigate if the vinblastine-induced 
increase  in  autophagosomes  depends  on  known  Atg  proteins  using  siRNA 
interference techniques. All siRNA experiments were carried out by Edmond 
Chan, a post-doc in our laboratory.
Since  primary  hepatocytes  are  difficult  to  transfect  and  can  not  be 
cultured for more than 3 days before they start to dedifferentiate they are not 
ideal for these experiments. We therefore decided to use HEK293A cells stably 
expressing GFP-LC3 (HEK293/GFP-LC3). HEK293/GFP-LC3 cells responded 
to vinblastine like primary rat hepatocytes. Incubation with vinblastine in FM 
for 60 minutes led to an increase in the number of autophagosomes as detected 
by the appearance of GFP-positive vesicles (Figure 5.8A).
Atg5 and Atg6/Beclin have both been shown previously to be required 
for mammalian autophagy (Kuma et al.,  2004;  Liang et al.,  1999;  Qu et al., 
2003).  Thus  we  transfected  HEK293A  cells  with  siRNAs  to  deplete  these 
proteins and asked if vinblastine treatment still resulted in an increase of GFP- 
LC3-II  by  western  blotting.  72  hours  after  the  siRNA  treatment  of  the
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HEK293/GFP-LC3 cells both Atg5 and Atg6 protein levels were depleted by 
more than 90% (Figure 5.8B). In those Atg5- or Atg6-deficient cells GFP-LC3 
conversion  from  GFP-LC3-I  to  GFP-LC3-II  was  strongly  reduced  after 
vinblastine  treatment  (Figure  5.8C).  As  a  control  we  used  siRNAs  against 
firefly luciferase, which engages the RISC complex but produces non-targeting 
siRNA.  The  increase  in  GFP-LC3-II  upon  vinblastine  treatment  was  also 
sensitive to  wortmannin  (Figure  5.8C).  Together these data suggest that  the 
stimulation  of autophagosome  formation  by  vinblastine  occurs  through  the 
normal pathway, dependent on Atg proteins and PI3-kinases.
155A C
FM  ES  w
rw i f ri co t ri
o  20 -i
+ V
o. 15-
-V
3  10
0   0  20  40  60  80  100  120
Time (mins)
o 20
S  15
c  10
ES + V 
FM + V 
ES
0
B
FM+VIN  ES+VIN
Mr(k)  -PI  +PI  -Pi  +PI
0  15 3012015 30120  15 3012015 30120 mins
Figure 5.7:  Vinblastine inhibits fusion  and induces  autophagy  in 
hepatocytes. A) Time course of autophagosome formation after vinblastine 
treatment. Hepatocytes were pre-treated with 50 pM vinblastine for 30 mins in 
FM, and either saponin extracted and fixed immediately, or incubated for a fur­
ther 15, 30, 60, 90 and  120 mins under various conditions. Samples with vin­
blastine treatment: FM, ES and ES+PI; samples without vinblastine treatment: 
FM+PI, ES and ES+PI. B) Hepatocytes were pre-treated with 50 pM vinblas­
tine and then incubated for a further 0, 15, 30 or 120 mins in FM or ES, without 
or with PI in the presence of vinblastine. At the given time points cells were 
harvested and analysed.  C) Time course of autophagosome formation after vin­
blastine treatment. Hepatocytes were incubated in FM or ES with vinblastine or 
in ES alone for 15 or 30 minutes and then saponin-extracted and fixed. Data in 
A and C (mean +/- SEM of 16 acquired fields) is representative of 2 indepen­
dent experiments Data in B and C is representative of 3  and 2  independent 
experiments, respectively.B
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Figure 5.8: Vinblastine induces autophagy in HEK293A cells in a Atg5 and 
Atg6 dependent manner. A) HEK293A cells stably expressing GFP-LC3 
(HEK293/GFP-LC3) were either left in FM or incubated in FM with vinblastine 
for 60 mins, and then visualized by confocal microscopy.  B) HEK293/GFP- 
LC3 cells were transfected with control siRNA (C) or siRNA for Atg5 or Atg6, 
lysed 72 hrs later, and then analysed by immunoblotting with antibodies for 
Atg5 or Atg6.  The positions of the Atg5-Atgl2 conjugate or Atg6 are indicated 
by arrowheads. C) HEK293/GFP-LC3 cells were transfected with siRNA4 s as 
above and incubated in FM for 2 hrs without or with 50 pM vinblastine or 
lOOnM wortmannin (WM). Data in C is representative of 3 independent experi­
ments.  Bar in A is  10 pm. These experiments were carried out by Edmond 
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5.6 Vinblastine  stimulated  autophaav  is 
independent of mTOR
The data presented above suggests that vinblastine activates a signalling 
pathway,  that  ultimately  leads  to  an  increase  in  autophagosome  formation. 
Since the kinase mTOR has been shown to play an important role in regulating 
autophagy in yeast and in many mammalian cell-lines (Klionsky, 2005), I asked 
if the  increase  in the number of autophagosomes by vinblastine  depends  on 
mTOR.
Incubation  of HEK293/GFPLC3  cells  for  120  minutes  in  FM  with 
rapamycin led to an increase in the amount of GFP-LC3-II, which was visible 
as soon as  15 minutes after the addition of rapamycin to the medium (Figure 
5.9A).  This  was  likely  through  inactivation  of mTOR  by  rapamycin  as  a 
corresponding decrease in the phosphorylation of threonine 389 of p70S6K was 
detected  in  the  same  lysates  (Figure  5.9B).  In  accordance  with  the  results 
obtained  in  Figure  5.8  vinblastine  treatment  over  120  minutes  induced 
autophagy when added to FM. However, vinblastine treatment did not result in 
an inactivation of mTOR (Figure 5.9B), despite the rapamycin-sensitivity of the 
HEK293/GFP-LC3  cells.  As  a  control,  we  confirmed  that  starvation  of 
HEK293/GFP-LC3  cells in ES resulted in mTOR inactivation and GFP-LC3 
conversion. These results show that the vinblastine stimulated increase in GFP- 
LC3-II in HEK293/GFP-LC3 cells, is independent of mTOR.
In contrast to HEK293A cells, autophagy in hepatocytes is rapamycin- 
insensitive (see also Chapter 4). Although rapamycin inactivated mTOR, it did
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not increase the number of autophagosomes (Figure 4.1  and Figure 4.2).  To 
investigate  what  effect  vinblastine  has  on  p70S6K  phosphorylation  in  rat 
hepatocytes,  I  pre-incubated  cells  in  FM  with  vinblastine  followed  by  120 
minutes incubation in FM or ES in the presence of vinblastine. As a control I 
used  hepatocytes  cultured  in  FM.  Interestingly,  I  could  detect  no  p70S6K 
phosphorylation (Figure 5.9C) after 120 minutes.
To further investigate if the inhibition of p70S6 kinase by vinblastine 
could induce autophagy, I analysed the time at which vinblastine causes mTOR 
inactivation.  I  therefore  performed  a  time  course  and  compared  p70S6K 
phosphorylation  in  cells  incubated  in  FM  plus  vinblastine,  or  ES  plus 
vinblastine, to untreated cells in ES (Fig. 91).
Vinblastine  clearly  inactivated  mTOR  in  FM  after  a  45  minutes 
incubation  in  FM  (30  minutes  pre-treatment  followed  by  an  additional  15 
minutes incubation). In ES, vinblastine clearly enhanced the starvation-induced 
inactivation of mTOR. It is, however, unlikely that the inactivation of mTOR 
by  vinblastine  is  the  reason  for  the  induction  of autophagy  in  hepatocytes, 
because the time course of mTOR inactivation by vinblastine in FM does not 
parallel  the  rapid  induction  of  autophagy.  While  autophagy  was  induced 
immediately after the addition of vinblastine and there was a high number of 
vesicles present after 30 minutes, mTOR was only inactivated after about 45 
minutes in FM.
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Figure 5.9: Vinblastine inhibits mTOR in hepatocytes but not in HEK293A 
cells A and B) Immunoblot analysis of HEK293/GFP-LC3 cells incubated for 0, 
15, 30, 60 and 120 minutes in FM with 55 pM rapamycin or 50 pM vinblastine 
or in ES alone, with either an A) anti-GFP antibody or B) threonine389 
phospho-p70S6K antibody.  In HEK293/GFP-LC3  cells,  a non-specific 
rapamycin-insensitive band is detected migrating slightly faster than p70S6K. 
(*) indicate positions of higher molecular weight rapamycin-insensitive bands, 
which are non-specifically detected by the phospho-antibody. C) Hepatocytes 
were incubated either in FM or in ES or FM plus vinblastine for 2 hours. The 
vinblastine samples were pre-treated with vinblastine for 30 minutes in FM. 
Samples were then solubilized and immunoblotted with the phospho-specific 
p70S6K antibody (upper blot). The position of p70S6K was confirmed with pan 
p70S6K antibody (lower blot). D) Hepatocytes grown in FM were either 
starved in ES for 0, 15, 30, 120 mins or pre-treated with 50 pM vinblastine in 
FM and then incubated for 0, 15, 30, 120 mins in FM or ES plus 50 pM vin­
blastine, solubilized and subjected to immunoblotting with phospho-p70S6K 
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5.7 Discussion
In this chapter I investigated the role of microtubules for the maturation 
of autophagosomes  in  cultured primary  rat  hepatocytes.  Using  drugs  which 
affect the stability of microtubules, I independently investigated formation, as 
well as fusion of autophagosomes with compartments of the endosomal system. 
The  drugs  I  used  were  nocodazole  and  vinblastine  to  depolymerise 
microtubules and taxol to stabilize microtubules.
The function of microtubules  in  fusion has been controversial  in the 
literature (see also Chapter 5.1  and Introduction); in Erlich ascites tumor cells 
(Reunanen et al.,  1988),  for example,  depolymerisation of microtubules with 
nocodazole  has  been  reported  to  have  no  effect  on  the  fusion  of 
autophagosomes  and  lysosomes,  while  in  NRK  cells  nocodazole  treatment 
caused  an  accumulation  of  autophagosomes,  which  did  not  contain  acidic 
hydrolases (Aplin et al., 1992b). More recently Webb et al. (Webb et al., 2004) 
showed that nocodazole treatment impaired the clearance of A53T a-synuclein, 
a protein that is normally cleared by autophagy (Webb et al., 2003).  Similar 
conflicting results have been published with vinblastine (Fengsrud et al., 1995; 
Punnonen et al., 1993).
One of the reasons for the discrepancies between the different reports in 
the  literature  may  be  that  they  use  different  cell  types.  Another  potential 
problem is that the microtubule depolymerising drugs were added at the time of 
starvation in most of the previous studies. It is conceivable that there is a lag 
period between the addition of the drug and the complete depolymerisation of
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the microtubule network, depending on the concentration of the drug and the 
cell line used.  Since I know that autophagosomes from rapidly after cells are 
transferred to starvation medium (see also Chapter 3.7) it is conceivable that 
autophagosomes form and fuse during this initial lag period.
I therefore decided to first investigate the time required to completely 
depolymerise the microtubule network. Nocodazole treatment of hepatocytes 
completely  depolymerised  the  microtubule  network  within  45  minutes. 
Vinblastine  treatment,  on  the  other  hand,  led  to  the  formation  of tubulin 
aggregates, which became visible after 45 minutes treatment. These aggregates, 
however, did not co-localize with GFP-LC3-spots (data not shown).
For the following experiments I therefore decided to pre-treat the cells 
for  30  minutes  with  the  respective  drug.  Intriguingly,  in  nocodazole  or 
vinblastine treated cells, the number of autophagosomes did not increase when 
the  samples  were  treated  in  parallel  with  lysosomal  protease  inhibitors, 
suggesting a block in fusion.  Taxol treated cells,  on the other hand behaved 
similarly  to  untreated  cells,  indicating  that  microtubules,  but  not  dynamic 
microtubules,  are  required  for the  formation  and  fusion  of autophagosomes 
with late endosomes.
The lack of effect of protease inhibitors could possibly be attributed to 
several  other  reasons.  Both,  nocodazole  and  vinblastine  could  affect  the 
integrity of the endosomal system, thereby indirectly affecting the ability of late 
autophagosomes to mature to autolysosomes or alternatively, the transport of 
hydrolytic enzymes to late endosomes and lysosomes could be disturbed. This 
would then prevent the degradation of an autolysosome,  and the addition of 
protease inhibitors would have no effect. To address these problems I stained
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acidic  compartments  in  GFP-LC3  expressing  hepatocytes  with  LysoTracker 
Red and investigated the number and distribution of LysoTracker Red-positive 
organelles  and the  amount  of overlap  between  LysoTracker  and  GFP-LC3. 
Neither,  nocodazole  nor  vinblastine  treatment  had  a  statistically  significant 
effect  on  the  number  and  distribution  of  late  endosomes  and  lysosomes, 
suggesting that those organelles are not affected by the short term incubation 
(up to 150 minutes total) with the microtubule disrupting drugs. In addition, the 
percent  area  overlap  between  LysoTracker  Red  and  GFP-LC3  was  clearly 
reduced in the drug-treated samples, showing that fusion was largely inhibited.
Interestingly,  the  total  number  of  GFP-LC3-positive  vesicles  in 
nocodazole and vinblastine treated samples was different from untreated cells 
starved in ES for 120 minutes in the presence of protease inhibitors. One would 
think that in the drug treated samples, if the drugs inhibited fusion only, the 
total number of accumulated vesicles would be equal to that in untreated cells 
incubated  in  ES  with  protease  inhibitors.  This  was  clearly  not  the  case; 
nocodazole-treated cells had about the same number or even slightly less GFP- 
LC3-positive  vesicles  than untreated  cells  in  ES  without protease  inhibitors 
while vinblastine-treated cells had clearly more autophagosomes than control 
cells,  regardless  of  the  treatment.  This  suggested  that  formation  of 
autophagosomes  was  affected as  well,  although  apparently through different 
mechanisms.
Using  the  quantitative  counting  assay  and  time-lapse  microscopy,,  I 
could show that the rate of formation is reduced in nocodazole treated cells. 
This data disagrees with the findings  of Aplin et al.  (Aplin et al.,  1992a)  in 
NRK  cells  where  the  number  of  A  Vis  was  not  affected  by  nocodazole
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treatment.  A possible  reason  for this  apparent discrepancy may be the  time 
point  of  nocodazole  addition  as  discussed  above.  It  is  likely  that 
autophagosome  formation  is  faster  than  the  depolymerisation  of  the 
microtubule network, necessitating pre-treatment.
My  data  suggest  that  microtubules  facilitate  formation,  but  are  not 
absolutely required for it. It is currently unclear why microtubules are needed 
for efficient formation.  Hamasaki et al.  (Hamasaki  et al.,  2003)  showed that 
components of the COPII coat and a functioning early secretory pathway are 
necessary for autophagosome formation in yeast. This was further confirmed by 
Reggiori et al.  (Reggiori et al., 2004b), who hypothesised that both, ER and 
Golgi, could be the membrane source for forming autophagosomes. In addition, 
Reggiori ruled out that endosomes are involved in autophagosome formation in 
yeast. In mammalian cells, the ER has also been implicated in autophagosome 
formation  (Dunn,  1990a).  Vesicular  transport  from  the  ER  to  the  Golgi 
complex via COPII coats is microtubule dependent. Disruption of microtubules 
with nocodazole  has  been  shown  to  disturb  the  structure  of the  Golgi  and 
transitional ER (tER), leading to a clustering of normally relatively immobile 
tER sites adjacent to immediate-sized Golgi structures (Hammond and Glick, 
2000).  It  is  possible  that  under  starvation  conditions,  when  the  rate  of 
autophagy is stimulated, a perturbation in the trafficking between the tER and 
Golgi  could lead to  a reduction in the  rate  of autophagosome  formation by 
disturbing membrane trafficking to the PAS; while in full medium,  the supply 
of  membranes  to  the  PAS  might  be  sufficient  to  meet  the  demand  for 
autophagosome formation. My data with nocodazole supports the proposal that
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the autophagosome is derived from a membrane source that requires transport 
from the ER to the Golgi (Reggiori et al, 2004b).
Vinblastine  treatment  of  hepatocytes,  on  the  other  hand,  had  a 
completely  different  effect  on  the  number  of  autophagosomes.  After  120 
minutes  in  ES  or  FM  with  vinblastine,  hepatocytes  had  approximately two 
times more autophagosomes than untreated cells starved in ES and at least 5 
times more autophagosomes than untreated cells in FM. Cells starved in ES had 
approximately  3  times  more  vesicles  than  cells  in  FM.  These  changes  are 
similar to those seen by Seglen et al. (Kovacs et al.,  1982) of 6.4-fold and 2.5- 
fold, in FM with vinblastine and in ES, respectively.  Similar increases in the 
number of autophagosomes after vinblastine treatment have also been seen in 
CHO  cells (Munafo  and Colombo, 2001)  and in murine exocrine pancreatic 
cells (Rez et al., 1991).
The  high  number  of  autophagosomes  in  cells  pre-treated  with 
vinblastine suggests that vinblastine can induce autophagy even in full medium. 
The number of autophagosomes doubled within 15 minutes after the addition of 
vinblastine, indicating that the inducing effect of vinblastine is independent of 
microtubules  as  the  stimulation  occurred  before  all  the  microtubules  were 
depolymerised. Interestingly, addition of vinblastine to ES accelerated the rate 
of formation  at  early  time  points.  This  could  either  mean  that  vinblastine- 
induced  autophagy  utilizes  a  pathway  that  is  independent  from  starvation- 
induced  autophagy,  and  both  pathways  have  a  cumulative  effect  on  the 
formation rate, or alternatively that vinblastine increases the signalling through 
the starvation-induced pathway.
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To  address  the  question  if  vinblastine-stimulated  autophagosome 
formation requires Atg proteins, we used siRNA knockdown to deplete Atg5 
and Atg6 in HEK293A cells, both of which have been shown to be required for 
autophagy (Kuma et al., 2004; Liang et al.,  1999; Qu et al., 2003; Yue et al.,
2003).  Both  siRNA  Smartpools  inhibited  vinblastine-induced  autophagy, 
showing  that  the  normal  autophagy  machinery  is  required.  Interestingly 
wortmannin completely blocked vinblastine induced autophagy, suggesting that 
vinblastine acts upstream of PI3 kinases.
I then asked if vinblastine can affect mTOR activity. mTOR has been 
shown to be essential for autophagy in yeast and in several cell lines (Gutierrez 
et al., 2004a; Ravikumar et al., 2004), but not in hepatocytes (Kanazawa et al.,
2004)(see  also  Chapter 4).  Intriguingly,  vinblastine  treatment resulted  in the 
inactivation  of  mTOR,  however,  with  kinetics  that  were  different  to  the 
vinblastine-induced  stimulation.  After  30  minutes  pre-treatment  cells  had 
already a large number of autophagosomes, although mTOR was still active at 
that time point.
In HEK293A  cells,  which  are  rapamycin-sensitive  in  comparison  to 
hepatocytes,  vinblastine  had  no  affect  on  mTOR  activity.  Thus,  in  both  a 
rapamycin-insensitive  and  rapamycin-sensitive  cell,  vinblastine  stimulated 
formation by a mTOR independent mechanism. This suggests that vinblastine 
stimulates  autophagy  either downstream  of mTOR or via  a novel yet  to be 
identified  signalling  pathway.  Further work  will be  required  to  identify  the 
target and signalling pathway of vinblastine.
As  an  aside  it  is  interesting  to  note  that  in  HEK293A  cells,  where 
starvation-induced autophagy  is  seemingly mTOR-dependent,  autophagy  can
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also  occur in the presence  of active mTOR.  One  explanation,  as mentioned 
above, for this could be that vinblastine acts either downstream or on a parallel 
pathway and therefore inhibition of mTOR and the modulation of the signalling 
pathway  downstream  of  mTOR  is  not  required  to  induce  autophagy. 
Alternatively,  however,  it  is  also  possible  that  rapamycin-treatment  of 
HEK293A cells, at least at high concentrations, has in addition to its specific 
effects on mTOR other unspecific effects on other signalling pathways, which 
could then increase the rate of autophagosome formation.
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6  IN  VITRO  RECONSTITUTION  OF 
AUTOPHAGOSOME FUSION
6.1  Aim
In yeast autophagosomes fuse directly with the vacuole. In mammalian 
cells  on  the  other  hand,  autophagosomes  fuse  with  compartments  of  the 
endocytic system, thereby acquiring lysosomal membrane proteins and proton 
pumps needed for the acidification, as well as degradative enzymes. However, 
it  is  not  clear  what  the  preferred  endosomal  compartment  for  fusion  is. 
Depending on the cell type there is evidence  supporting both a fusion event 
with early endosomes (Berg et al., 1998) and late endosomes (Berg et al., 1998; 
Punnonen et al., 1993; Tooze et al., 1990) as well as with lysosomes (Lawrence 
and  Brown,  1992).  In  addition,  there  is  also  data  that  suggests  that 
autophagosomes first acquire proton pumps and membrane proteins by fusing 
with  small  endosome  derived  vesicles  before  fusing  with  late  endosomes 
(Dunn, 1990b; Punnonen et al., 1993).
I therefore decided to develop an in vitro fusion assay to firstly identify 
the  fusion  partner(s)  of autophagosomes  and  secondly  to  investigate  which 
proteins are involved in the fusion reaction, with special regards to the SNARE 
and Rab proteins involved in the homotypic and heterotypic fusion events of 
late  endocytic  compartments.  In  the  following  chapter  I  will  discuss  the 
underlying principle  of the  fusion assay  and the  progress  I  made to  date  in 
setting up the assay.
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6.2 Underlying  principle  of  the  in  vitro  fusion 
assay
My  in  vitro  fusion  assay  is  based  on  the  widely  used  approach  of 
content mixing between purified autophagosomes and purified compartments of 
the endo-lysosomal system (see Figure 6.1). The method I developed is based 
on  published  in  vitro  fusion  assays,  which  were  used  for  investigating 
endosome -  lysosome fusion and endosome -  endosome fusion (Bright et al., 
1997; Clague et al.,  1994; Colombo et al., 1991; Colombo et al., 1992; Diaz et 
al., 1988; Ellis et al., 1992; Mills et al., 1998; Mullock et al., 1998).
In order to measure the extent of fusion, I internalized specific markers 
into endosomes, as well as lysosomes. Since the organelles I want to load are 
acidic, the markers had to be resistant to degradation by lysosomal hydrolases. 
Initially, I therefore decided to use a system based on biotin-HRP and avidin. In 
order to label endosomes I internalized biotin-HRP as a fluid phase marker into 
hepatocytes (see Chapter 0). To label autophagosomes I over-expressed avidin 
in my hepatocytes,  using an  adenoviral expression system  (see  also  Chapter 
6.3). I then induced autophagy by starving the cultured hepatocytes in ES, to 
allow the sequestration of the cytosolic avidin into forming autophagosomes. 
However,  it became quickly  apparent that the over-expressed avidin did not 
bind biotin and was toxic for the hepatocytes (data not shown). Since avidin is a 
tetramer  and  the  monomers  bind biotin with  a  lower  affinity,  I  decided  to 
modify  the  system  and  use  streptavidin  instead.  To  facilitate  targeting  to 
autophagosomes I tagged streptavidin with LC3 at the C-terminus. In addition, 
I added the sequence for the HA epitope at the N-terminus (HA-SV-LC3).
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I  then  purified  different  endosomal  populations  (Chapter  0)  and 
autophagosomes  (Chapter  6.3),  containing  their  respective  markers  and 
attempted  to  reconstitute  fusion  in  vitro,  by  adding  cytosol  and  ATP- 
regenerating system to the purified vesicles.  As  an alternative to biotin-HRP 
internalization I used anti-HA antibodies.
To assess the extent of fusion I then measured the meeting of the two 
internalized  markers.  In  case  of  the  biotin-HRP  internalization  I 
immunoprecipitated  HA-SV-LC3  using  an  anti-HA  antibody  and  measured 
HRP  activity.  In  the  case  of the  anti-HA  antibody  internalization  I  added 
protein  G-sepharose  beads  to  the  lysed  fusion  reactions  and  then 
immunoblotted  for LC3.  The  following  sections  summarize  my  progress  to 
date.
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Figure 6.1: In vitro fusion assay scheme:Chapter 6
6.3 HA-SV-LC3  localizes  to  purified
autophaaosomes
The underlying principle of the fusion assay requires that the lumen of 
the autophagosomes is specifically loaded. I decided on using streptavidin as 
the marker for autophagosomes and fused it to LC3 at the C-terminus to ensure 
that it is specifically targeted to newly formed autophagosomes. In addition, I 
added an HA epitope to  the N-terminus of streptavidin,  to be able to  easily 
immunoprecipitate it from the fusion reaction. The construct was then sent to 
the company Viraquest for the generation of adenoviruses.
To  ensure  that the  construct  is  correctly  targeted  to  autophagosomes 
upon starvation,  I infected cultured primary rat hepatocytes for 2 hours with 
both the GFP-LC3  and the HA-SV-LC3 encoding adenoviruses together. The 
following day the cells were starved for 120 minutes in ES, before being fixed 
and stained with an anti-HA antibody and an Alexa 555  secondary antibody. 
Control cells were incubated in FM. As expected, in hepatocytes grown in full 
medium (Figure 6.2A), GFP-LC3 was localized diffusely in the cytosol, as well 
as in the nucleus. HA-SV-LC3, on the other hand, localized in addition to its 
cytosolic staining also to a number of distinct punctate structures of unknown 
origin. After starvation (Figure 6.2B) as expected there was  a dramatic increase 
in  autophagosomes  labelled  with  GFP-LC3.  Most  of the  bigger  structures 
perfectly  co-localized  with  HA-SV-LC3,  however,  there  were  also  some 
smaller GFP-positive  structures  which  did not co-localize with HA-SV-LC3 
(Figure 6.2B). One possible explanation for this could be that these GFP-LC3-
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positive vesicles represent amphisomes or AVds and that GFP is more stable 
than the HA tag.
To further confirm that HA-SV-LC3 localizes correctly and to generate 
material for the fusion assay, I purified autophagosomes from cultured primary 
rat  hepatocytes,  expressing  HA-SV-LC3,  using  a  method  established  by 
Stromhaug  et  al.  (Stromhaug  et  al.,  1998).  As  a  control  I  used hepatocytes 
expressing GFP-LC3. To get enough material for the purification, I seeded the 
cells  from  half a  liver  on  five  625  cm  tissue  culture  plates.  This  equals 
approximately 2.5 x 108  cells in total. The following day the cells were shifted 
to  ES  containing  vinblastine  for  120  minutes  to  induce  autophagosome 
formation. I subsequently generated a PNS and enriched the autophagosomes 
on a nycodenz step gradient as described in Chapter 2.2.8.4. The addition of 
vinblastine  should  ensure  that,  firstly,  autophagosome  formation  is  highly 
induced and secondly, that most autophagosomes are AVis (see Chapter 5.3).
To  verify that  I  had obtained  autophagosomes  and  that  HA-SV-LC3 
localizes to the purified autophagosomes, I collected samples at each step of the 
purification and blotted them against GFP or HA, respectively (Figure 6.3). In 
the PNS I found both GFP-LC3  forms, GFP-LC-I and GFP-LC3-II,  showing 
that autophagy was strongly induced. After the gradient, on the other hand, the 
cytosol fraction (top of gradient) only contained the soluble GFP-LC-I, but no 
membrane  bound  GFP-LC3-II,  while  the  putative  autophagosome  fraction 
contained  only  the  GFP-LC3-II  form,  showing  that  it  is  highly  enriched  in 
autophagosomes. HA-SV-LC3 behaved similarly to GFP-LC3. In the cytosolic 
fraction I  could only find the HA-SV-LC3-I  form while  the  autophagosome 
fraction contained both LC3 forms.
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The fact that HA-SV-LC3-II localized to the same region of the gradient 
as  GFP-LC3-II,  shows  that  HA-SV-LC3  can  bind  to  autophagosomes.  In 
addition, the autophagosome fractions also contained high amounts of HA-SV- 
LC-I. This might be sequestered cytosolic HA-SV-LC3-I, which can be seen on 
the blots, perhaps due to a higher HA-SV-LC3 than GFP-LC3  expression.  In 
addition, HA-SV-LC3-I can also be found in the mitochondrial fraction. It is 
possible  that  some  streptavidin  binds  to  mitochondrial  proteins,  such  as 
monocarboxylate transporter 1  (MCT1), which is responsible for biotin uptake 
into mitochondria (Daberkow et al., 2003). In the mitochondria biotin binds as 
a co-factor to mitochondrial enzymes, such as pyruvate-carboxylase.
In summary these data suggest that HA-SV-LC3 is targeted correctly to 
newly  formed  autophagosomes  and  that  I  can  obtain  highly  enriched 
autophagosomes from cultured primary rat hepatocytes in order to use them for 
the in vitro fusion assays.
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Figure 6.2:  HA-SV-LC3  localizes to autophagosomes. Hepatocytes were 
infected with adenoviruses encoding GFP-LC3  and HA-SV-LC3  and cultured 
overnight. The following day cells were either incubated in FM (A) or ES (B) 
for 120 minutes, before being fixed. HA-SV-LC3 was stained using an anti-HA 
antibody and Alexa555  secondary  antibodies.  Arrowhead  indicates  an 
autophagosome that is GFP-LC3  and HA-SV-LC3-positive.  Arrows indicate 
autophagosomes that contain no detectable HA-SV-LC3. Bar equals 10 pm.Figure 6.3: HA-SV-LC3-II localizes to purified autophagosomes. Isolated 
hepatocytes were infected with GFP-LC3  (upper blot) or HA-SV-LC3  (lower 
blot) encoding adenoviruses and cultured overnight.  The next day cells were 
starved  for  120  minutes  in  the  presence  of 50  pM  vinblastine  and 
autophagosomes were purified as described in Materials and Methods.  1/700th 
or 1/400th, of each fraction was loaded on a SDS-PAGE gel and analysed by 
blotting with either an anti-GFP antibody or an anti-LC3 antibody, respectively.Chapter 6
6.4 Endosome Purification
Having established that HA-SV-LC3 localizes to autophagomes and that 
I  can obtain those  autophagosomes  from  cultured primary rat hepatocytes,  I 
decided to develop a method to generate highly enriched endosome fractions.
I chose to modify a published protocol by Ellis et al. (Ellis et al., 1992) 
for homogenized rat liver, so that I could internalize the fluid phase markers 
biotin-HRP or anti-HA antibody. For this reason I perfused livers of ad-libidum 
fed Wistar rats, continuously for 30 minutes with 50 ml re-circulating perfusion 
buffer, containing either 2 mg/ml biotin-HRP or 0.2 mg/ml anti-HA antibody. I 
then homogenized the liver and separated the endosomes on a continuous 1  % - 
22% Ficoll gradient as described in Chapter 2.2.8.3.
To  identify  the  different  endosomal  population  I  compared  the 
localization of different markers, as well as the internalized anti-HA antibody, 
across the gradient (Figure 6.4 : Endosome purification). Early endosomes were 
identified by the presence of EEA1  and could be found in fractions 27 -  32. 
Late  Endosomes  were  identified  by  the  presence  of the  cation-independent 
Mannose-6-phosphate receptor (CI-MPR)  and Rab7  in the  fractions  19-26, 
while lysosomes, identified by Lamp2, were in fraction 4-9, just above the 
nycodenz  cushion.  The  anti-HA  antibody  was  found  in  all  endosomal 
population after the 30 minute pulse, peaking in fractions 25 -  26. The above 
described  fractions  were  then  collected  and  the  endosomes  were  further 
concentrated by  centrifugation,  before  being  snap-frozen  in  liquid  nitrogen.
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Since the peaks of CI-MPR and Rab7, which should represent late endosomes, 
were slightly shifted I collected the fractions 25 -  26 and 19-24 separately.
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Figure 6.4: Endosome purification (A) anti-HA antibody (0.2 mg/ml) was 
internalized for 30 minutes into perfused liver rat liver. Endosomes were puri­
fied on a  l%-22% Ficoll gradient as described in Materials and Methods.  36 
fractions were collected from each gradient and fractions 4-36 were blotted 
with the following antibodies:  EEAl  (early endosomes),  CI-MPR (TGN and 
late endosomes), Rab 7 (late endosomes),  Lamp2 (lysosomes) and an HRP- 
conjugated anti-mouse antibody to detect internalized anti-HA.  Fractions col­
lected for use in the in  vitro fusion assay are indicated. (B) Refractive Index of 
fractions from endosome preparation gradient.Chapter 6
6.5 Biotin-HRP-based assay
After  I  had developed the  techniques  to  specifically label  and purify 
autophagosomes  and  endosomes,  I  next  wanted  to  establish  a  method  to 
measure the extent of fusion between those compartments.
First, I tested if I could immunoprecipitate HA-SV-LC3 from purified 
autophagosomes (Figure 6.5) as this was a requirement for all the subsequent 
steps.  I  therefore  induced autophagy in HA-SV-LC3  expressing hepatocytes, 
purified autophagosomes as described in Chapter 6.3  and immunoprecipitated 
HA-SV-LC3. As expected from Figure 6.3 I saw two bands one corresponding 
to HA-SV-LC3-I and one to HA-SV-LC3-II in the  10% control lane.  I could 
clearly immunoprecipitate HA-SV-LC3 from purified autphagosomes, showing 
that the HA-SV-LC3 construct can be pulled down using my anti-HA antibody.
Next,  I  wanted  to  test  if  I  could  co-immunoprecipitate  biotin-HRP 
bound  to  HA-SV-LC3.  I  therefore  over-expressed  HA-SV-LC3  in  cultured 
primary rat hepatocytes and generated a PNS. In parallel, I internalized 2 mg/ml 
biotin-HRP  into  cultured  hepatocytes  for  30  minutes,  washed  the  cells  and 
generated a second PNS. The two lysates were mixed and solubilized with 5x 
TNTE to allow internalized biotin to bind to the over-expressed HA-SV-LC3. 
HA-SV-LC3 was then immunoprecipitated with an anti-HA antibody and the 
HRP activity was measured in a spectrophotometer using a colorimetric assay 
(Figure 6.6). As a control I used either lysates from non-infected cells or from 
cells which had not been incubated with biotin-HRP  in the medium.  I  could 
clearly  measure  HRP  activity  in  the  complete  reaction  mix  after  the
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immunoprecipitation. The controls had no HRP activity or a reduced amount of 
HRP  activity,  indicating that biotin-HRP  specifically binds  the  HA-SV-LC3 
construct  and  retains  its  activity  during  the  time  course  of the  experiment. 
Additionally,  the presence of some background HRP  activity in the  controls 
suggest that biotin-HRP either sticks to the beads or the Eppendorf tube.
Since I used detergent-solubilized lysates for the experiments above, I 
next wanted to test if I can co-immunoprecipitate biotin-HRP in a mock fusion 
assay scenario  (Figure  6.7).  Over-expressed HA-SV-LC3  is  largely cytosolic 
and only a comparatively small fraction binds to autophagosomes  (see lower 
blot in Figure 6.3). I anticipated that using purified autophagosomes in contrast 
to  lysates, therefore might potentially result in less biotin-HRP pulled down. 
Thus,  I purified endosomes and autophagosomes,  containing biotin-HRP  and 
HA-SV-LC3, respectively.  I then mixed  100  pi autophagosomes with  100  pi 
late  endosomes  or  lysosomes  with  or  without  cytosol,  and  added  anti-HA 
antibody to pull down biotin-HRP via HA-SV-LC3. To lyse the membranes I 
added 5x TNTE.  Streptavidin-agarose was used to directly pull down biotin- 
HRP.  As  a  control  I  used  10  pi  and  50  pi  late  endosomes  and  lysosomes. 
However,  I  could not measure any HRP  activity when I  immunoprecipitated 
HA-SV-LC3  with  an  anti-HA  antibody  in  the  presence  of  cytosol.  In  the 
samples were I used streptavidin-agarose  a low amount of HRP-activity was 
detected,  approximately a quarter of the  activity in 50  pi  late  endosomes  or 
lysosomes. The HRP activity, pulled down with the streptavidin-agarose from 
the fusion mixture containing late endosomes and autophagosomes, was higher 
when  I  omitted  cytosol,  however,  this  was  not  the  case  when  the  lysosome 
fraction was used.
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These results indicate that under fusion assay conditions, I can not co- 
immunoprecipitate  HRP  activity.  It  is  possible  that  endogenous  biotin binds 
HA-SV-LC3 and thereby at least partially prevents biotin-HRP binding. Using 
streptavidin-agarose instead, I could pull down some internalized HRP activity 
in the presence of cytosol, but even then it was only about 12% of the activity 
present in the total,  suggesting that most internalized biotin-HRP does either 
not bind the added streptavidin, possibly due to endogenous biotin, or because 
HRP loses its enzymatic activity during the pull down, which, however, seems 
unlikely.  Together  these  results  suggest  that  the  biotin-HRP/HA-SV-LC3 
system may not suitable for an autophagosome -  endosome fusion assay.
182Figure 6.5:  HA-SV-LC3 can be immunoprecipitated. Hepatocytes were 
infected for 2 hours with adenoviruses encoding HA-SV-LC3 and cultured over 
night. The following day autophagosomes were isolated and HA-SV-LC3 was 
immunoprecipitated from 300  pi  autophagosomes with anti-HA antibodies, 
bound to protein-G, and blotted for LC3.+  +  +  HA-SV-LC3
+  -  +  +  bHRP
+  +  -  +  anti-HA
Figure 6.6:  HA-SV-LC3 pulls down biotin-HRP from lysates. Hepatocytes 
expressing HA-SV-LC3  were used to prepare a PNS.  In addition, 2  mg /ml 
biotin-HRP were internalized into a second culture of hepatocytes for 30 min­
utes before the cells were used to generate a PNS.  Equal volumes of both 
lysates were mixed in the presence of anti-HA, protein-G beads and 5x TNTE 
and incubated for 2 hours at 4° C on a rotator. Beads were washed 3 x in PBS 
and HRP activity was measured in as described in Materials and Methods. As 
controls either the HA-SV-LC3  lysate or the biotin-HRP lysate were replaced 
with lysates from uninfected hepatocytes or the anti-HA antibody was omitted. 
Data is the average of two replicates.0.4-
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Figure 6.7:  HRP activity can  not be pulled down in  a  mock fusion assay. 
biotin-HRP was  internalized  into  rat liver and  late  endosomes (LE)  and 
lysosomes (LY) were isolated as described in Materials and Methods. In paral­
lel  autophagosomes  (AVs)  were  purified  from  HA-SV-LC3  expressing 
hepatocytes.  100 pi of the different endosomal populations were mixed with 
100 pi autophagosomes in the presence or absence of 100 pi rat liver cytosol 
(20 mg/ml) and 5x TNTE to lyse all membranes. The mixture was then incubat­
ed for 2 hours at 4° C on an end over end rotator with either anti-HA antibody 
and protein-G sepharose or SV-agarose beads. The beads were washed 3x with 
PBS and HRP activity was measured.  As a control we measured  the total HRP 
activity from 10 pi and 50 pi late endosomes or lysosomes. Data is the mean of 
two replicates.Chapter 6
6.6 HA-antibodv based assay
Since the biotin-HRP based assay turned out to be problematic I decided 
to try an alternative approach. Instead of internalizing biotin-HRP I internalized 
0.2  mg/ml  anti-HA  antibody  into  rat  liver  and  subsequently  purified  the 
different endo-lysosomal populations (see also Figure 6.4). If autophagosomes 
and endosomes fuse, I should be able to immuno-isolate the anti-HA-HA-SV- 
LC3 complex and detect it by immunoblotting with an anti-LC3 antibody.
First,  I  tested  if the  amount  of antibody  and HA-SV-LC3  present  in 
endosomes  and  autophagosomes  is  sufficient  to  generate  a  signal  after  an 
immunoprecipitation (Figure 6.8). I therefore mixed 100 pi late endosomes or 
lysosomes,  containing  internalized  antibody,  with  100  pi  autophagosomes, 
containing HA-SV-LC3.  In addition,  I  added TNTE  to lyse the vesicles  and 
allow content mixing. This mixture was incubated at 4 °C for 2 hours in the 
presence of protein-G sepharose beads, before the beads were washed 3x with 
PBS and bound protein was eluted by boiling in sample buffer and analysed by 
immunoblotting with an anti-LC3 antibody. The amount of antibody present in 
late endosomes and lysosomes was clearly high enough to immunoprecipitate 
HA-SV-LC3 from autophagosomes. However, the HA-SV-LC3 signal obtained 
from the lysosomes was much lower than in the late endosomes. This was also 
apparent  in  the  controls  that  were  not  immunoprecipitated,  however,  the 
difference  between  the  late  endosome  and  lysosome  sample  was  less 
pronounced (lanes 2 and 3 vs. 5 and 6, Figure 6.8). It is possible that HA-SV- 
LC3,  as  well  as  the  anti-HA  antibody,  are  being  partially  degraded  by
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lysosomal enzymes after the addition of TNTE, which then results in a loss of 
signal. This is a potential problem for the in vitro fusion assay as it can make 
the assessment of the fusion efficiency difficult. For this reason I decided to add 
lysosomal protease inhibitors to the next experiment.
With my preliminary data suggesting that the read out of the assay is 
working,  I  then  carried  out  an  in  vitro  fusion  assay.  I  therefore  isolated 
autophagosomes  from  HA-SV-LC3  expressing hepatocytes  and  purified  late 
endosomes,  containing  internalized  anti-HA  antibody.  The  two  vesicle 
populations were mixed in the presence of cytosol, ATP-regenerating system 
and  HA  peptide,  in  order  to  block  the  antibodies  released  from  broken 
endosomes (Figure 6.9).
The  reaction  was  subsequently  incubated  at  37  °C  or  4  °C  for  45 
minutes, followed by the addition of TNTE and protein-G beads to pull down 
HA-SV-LC3.  Fusion was analysed by immunoblotting the immunoprecipitate 
with an anti-LC3 antibody. Fusion was sensitive to temperature; no LC3 was 
detected when samples where incubated at 4 °C, suggesting that fusion did not 
occur. In addition, effective fusion was dependent on cytosol. However, fusion 
occurred efficiently in the absence of an ATP-regenerating system.  This was 
unexpected since fusion between late endosomes and lysosomes, for instance, 
requires ATP (Mullock et al., 1994). It is however conceivable that the desalted 
cytosol still contained trace-amounts of ATP, sufficient to drive fusion. If this is 
the  case,  addition of apyrase,  an ATP  diphosphohydrolase,  could be used to 
efficiently deplete ATP.
As a additional control I omitted the HA peptide in the reaction mix. 
This should give the strongest possible signal after the detergent lysis and the
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immunoprecipitation  and  should  therefore  constitute  “100  %  fusion”. 
Unexpectedly,  this  did  not  lead  to  an  increase  in  the  amount  of 
immunoprecipitated  HA-SV-LC3,  suggesting  that  the  amount  of  anti-HA 
loaded endosomes was limiting.
In summary, these results suggest that in vitro reconstitution of fusion 
between autophagosomes and endosomes may be possible. Using internalized 
anti-HA  antibody  and  HA-SV-LC3  as  markers  for  endosomes  and 
autophagosomes,  respectively,  I  could immunoprecipitate  HA-SV-LC3  when 
the two vesicle populations were incubated at 37 °C in the presence of cytosol 
and ATP regenerating system. Cytosol was required for the effective meeting of 
the two markers. Omitting the ATP regenerating system unexpectedly had no 
influence on the meeting of the markers.  Together these data suggests that I 
have developed an in vitro fusion assay which is suitable, once optimized, to 
analyse  autophagosome  fusion  and to  first,  identify  the  fusion  partner(s)  of 
autophagosomes and second, identify the proteins regulating fusion.
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Figure 6.8:  Anti-HA antibody internalized into endosomes  can  immuno­
precipitate HA-SV-LC3 from purified  autophagosomes.  Autophagosomes 
(AVs) were purified from HA-SV-LC3 expressing hepatocytes and 100 pi were 
mixed with either 100 pi late endosomes (LE) or 100 pi lysosomes (LY), con­
taining internalized anti-HA antibody and protein-G sepharose beads (lanes 5 
and 6).  Membranes were lysed by the addition of 5  x TNTE.  Samples were 
incubated for 2  hours at 4° C on a rotator and the immunoprecipitate was 
washed 3 x with PBS and analysed by immunoblotting with an anti-LC3 anti­
body. As a control 50 pi AVs (lane 1) or 50 pi of mixed AVs + late endosomes 
(lane 2) or lysosomes (lane 3) were loaded. Additional controls included pro­
tein-G sepharose beads alone (lane 4) and immunoprecipitations from  100  pi 
AVs or LE or LY with protein-G sepharose beads (lanes 7-9). (I) HA-SV-LC3-I, 
(II) HA-SV-LC3-II, (US) indicates unspecific band, which most likely is pro­
tein-G eluted from the sepharose beads.A
Mr(k) 
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Figure 6.9:  Late endosomes and autophagosomes  fuse  in  a  temperature 
and cytosol dependent manner. A) In vitro fusion assay between purified late 
endosomes, containing anti-HA antibody and autophagosomes purified from 
HA-SV-LC3  expressing hepatocytes.  Endosomes  were pelleted and either 
resuspended in rat liver cytosol or in STM buffer.  100  pi endosomes were 
mixed with  100  pi autophagosomes, 25  pi HA-peptide (1  mg/ml)  and  10  pi 
ATP regenerating system, containing GTP  (lane A and B). In control samples 
either the ATP regenerating system, the cytosol or the HA-peptide was replaced 
with STM buffer or water (lane B to E). The reactions were incubated either at 
37 °C or 4 °C for 45 minutes before the addition of protein-G sepharose. The 
samples were analysed by immunoblotting with an anti-LC3 antibody. (*) 30% 
autophagosomes. As a control, parallel complete samples, incubated at 37 °C or 
4  °C, were loaded directly without prior immuno-precipitation (20% of total 
reaction)  (lane  F  and  G).  B)  Densitometric  quantification  of both 
immunoprecipitated HA-SV-LC3  (I and II) bands from (A) with ImageJ soft­
ware. Bars are the average of 2 replicates. (I) HA-SV-LC-I, (II) HA-SV-LC3-II, 
(US) non-specific band.
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6.7 Concluding Remarks
There are several important points regarding the progress I have made 
so  far in establishing  an  in  vitro  fusion assay  for autophagosome-endosome 
fusion.  Initially,  I  wanted to base the  assay  on  the markers biotin-HRP  and 
avidin or HA-SV-LC3. However, this turned out to be problematic for several 
reasons.  Although  I  were  able  to  purify  autophagosomes  from  avidin 
expressing hepatocytes, I found that avidin over expression was toxic for these 
cells. HA-SV-LC3 over expression, on the other hand, did not seem to have any 
effect on the viability of the cells. However, when I tried to pull down biotin- 
HRP  via HA-SV-LC3  I  would  only  get  low  or no  HRP  activity  at  all  (see 
Figure 6.7). To ensure that the low signal was not due to a loss of HRP activity 
during  the  time  course  of the  experiment,  I  measured  the  HRP  activity  in 
endosomes directly (Figure 6.7). The results clearly showed that although there 
was strong HRP activity present in the endosomes, I was not able to pull down 
a significant amount of this activity, suggesting that the binding of biotin-HRP 
to  HA-SV-LC3  is  impaired.  Several reasons  are  feasible  for this.  Liver is  a 
tissue with high biotin levels.  It is therefore possible that endogenous biotin 
binds  to  most  of  the  newly  synthesized  HA-SV-LC3,  thereby  making  it 
unavailable  for binding  biotin-HRP.  I  thus  tried to  grow  the  hepatocytes  in 
biotin-free growth medium, however, this did not improve the binding between 
biotin-HRP and HA-SV-LC3 (data not shown). Alternatively, it is possible that 
streptavidin can not bind biotin so well because it is tagged on both sides with 
HA and LC3, or that the amount of HA-SV-LC3, present in autophagosomes, is 
too little to pull down significant amounts of biotin-HRP. The latter is unlikely,
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however,  because  using  streptavidin-agarose  beads  and  unlabeled 
autophagosomes,  instead  of HA-SV-LC3  containing  autophagosomes,  only
aL
approximately 1/8  of the total HRP activity present in endosomes was bound 
(Figure 6.7). The binding capacity of the streptavidin-agarose beads for biotin, 
should have been large enough to pull down all of the biotin-HRP present in the 
endosomes, assuming that there is no endogenous biotin present.
Having been unable to establish a read-out using biotin-HRP and HA- 
SV-LC3 for my proposed fusion assay, I decided to try an alternative approach. 
Instead  of biotin-HRP  I  internalized  anti-HA antibody into  endosomes.  This 
approach  proved  to  be  more  promising  because  I  could  immunoprecipitate 
enough  HA-SV-LC3  with  the  anti-HA  antibody  to  detect  the  LC3  by 
immunoblotting the precipitates with an LC3 antibody (Figure 6.8). After those 
initial  and  encouraging  results,  I  performed  a  fusion  assay  between 
autophagosomes  purified  from  HA-SV-LC3  expressing  hepatocytes,  which 
have  been  starved  in  ES  in  the  presence  of vinblastine,  and  purified  late 
endosomes, containing internalized anti-HA antibody. I could show that the two 
markers for endosomes and autophagosomes met in a temperature and cytosol 
dependent manner, suggesting that I was observing vesicle fusion in this assay. 
Unexpectedly, however, omitting the ATP-regenerating system had no effect on 
the meeting of the markers. This could either mean that the in vitro fusion is 
independent of ATP or alternatively, that some ATP remained in the cytosol 
despite it being desalted on PD-10 columns prior to the assay. A possible way 
to  overcome  this  problem  would  be  to  add  apyrase  to  the  fusion  assay  to 
completely deplete any ATP left in the cytosol
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In summary these preliminary results suggest that I have established an 
in vitro fusion assay. The development of this assay is still at an early phase and 
the assay is not optimized. In particular, the lack of effect after omission of the 
HA-peptide  suggests  that  the  amounts  of autophagosomes,  endosomes  and 
buffer  used,  have  to  be  titrated.  In  addition  controls  such  as  electron 
microscopy to assess the fusion will be necessary. It is feasible that once all the 
controls have been carried out, it will be possible to use this assay to identify 
the fusion partner(s) of autophagosomes and to determine which proteins are 
required  for autophagosome  fusion,  such  as  SNAREs  and  Rab  proteins  and 
other proteins potentially regulating the fusion between autophagosomes  and 
endosomes.
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7  CONCLUDING REMARKS
Although autophagy was observed the first time at least 45 years ago, 
there  is  still  much  to  be  discovered  about  the  molecular  details  of 
autophagosome  formation  and  fusion.  Details  about the  signalling  pathways 
leading to autophagosome formation have only recently begun to be uncovered. 
On a molecular basis, some of the unanswered questions asked in the field are, 
where autophagosomes originate from, which signalling pathways are involved 
in the formation, and how autophagosomes interact with the endosomal system.
In this thesis I have tried to address some of these questions using an 
experimental system based on cultured primary rat hepatocytes.  Here I  show 
that hepatocytes are amenable to genetic manipulation using adenovirus-based 
transduction  methods.  To  accurately  measure  autophagosome  formation  and 
fusion  in  fixed  and  live  cells  I  have  developed  a  light-microscopy  based 
quantification system.
I could show that autophagosome formation in primary hepatocytes is 
independent  of  mTOR  and  can  be  efficiently  inhibited  by  leucine  alone, 
possibly through a novel plasma-membrane receptor. This might indicate that 
several signalling pathways are triggered simultaneously to induce autophagy. 
mTOR  is  undoubtedly  involved  in  autophagy  in  many  cell  types,  but  the 
relative importance in relation to other signalling pathways might be different 
in different cell types and depend on cell and tissue specific protein expression 
patterns.
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Additionally, I investigated the role of microtubules for autophagosome 
formation and fusion, a topic which has been discussed controversially in the 
literature.  I  found that microtubules  facilitate  autophagosome  formation  and 
that they are absolutely required for fusion.
Finally, I developed an in vitro fusion assay, with the aim to understand 
autophagosome  maturation and  in particular to  identify  and  characterize  the 
protein-machinery required for the fusion of autophagosomes with endosomes. 
The development of the assay has reached the stage, where I can reconstitute 
fusion  in  a  cytosol  and  temperature  dependent  manner.  Once  it  has  been 
optimized,  the  assay  will  undoubtedly  be  useful  to  study  autophagosome 
maturation in vitro.
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